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ABSTRACT 
 
While numerous treatments exist to manage diabetes, adherence to guideline-
recommended medications remains suboptimal. Both tailoring health messages and text 
messaging have been observed to improve medication adherence, but analysis of their combined 
effect is limited. This study aimed to (1) construct a library of and successfully deliver condition 
and treatment-related tailored text messages to influence medication-taking behavior among 
adults with diabetes and (2) assess the effect of tailored text messages on diabetes-related health 
beliefs, technology acceptance, and diabetes medication adherence between patients receiving 
tailored text messages and standard care alone. 
Adults with uncontrolled diabetes were recruited from a western Michigan health system 
and randomized into two study arms where subjects received either a daily tailored text message 
or standard care for 90 days. Self-Determination Theory and the Health Belief Model guided 
message development and a library of 168 theory-driven and 128 medication-specific tailored 
messages were developed and formatted for automated delivery to mobile phones. An algorithm 
was applied to determine the order and timing of messages with the aim of progressively 
influencing diabetes-related beliefs affecting adherence to medication. Baseline responses to a 
survey instrument were used to establish the series of tailored messages for each participant. 
Changes from baseline in mean responses to seven theory-driven items and medication 
adherence were evaluated using endpoint surveys and pharmacy claims data, respectively. Four 
survey items captured technology acceptance and personal interviews were conducted after the 
intervention. 
A total of 48 subjects were randomized into two cohorts. The receipt of a daily tailored 
text message was well accepted by intervention subjects and most were interested in continuing 
xv 
 
to receive similar messages. Adjusted analysis indicated there were no statistically significant 
differences between groups in the seven theoretical concepts resulting from the intervention; 
however, changes for most constructs were in the desired direction for intervention subjects. 
Similarly, no statistically significant changes in adherence to diabetes medications were observed 
between or among cohorts after the three-month intervention, and mean adherence values 
declined over nine months.  
The tailoring of diabetes-specific text messages remains an area of opportunity to 
improve medication adherence and provide motivation to adults with diabetes but larger studies 
are needed to fully understand their effectiveness. 
1 
 
 
 
CHAPTER I. LITERATURE REVIEW AND BACKGROUND 
 
The former United States Surgeon General, Dr. C. Everett Koop, once stated that, “Drugs 
don’t work in patients that don’t take them.” Although obvious in its observation, this statement 
sheds light on an issue that has challenged patients and providers alike: a limit of medicinal 
therapy is the extent by which patients follow what was prescribed. Years later, medication 
nonadherence remains a prevalent issue, impacting the effectiveness of a variety of medications, 
both for acute and chronic use, in spite of the mounting evidence connecting high rates of 
adherence to improved outcomes.
1
  
This chapter begins by providing an overview of medication adherence with a specific 
focus on contributing factors and the extent of this issue in patients with diabetes. Next, it 
examines what has been attempted by researchers to address nonadherence by describing 
interventions focused on diabetes, how tailoring has been applied to improve medication use, and 
how mobile devices have been leveraged to date to improve adherence across conditions. 
Finally, the need for an intervention using tailoring and mobile communication is synthesized 
from what is currently understood, the theoretical foundations upon which this study were 
designed are outlined, and the aims and related hypotheses are described. 
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Medication Adherence 
 
Defining Adherence 
 
Adherence is generally defined as the extent to which patients take medications as 
prescribed by their health care providers.
2
 At one point, the term ‘compliance’ was used to 
describe this behavior but has been replaced by ‘adherence’, a concept implying a more 
collaborative process and one that attempts to move away from the stigmatization of behavior as 
deviant or placing blame on the patient.
3
 This transition further suggests a communicative 
process between providers and patients, stressing agreement on the treatment approach that 
places the patient at the center of the plan.  
 The extent of adherence is generally reported in a fashion indicative of the metric used to 
capture the behavior, meaning our interpretation of adherence may change based on how we 
measure medication use; however, we typically see adherence described on a continuum from 0 
to 100 percent or dichotomized as adherent or not. The latter tends to provoke the most 
controversy since no gold standard exists to define the point at which one is definitively 
considered adherent, although a generally accepted value is 80 percent.
4
 This value has 
repeatedly been applied in studies in order to compare outcomes between patients who are 
categorized as either high or low adherers. Multiple studies have supported this delineation by 
demonstrating a connection between lower adherence to chronic disease treatment and poorer 
health outcomes.
5-8 
 Properly defining what it means to be adherent, however, must be further differentiated 
by the stage of treatment in order to be fully understood as it encompasses a range of medication-
taking behaviors over time. This process begins at the point of prescription where the health care 
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provider and patient initially decide upon a particular avenue of treatment for one or more 
conditions. ‘Primary nonadherence’ is then a patient’s delay or failure to fill a prescription when 
first written.
9
 Relatively little is known about the extent of this problem as significant 
investigations of this portion of adherence are lacking. A major hindrance to studying primary 
non-adherence is the difficulty associated with tracking initial fill rates as well as the historical 
methods by which prescriptions have been written. The recent increase in the use of electronic 
prescribing (e-prescribing), however, has improved the availability of usable data. A recent 
database analysis of e-prescribing in a community setting found that 28% of prescriptions for 
newly prescribed medications were never filled.
10
 Other studies have employed survey methods 
in an attempt to capture this behavior with non-adherence estimates ranging from 4% to 
31%.
9,11,12
 Regardless of the methods employed, results consistently remind the health 
community that the initiation of medicinal treatment remains problematic, placing patients whose 
need for therapy has been identified at risk of further complications by foregoing treatment. 
 Once the prescription has been received the issue of adherence turns to the regular 
medication-taking behaviors of patients as instructed by their provider. This includes taking the 
medication(s) as scheduled, as directed, at the correct dosage, and while avoiding potentially 
dangerous concomitant drug usage. Arguably, this is the central element of treatment adherence- 
the repeated and direct taking of medication. While the proper execution of such a prescribed 
procedure in the course of treating chronic conditions may be done countless times, this behavior 
is also the most difficult to accurately measure- even direct methods, such as patient observation 
and blood levels can be misleading. Truly reliable methods of capturing when and how patients 
take individual medications, and how closely that resembles the initial directions, have proven 
challenging: both remote monitoring and self-report approaches have been employed, but either 
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lack clear precision in capturing medication-taking behaviors or are significantly biased.
4
 Self-
reported estimates rely on carefully crafted survey instruments, diaries, or pill counts to evaluate 
or record behavior, all of which depend heavily on patient recall and honesty in reporting. The 
use of diaries or requesting pill counts can be problematic since they can be easily altered but 
instruments, such as the Morisky Scale and the Adherence Estimator, have proven to be reliable 
mechanisms of measuring or predicting medication use.
13,14
 However, while convenient and 
economical to implement, such approaches may introduce significant bias to the estimates due to 
recall and the propensity to report socially acceptable responses.
15
  
Alternatively, electronic monitoring of adherence, while precise, is currently 
prohibitively expensive for widespread use and leaves patients aware that they are being 
monitored. Additionally, as with retrospective assessment through surveys or pill counts, the 
actual ingestion of medication cannot be discerned. A recent review of adherence in the past 50 
years compared measures of medication-taking behavior and found that a majority of studies 
employed subjective methods (such as self-report), but, more importantly, that the methods 
employed to measure adherence can impact the results. The average percent adherent was similar 
between electronic (69.0) and self-reported (71.8) means; pill counts reported the highest average 
percent adherent at 85.1%.
16
 Considering the inherent flaws of each approach, however, a 
combination of measures is recommended. 
 Beyond the regular behavior of taking medication, adherence also encompasses a more 
global definition of behavior, particularly in chronic disease. Properly addressing chronic disease 
requires both regular and continued medication delivery; thus, ‘persistence’, or the extent by 
which a patient remains on therapy over time, is equally important to the treatment process. 
Refill rates, often provided by pharmacy claims databases, are a commonly used means of 
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evaluating this ongoing medication-taking behavior, assessing the percentage of days (either as a 
percent of days covered [PDC] or as a medication possession ratio [MPR]) for which the patient 
had been provided treatment. Numerous analyses across a variety of chronic conditions have 
determined that adherence at this level is suboptimal, observing significant stoppages in therapy 
as early as one to three months post-initiation.
8,17,18,19
 Regardless of the point at which 
medication-taking behavior deviates from what has been prescribed or the means by which this 
behavior is measured, nonadherence requires significant attention from the healthcare 
community in order to curb the impact it may have on treatment outcomes. The extent of this 
issue is outlined in the following section. 
 
Adherence Landscape 
 
As a whole, adherence is a widespread issue: the World Health Organization has 
suggested that adherence to medications for chronic conditions averages 50% in developed 
nations.
20
 In the United States, medication nonadherence plagues the healthcare system with 
avoidable costs and, more importantly, detrimental health outcomes. Recent estimates suggest 
that medication non-adherence adds $290 billion in annual avoidable costs and contributes to 
significant, adverse clinical outcomes, including 10% to 25% of all hospitalizations and nursing 
home admissions and 125,000 deaths each year.
21,22
 A survey conducted by the National 
Community Pharmacists Association identified the extent of the problem at the patient level, 
polling specific medication-taking behaviors. Findings indicated that approximately three out of 
four American consumers reported not taking their prescription drugs, as directed, to some 
extent; specifically, 31% had not filled a prescription they were given, 29% stopped taking a 
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medicine before the entire supply had been exhausted, and 49% had forgotten to take at least one 
dose.
11
  
Additionally, estimates of those remaining adherent to long-term medication regimens in 
the United States has been suggested to range from 17% to 80%.
1
 The landscape for adherence in 
specific chronic diseases is diverse. Estimates suggest that 9% to 47% of patients on therapies to 
control hypertension are non-adherent, the variation due to the methods employed to measure the 
behavior- electronic versus self-report.
19
 Similarly, across multiple studies, approximately half of 
patients on lipid-lowering agents were adherent according to generally accepted thresholds.
23
 
Moreover, adherence to medications prescribed for asthma and osteoporosis have been reported 
to be 39% and 60%, respectively.
24,25 
 The landscape of nonadherence is especially concerning in diabetes. A disease whose 
prevalence continues to rise at alarming rates, diabetes remains a growing public health threat in 
the United States.
26
 Current estimates suggest the number of Americans diagnosed with diabetes, 
and the costs required to treat these patients, will more than double in the next 25 years;
27
 the 
cost to treat this condition is already approaching $200 billion per year.
28
 Nonadherence to 
diabetes medications complicates this economic issue, but, more importantly, places patients 
with diabetes at an increased risk of detrimental health outcomes.
7 
 Numerous investigations have studied the extent of medication nonadherence in diabetic 
populations throughout the United States, considering how these patients adhere to both oral 
medications and insulin. A systematic review of studies from 1966-2003 highlighted medication-
taking in both of these classes and incorporated both retrospective and prospective analyses. 
Cramer (2004) found that overall adherence to oral medications ranged from 36% to 93%, for 
patients completing at least six months of initial therapy, when examined retrospectively.
29
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Moreover, this review observed that adherence to insulin therapy—in patients with type 2 
diabetes—was consistently suboptimal, ranging from 62% to 64%.29 These results highlighted 
both the wide range of nonadherence rates throughout earlier observations of diabetic medication 
use as well as the differences in the manner by which patients take difference classes of diabetes 
medications.  
A more recent review of studies examining adherence to diabetes medication, spanning 
investigations from 1990 to mid-year 2007, found similar variability of results. Odegard and 
Capoccia (2007) reviewed 36 published articles, 28 of which focused on retrospectively or 
prospectively assessing medication adherence in patients with either type1 or type 2 diabetes (the 
remaining studies were active interventions).
30
 Adherence rates were found to vary from 31% to 
87% in retrospective studies and from 53% to 98% in prospective studies.
30
  
 Despite the reported range of adherence rates across studies reviewed, average measures 
of adherence in patients with diabetes have been fairly consistent. Examining studies between 
2000 and 2005, Cramer and colleagues (2008) found that average 12-month MPRs were 
approximately 76% for patients on oral therapy.
23
 Similarly, Yeaw and colleagues (2009) 
reported average 12-month adherence rates of 72% when analyzing oral medication use over a 
one-year aggregation of health plan claims data.
25
 While these reports give us a robust estimate 
of diabetes medication use, they all share a common theme: adherence to these medications is 
suboptimal.  
Data from multiple studies have suggested that improved medication use in patients with 
diabetes can be tied to lower levels of circulating blood glucose. Krapek and colleagues (2004) 
demonstrated a connection between levels of self-reported adherence (4-item Morisky score) and 
lower hemoglobin A1c for both oral medications and insulin.
31
 Similarly, Pladevall and 
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colleagues (2004) observed that a 10% reduction in adherence led to a 0.14% increase in 
hemoglobin A1c (A1c).
32
 More recently, Rhee and colleagues (2005) found that achieving an 
adherence level of at least 75% led to a reduction in A1c of at least 1%; a reduction of 0.35% 
was associated with each increase in adherence of 25%.
33
 Differences in resource utilization and 
healthcare costs have also been tied to varied levels of adherence. Hepke and colleagues (2004) 
found that higher levels of adherence led to decreased medical costs as well as fewer emergency 
room visits and inpatient admissions.
34
 More recently, Ho and colleagues (2006) observed that 
patients with diabetes not achieving an adherence level of at least 80% were associated with 
more hospitalizations and all-cause mortality.
8
 Resultantly, more must be done to better 
understand what leads to nonadherent behavior and how we may better influence medication-
taking so that more patients can be put on the path to improved outcomes. Observations from 
previous studies help us understand what contributes to ongoing medication use and these are 
outlined below.  
 
Contributing Factors 
 
Beyond describing the prevalence of the issue, research focusing on medication 
adherence has also extensively studied the individual factors that have a significant impact on 
this behavior. By and large, adherence has been described as a multifaceted issue where a 
combination of factors contributes to the ultimate behavior. While varied, these influences may 
be grouped according to their place within the process of care and the following five sections 
give an overview of influencers, closing with what has been observed to influence medication-
taking in diabetes. 
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Socioeconomic Factors 
 
As is the case for access to care and treatment outcomes, disparities due to patient 
demographics have been found to play a role in medication non-adherence. Over the course of 
numerous studies a variety of characteristics have been analyzed, most leading to either varied or 
conflicting results. Traits such as age and ethnicity have included either results of no effects or 
findings in one direction: older patients
35-37
 and Whites
38,39
  tended to have improved adherence 
compared to younger or minority patients, respectively, if a significant effect was observed. 
Mixed findings have been reported for a number of characteristics, including educational-
level,
38,40,41
 gender,
35,42,43
 and marital status,
37,44,45
 suggesting that the impact of these factors is 
yet conclusively undetermined. Several socioeconomic factors, however, have been found to 
consistently affect adherence to medication. Over multiple studies, patients with health insurance 
as well as those with an established support structure have been connected with improved 
medication adherence.
1
  
 
Condition and Medication-specific Issues 
 
Central to the discussion of medication adherence as a whole are the conditions being 
treated and the medicinal therapies chosen to address them. The complexity of prescribed 
treatment regimens—addressing issues such as the number of medications and doses required—
has repeatedly been connected with poorer adherence as the complication of the regimen 
increases.
46,47,48
 Considering the rate at which the number of medications has observed to 
increase with age, this is particularly problematic in managing chronic disease. Similarly, 
embarrassment or the inconvenience of therapy has also been found to reduce adherence, 
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suggesting that significant stigma may be attached to particular forms of therapy, ultimately 
leading to problematic levels of medication-taking behavior.
49-51
 Additionally, fear of side 
effects, even as medications have become safer, remains a prevalent issue and one that 
negatively impacts adherence to prescribed regimens.
52-54
 Likewise, if patients are unaware of or 
believe that a treatment effect is not being realized then subsequent medication-taking behavior 
may suffer.
55
 Also, the cost of the medications themselves is a significant deterrent to adherence 
in patients both with and without adequate prescription drug coverage. Analysis of patient 
populations across a range of out-of-pocket medication expenses has demonstrated that 
adherence suffers as prescription drug cost-sharing increases.
56-58
  
 Disease-related factors have also been shown to play a role in the medication-use process. 
Both the number and even a lack of symptoms connected to the disease(s) being treated 
significantly impact adherence to the prescribed medications.
37,59
 Studies examining the severity 
of disease have produced mixed effects on medication adherence, suggesting that such a 
connection may be condition-specific or rely on the presence of other factors.
44,60
 Additionally, 
the extent to which the patient is knowledgeable about their condition has been shown to affect 
the degree to which they remain adherent to their prescribed therapy, but conclusive evidence of 
the direction is still yet undetermined.
37,50 
 
System-level Effects 
 
Several characteristics of the health system at large have been observed to affect the 
manner in which patients take their medications. Multiple studies have demonstrated that the 
patient-physician relationship is a particularly strong predictor of adherence: supportive and 
positive relationships with healthcare providers, where a significant level of trust has been 
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established, are more likely to lead to improved adherence.
61-63
 Further, the regularity with which 
patients are seen by their physicians also has been connected with higher rates of adherent 
behavior.
40,50
 Relationships with healthcare providers other than physicians have been shown to 
affect adherence. The Federal Study of Adherence to Medications in the Elderly (FAME) 
demonstrated the impact the pharmacists may have on medication-use behaviors, suggesting that 
pharmacists take a more active role in encouraging adherence to prescribed treatment regimens.
64
 
Collectively, these findings suggest that effective communication and interaction with patients is 
an important mechanism through which a number of other factors known to influence adherence 
may be addressed. 
 
Patient Behaviors and Psychological Status 
 
The regular and ongoing taking of medications has also been studied with a host of 
patient behaviors and attitudes in mind. Among this list of contributing factors, several have 
emerged as the most prominent and significant. The subject of numerous adherence 
interventions, forgetfulness has become a plague on adherent behavior, contributing to declines 
in the regular medication-taking performance of many patients, potential solutions for which 
have been addressed from multiple angles with limited success.
51,52,65
 Adherence also suffers due 
to the comorbid presence of psychological disorders, primarily depression,
66-68
 but other 
conditions, such as bipolar disorder,
69
 have been observed to negatively impact the ongoing 
taking of medications. Additionally, impaired cognitive function, independent of age, has also 
been tied to decreases in adherent behavior. Conversely, favorable mood attributes, such as a 
positive attitude or a ‘fighting spirit’, have been shown to improve adherence to medications.52, 
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Factors Influencing Adherence to Diabetes Medications 
  
Considering the complexity of treating, prevalence of, and known level of nonadherence 
related to diabetes, numerous studies have sought to uncover the barriers to and influential 
factors of medication taking in patients with this condition. A recent review of 36 studies 
published between 1990 and 2007 synthesized the most common influencers of diabetes 
medication nonadherence. Odegard and Capoccia (2007) found that the most often cited issues 
included: the complexity of the regimen, dosing frequency, product education, cost, self-
confidence, depression, and experiencing or a fear of adverse effects.
30
 Beyond those most 
commonly cited a host of additional patient factors were described that had been observed in 
previous investigations. These included condition-related fears (disease severity, needles, stigma, 
and weight gain), self-efficacy, remembering doses, education, and health beliefs. Additional 
barriers identified by adherence studies include patients’ health beliefs,71 reading the medication 
label,
72
 and issues with taking the medications as well as understanding the need for ongoing 
medication use.
73
 Such variety in the reported barriers to medication adherence in diabetes 
suggests that multiple angles must be taken to address this issue and need to consider challenges 
including, but not limited to, regimen complexity, self-efficacy, and patient education.  The 
following section examines what has been attempted in interventions aimed at improving 
medication taking in patients with diabetes. 
 
Interventions to Address Medication Nonadherence in Diabetes 
 
 Multiple studies have aimed to curb the problem of medication nonadherence in patients 
with diabetes using a variety of approaches. Results have been varied but provide guidance for 
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future studies with a similar aim in mind. Table 1.1 provides an overview of the methods and key 
results observed in these investigations and this section provides highlights from these 
investigations. 
 Of those reviewed, the studies ranged in length from as little as three months to as long as 
three years in terms of an active intervention. Most used standard care as their comparison; 
however, active controls were used in several cases which included the use of nurse 
management, lowered medication coinsurance, or educational materials; only two studies lacked 
a specified control group of patients. To assess the impact of each intervention on medication 
use, a range of approaches were applied by study investigators to measure medication adherence. 
The most commonly used metrics were either self-reported measures or MPR/PDC, but other 
approaches included adherence scores (e.g. Morisky), visual analog scales, active monitoring 
through MEMS caps, or simple counts of refills over the course of the study. While these studies 
all included patients with established diabetes, several studies limited their adherence analysis to 
medications other than those indicated for diabetes, examining the indirect effects that 
medication-taking in this condition may have on other concomitant disorders (e.g. depression). 
Additionally, both type 1 and type 2 diabetes were represented across these trials and both 
adolescent and adult patients were the focus. The most commonly applied method of intervention 
was contact from a healthcare provider (nurse, physician, or pharmacist) involving either 
adherence support, counseling, coaching, or care plan follow-up. Disease management, either 
through case managers, pharmacists (with or without MTM services), or nurses, was common or 
could have been either in-person or over the phone. Other commonly applied methods of 
behavior change included reminders, family or community–based programs, and education. The 
majority of these studies tested only one interventional approach but several studies either had 
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multiple methods applied to the active arm or had multiple active arms with differing approaches 
being investigated. 
 No single type of approach employed by the included investigations led to consistently 
improved adherence to medications, meaning that both positive and null differences were 
observed across each type of behavioral technique. The results were mostly mixed for trials 
employing simple reminders,
74-76
 condition or treatment education,
77-82
 and family, peer, or 
community-based programs.
80,81,83,84
 However, when limited to pediatric or adolescent patients, 
family-based or combined contact and educational programs did lead to improved adherence 
when compared to standard care.
79,80
  
While no single intervention method was universally successful, two types of behavioral 
approaches did lead to more consistently improved levels of medication adherence: increased 
patient contact and case management. Successful mechanisms of increased contact included the 
application of telephone assessments/follow-up,
85-90
 monitoring,
88
 and adherence support.
89
 Case 
management ventures that proved successful included the use of disease management,
91
 MTM,
90
 
health coaching,
86,92
 counseling,
87
 and simple case management.
78,79
 These results suggest that 
patients with diabetes appear to respond favorably, albeit to a small degree overall, to regular 
interaction with a healthcare provider or case manager, either through direct follow-up or during 
interactive management sessions, at least in terms of improving medication use. Future studies 
should consider incorporating frequent patient contact, either in person or by phone, and leverage 
disease or case management approaches into their mechanisms of behavioral influence in order 
to realize improved results.  
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Table 1.1 Interventions to Improve Medication Adherence in Patients with Diabetes  
First Author, Year Study Population Length Intervention Control Effect on Adherence Limitations 
Smith, 1986 Diabetic patients 
of a university IM 
clinic (N=859) 
7 months Increased contact 
and visits, including 
mailings, phone 
calls, and home 
visits 
Standard care Nonsignificant 
difference in 
prescription refills 
Total fills only, 
no separation of 
effect between 
interventions 
Skaer, 1993 Diabetic patients 
covered by 
Medicaid in South 
Carolina (N=258) 
1 year 3 active arms (all 
included 
pharmaceutical 
care): refill 
reminder, unit-of-
use packaging, or 
both 
Standard 
pharmaceutical care 
All arms improved 
MPR compared to 
control; both 
interventions 
outperformed either 
individual 
intervention 
Generalizability, 
limited to one 
medication 
Piette, 2000 Patients with 
established 
diabetes, <75 
years of age, and 
an active 
prescription for a 
hypoglycemic 
agent (N=248) 
12 months Automated 
telephone 
assessments and 
nurse follow-up 
Usual care Fewer self-reported 
issues with 
medication 
adherence 
3-item self-
reported measure 
of adherence 
Grant, 2003 Adult patients 
with type 2 
diabetes (N=232) 
3 months Pharmacist tailored 
education 
Standard care No difference 
between groups 
(already high) 
Only self-
reported 
measures 
Katon, 2004 Adult patients 
with diabetes and 
major depression 
or dysthymia 
(N=329) 
12 months Enhanced education 
and support from 
case management 
Standard care Improved odds of 
antidepressant 
adherence 
No measures of 
diabetes 
medication 
adherence 
Krein, 2004 VA patients with 
uncontrolled 
diabetes (>7.5%) 
(N=246) 
18 months Collaborative case 
management 
including contact 
and goal setting 
Educational 
materials and 
standard care 
No difference in 
treatment intensity or 
use of other 
medications 
No direct 
measure of 
diabetes 
medication 
adherence 
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Rosen, 2004 Nonadherent 
patients with 
diabetes of a VA 
clinic (N=33) 
4 months Smart Caps 
(MEMS) cue 
training 
Standard care No significant 
differences 
Small sample 
size, singular 
focus, MEMS 
monitoring 
Yopp, 2004 Adolescents with 
type 1 diabetes 
(N=53) 
7 months Home-based 
psychotherapy 
Usual care No difference 
according to the 
Diabetes 
Management Scale 
for insulin; Better 
insulin use according 
to 24-hour recall 
Generalizability 
and conflicting 
results 
Ellis, 2005 Adolescents with 
uncontrolled type 
1 diabetes 
(N=127) 
6 months Intensive, family-
centered, 
community-based 
treatment 
Standard medical 
care 
Nonsignificant effect 
on adherence to 
insulin 
24-hour recall for 
adherence 
Howe, 2005 Ages 1 to 16 with 
uncontrolled type 
1 diabetes (N=75) 
6 months Education only; 
education and 
telephone case 
management 
Standard care Education and 
telephone case 
management 
improved the 
adherence score 
Physician sourced 
measure of 
adherence 
Odegard, 2005 Adult patients 
with uncontrolled 
type 2 diabetes 
taking one or 
more oral 
medications 
(N=77) 
6 months 
active and 
6 months 
follow-up 
Pharmacist-driven 
diabetes care plan 
Normal care with 
the primary 
physician 
Nonsignificant Self-reported, two 
question recall 
used for 
adherence 
Wysocki, 2007 12-17 years, type 
1 diabetes at least 
1 year, and a 
qualifying family 
member (N=104) 
3 months Group educational 
and social support 
meetings; 
Behavioral-Family 
Systems Therapy  
Current therapy Behavioral-Family 
Systems Therapy 
significantly 
improved adherence 
versus standard care 
and at two time 
points for education 
and support 
Indirect estimate 
of adherence 
Gazmararian, 2010 Adult patients 6 months 3-part pharmacy- Usual care Slight improvement Adherence 
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with diabetes 
taking at least one 
medication 
(N=173) 
based health 
literacy program: 
reminder calls, 
prescription cards, 
pharmacist 
communication 
training 
in refill adherence 
but NS between 
groups 
measure not 
specific to 
diabetes 
Heisler, 2010 Men with diabetes 
being seen in a 
VA clinic 
(N=244) 
6 months Peer support 
program 
Nurse care 
management 
No difference in 
self-reported 
adherence 
Self-report, no 
true control 
Wolever, 2010 Adults with type 2 
diabetes (at least 1 
year) and taking 
oral medication 
(at least 1 year) 
(N=56) 
6 months Integrative health 
coaching (14, 30-
minute telephone 
sessions) 
Usual care Significant 
improvement in self-
reported adherence 
(8-item Morisky) 
Likely 
acquiescence bias 
Gibson, 2011 Enrollees of 
employer-
sponsored 
insurance with 
diabetes 
(N=2,204) 
3 years Disease 
management and 
lowered medication 
co-insurance 
Lowered 
medication co-
insurance 
Higher adherence 
and percent adherent 
in all 3 years of the 
study for insulin and 
orals 
Voluntary 
program 
enrollment (self-
selection), single 
employer 
Brennan, 2012 Enrollees of a 
single employer-
sponsored plan 
with diabetes 
(age> 39) 
(N=29,247) 
6 months Counseling, follow-
up calls, and a free 
testing kit,  
Standard care Increase in days’ 
supply during 
intervention period; 
greater effect in 
retail versus mail 
order 
Single employer 
study 
APhA, 2012 Adult, 
nonadherent 
patients with 
diabetes on at 
least one 
medication 
(N=216) 
6 months Motivational 
interviewing 
Standard care Small improvement 
in PDC over 6 
months 
Potential 
selection and 
acquiescence 
biases 
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Bogner, 2012 Adults (age>30) 
with type 2 
diabetes and 
depression with 
oral medication 
for both (N=180) 
12 weeks Personalized in-
person and phone-
based monitoring 
Standard care Higher proportion 
achieved 80% or 
higher adherence at 
6 and 12 weeks 
MEMS used for 
tracking 
Collins-McNeil, 
2012 
African American 
adults with 
diabetes (N=12) 
12 weeks Church-based, 
culturally targeted 
self-management 
education 
None Significant 
improvements in 
medication and 
insulin 
administration 
Small size, visual 
analog scale of 
management 
Crowley, 2013 African American 
women with type 
2 diabetes 
(N=359) 
12 months Nurse-led telephone 
self-management 
education 
Standard care Improved odds of 
self-reported 
adherence 
Recall bias and 
generalizability 
Odegard, 2013 Patients with type 
2 diabetes 
(age>60 years) 
(N=120) 
12 months Pharmacist-initiated 
phone adherence 
support 
None Modest reduction in 
refill gaps over 12 
months 
No control group, 
limited reasons 
approached 
Moore, 2013 High risk, adult 
enrollees of an 
employer-
sponsored plan 
(N=4,500) 
Up to 12 
months 
MTM program with 
follow-up 
Standard care MPRs were 
unchanged for 
diabetes medications 
Control group 
matched from 
dissenters, high 
risk only, single 
firm 
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Moreover, the reviewed studies also provide guidance on the how interventions may 
layer their approaches. Across these investigations it was found that the use of only a single 
approach to behavior change led to mixed results in terms of altering medication nonadherence. 
However, the most consistently favorable results were observed in studies employing multiple 
approaches to behavior change (e.g. counseling and follow-up, lowered cost-sharing and disease 
management), a notion that has been previously suggested.
93
 Considering the multifaceted nature 
of medication adherence, these results should be of little surprise. Moving forward, studies 
aiming to improve medication use should consider the effectiveness that more complex 
interventions have had on adherence and approach this issue from multiple perspectives, either 
by using several separate and concurrent approaches to behavior change or by addressing 
multiple reasons for nonadherence. Overall, what these studies tell us is that much work remains 
if we are to more effectively influence the taking of medications in patients with diabetes. The 
next section examines a specific approach that has been taken to improve the specificity by 
which nonadherence may be addressed.  
 
Tailoring and Behavior Change 
 
 Health behavior interventions have become increasingly specific in recent years, 
attempting to concentrate on more precise factors that may hinder or reinforce change. 
Historically, this has involved the application of targeted messaging whereby a particular 
population (generation, disease, etc.) received the same type of message aimed at eliciting a 
particular behavior based on that group’s assumed shared characteristics.94 There is some 
evidence that this level of communication can lead to individual behavior change but the effects 
are limited.
95
 Studies using targeted interventions have focused on conditions including 
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hypertension, diabetes, and hyperlipidemia with mixed results reported in a review by Cutrona 
and colleagues (2010).
96
 They reported on a host of studies aiming to improve medication 
adherence, including those with patients thought to be more sensitive to targeted messages due to 
their condition or point in treatment (e.g. post-hospitalization or following a surgical 
intervention). Among the strategies mentioned, targeted messages were automated and built 
using patient feedback.
85,97
 While some strategies reported were successful, these results suggest 
that more precise approaches, particularly focusing on increased receptivity, should be explored. 
The pursuit of improved processes by which to change health-related behavior led to 
means of tailoring messages for individuals. This method identifies person-specific barriers and 
factors related to a particular behavior or outcome and then crafts individualized messages that 
are concurrently focused on multiple factors. Tailoring improves the specificity by which 
individuals are targeted based on their personal characteristics (e.g. age, gender, or race), 
preferences, beliefs, condition, or treatment, and is regarded as the most precise method by 
which subjects may be messaged. Tailoring follows a precise process, grounded in theory and 
having been robustly tested, the result of which is a set of messages that are personally relevant 
to each subject. 
 
Elaboration Likelihood Model 
 
The basis for tailoring is rooted in information processing theory specifically that people 
are more likely to thoughtfully process information when they perceive that information to be 
more personally relevant. Petty and Cacioppo (1986) argue that personal relevance may be the 
single most important influencer of the receiver’s likelihood to elaborate a particular message.98 
Building off of findings surrounding information processing, Petty and Cacioppo developed a 
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dual processing model describing the management of information: the Elaboration Likelihood 
Model (Figure 1.1). The model describes a general framework of the processes underlying 
persuasive communication and how they may be best applied to an individual. Several concepts 
interact to form the framework, beginning with the receiver’s motivation for processing the 
message.  
 
Figure 1.1 Elaboration Likelihood Model 
  
 
 
 
Persuasive Communication 
Motivated to Process? 
Ability to Process? 
Nature of Processing 
Favorable 
Thoughts 
Unfavorable 
Thoughts 
Neither or 
Neutral 
Cognitive Structure Change 
Central Attitude Shift 
Peripheral Attitude Shift 
Peripheral Cue Present? 
Retain Initial 
Attitude 
Yes 
Yes 
Yes 
Yes 
Yes 
No 
No 
No 
No 
Adapted from Petty & Cacioppo, 1986
98
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The argument holds that messages perceived to have higher personal relevance are more 
likely to be thoughtfully considered and processed.
99
 Moreover, a person’s need for cognition, or 
the level of or desire for effortful analytic activity, helps dictate the type of processing most 
likely to be individually persuasive.
100
 An individual’s need for cognition may be evaluated 
using an instrument developed and validated by the model’s authors.100,101  
At this point, the suggestion is that two separate routes of processing influence how 
individuals manage the receipt of information. The peripheral route relies on cues present in the 
message, such as the credibility or attractiveness of the source, the use of a catchy slogan, or the 
repetition of a particular message.
98
 Comparatively low levels of elaboration are applied in this 
case and weaker or shorter lived effects are more often realized.
102
 On the contrary, the central 
route is thought to be used by those requiring a high level of elaboration, relying on careful 
scrutiny of the message and the underlying argument made.
98
 Along this route, if the individual 
is motivated to process the message and has the ability to process the message, meaning they are 
not distracted and may have been repeatedly exposed, then favorable (or even unfavorable) 
thoughts toward the message, and ultimately persuasion, are more likely. However, as can be 
seen from the model, such central processing requires a continuum of processes for this level of 
elaboration to be realized; otherwise peripheral cues may be better suited to deliver the message 
to the individual. 
Tailoring exploits messaging processing and follows the ELM by first increasing the 
personal relevance of a particular message using inputs from individuals. Further, it creates a 
type of message that is most likely to be considered by the intended audience, either through 
thoughtful consideration of an argument (the evidence behind a particular behavior provided by 
research) or the use of peripheral cues (reminders to perform an activity provided by celebrity 
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figure). Regardless of the route taken, the combination of personally relevant details with 
identified levels of elaboration has been effective in delivering specific messages to target 
audiences.  However, a defined approach has been suggested by thought leaders in tailoring and 
is outlined below, followed by results from key studies involving nonadherence. 
 
Tailoring Process 
  
Considering the specificity with which tailoring interventions are working, the building of 
deeply tailored messages can be cumbersome. To streamline the process, experts in the field of 
health communication have suggested a step-wise procedure. Such steps have been developed 
with a wider range of health professionals in mind, so that tailored communication may be 
applied to a larger host of patients and by a variety of practitioners.
95
 As described by Kreuter, 
five general steps have been suggested when tailoring messages with computer assistance. 
 
1. Analyzing the problem  
The initial step is gaining or confirming a thorough understanding of the problem to be 
addressed. Often this will include searching the literature for the concepts, constructs, or 
correlates observed by previous research that have shown to be associated with particular 
conditions, health behaviors, or treatments. This step may be best approached with established 
behavioral theories in mind, such as the Transtheoretical Model, the Health Belief Model, or 
Social-Cognitive Theory; the specific theory and their included constructs are dependent on the 
target behavior(s) and population(s) to be addressed. Since these concepts will form the 
backbone against which the intervention will eventually rest, it is essential to methodically 
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investigate the issue at hand and balance the number of concepts with those known to have the 
highest likelihood for behavioral change.  
 
2. Assessment tool development 
Once concepts relevant to the target behavior have been identified and agreed upon, an 
instrument that will assess baseline values in the study population must be developed. While 
some subject details may be obtained without the use of an assessment tool (e.g. through 
electronic medical records), information related to latent, theory-driven items (e.g. beliefs and 
attitudes) will require surveying. This may be done by either adapting an established and tested 
instrument to the target population or by creating an original battery of items that adequately 
evaluate the included concepts. Either way, each included set of items should have reliable 
psychometric properties with close-ended options to improve the efficiency of tailoring. The 
length of the instrument and mode of data collection are important considerations as sufficient 
details need to be extracted from the target population without undue burden placed on the 
respondents. Careful planning paired with a sufficient understanding of the target population will 
ease both the creation of an appropriately sized instrument that is conducted in a manner 
convenient to the subjects. 
 
3. Message creation 
At this stage, a host of messages must be drafted to include all possible response options 
to the items in the assessment tool. For instance a 7-item Likert scale item may require the 
drafting of up to seven individual messages that correspond to each of the available responses. 
This may also include determining cut points for message options relating to responses that 
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indicate a relative value, such as “high”, “medium”, and “low.” The general approach is to list 
each response option for each survey item and draft messages connecting the concept with the 
target behavior. Messages should then be drafted with the behavior and the chosen concepts in 
mind as a framework for how the intervention will encourage change. A sound understanding of 
how each concept (e.g. beliefs, attitudes, barriers, and knowledge) relates to the target behavior 
or how related strategies may be employed is necessary at this stage as a range of possibilities 
exists in any target population. For example, when targeting medication adherence, messages 
focused on strategies may suggest the use of pill boxes or reminder triggers while conceptual 
messages may focus on the subject’s understanding of their condition (disease knowledge), their 
treatment (medication mechanism of action), or potential hindrances (cost, access, etc.). 
Moreover, the magnitude of each influencer must be considered and built into the drafting 
process as the importance of each concept is likely to vary between and within subjects. Ideally, 
potential messages would be pre-tested by representative members of the target population, 
allowing for editing prior to implementation. The result is a library of “message stems” 
(individual phrases that can be amended with other details) that will later be combined with other 
subject characteristics (name, age, gender, etc.) to more deeply tailor each message.  
 
4. Database development 
At this stage, it is vital to create a coding system by which the message stems may be 
connected with the appropriate item in the assessment tool. For example, a medication use 
intervention including messages about cost may code an item as “barrier_cost” in both the survey 
and message library so that the respondent’s answer would indicate to the system the level at 
which cost was a barrier to them and they may then receive the appropriately tailored message.  
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5. Algorithm development and programming 
The final step in creating tailored messages is to link the responses with the message 
stems to create a fully tailored message. This involves the writing of code that can take the 
survey response for each item and properly match it with the appropriate stem from with the 
library. Often, depending on the chosen software or program, this may be accomplished through 
the use of simple “IF/THEN” statements that look up the appropriate message based on the 
response level. Common programs to do so include Microsoft Word and Excel; however, open-
source software, such as the Michigan Tailoring System (University of Michigan Center for 
Health Communication Research) exists for research purposes. The purpose of the algorithm is 
two-fold. First, it determines the basket of messages that will and will not be delivered to each 
individual based on the responses given in the survey instrument. This provides for the most 
accurately tailored set of messages and intervention for each subject. Secondly, the algorithm 
may also determine the order in which the messages will be received, if a longitudinal approach 
is to be taken by the intervention and if the order or timing of the messages is important to the 
chosen mode or model of behavior change.  
 
Tailoring Interventions 
 
 In recent years, tailored interventions have become increasingly popular and applied 
across a wide variety of health behaviors. To date, the vast majority of these interventions have 
either been print-based, involving the sending of physical materials, web-based, requiring online 
interactions, or a combination of these two channels. Targeted health behaviors of these 
interventions have included, but are not limited to, weight loss, smoking cessation, physical 
activity, and preventive screening. A large majority of published studies were theory-driven, and 
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multiple theories have been applied by investigators of these studies. Most often, researchers 
relied on the Stages of Change/Transtheoretical Model, Social Cognitive Theory, or the Theory 
of Planned Behavior/Reasoned Action. In multiple cases, the Health Belief Model was applied 
and resulting effect sizes have been seen to range from small to moderate.
103
   
Reviews of these investigations have demonstrated the impact that tailoring can have on 
particular behaviors and provide guidance for future studies. The overarching findings suggest 
that tailoring is effective with effect sizes varying due to the nature of tailoring, the method of 
message delivery (web versus print), and the conditions or behaviors being targeted.  
Noar and colleagues (2007) summarized the results of print-based tailoring interventions 
that addressed behaviors including smoking cessation, diet, screening, and exercise. An overall 
small effect size across all included studies was found (0.074) and significant heterogeneity was 
described by the study authors.
103
 Aside from this overall magnitude of effect, other moderating 
variables and methodological features related to tailoring were detailed. For studies involving 
print-based tailoring, larger effect sizes were observed in studies outside of the United States, 
focused on preventive or screening behaviors, using messages delivered by pamphlets or leaflets, 
when more than one contact was made, and using shorter follow-up periods. It was also reported 
that tailored messages outperformed both simple control groups as well as other types of 
messages (e.g. targeted or generic). Importantly, it was also observed that studies involving 4-5 
theoretical concepts as well as those employing theoretical, demographic, and behavioral 
concepts in the tailoring outperformed interventions using 3 or fewer theoretical concepts and 
only tailoring on behavioral or theoretical concepts alone, respectively.
103
  
More recently, Krebs and colleagues (2010) built upon Noar’s earlier analysis and 
reported a meta-analysis regarding the evidence of computer-based tailoring- the use of computer 
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systems to create and deliver tailored messages via the Web. Similar to the review highlighted 
above, this more recent review included behaviors ranged from smoking cessation to physical 
activity, diet, and exercise. A modestly higher overall effect size (0.17) was determined across 
the 88 studies assessed with the largest effects observed in interventions involving smoking 
cessation or diet.
104
 Additionally, effects were found to peak between four and 12 months post-
baseline and decrease over time, particularly after the first year; however, when tailoring was 
dynamic (involving feedback/assessment iteration) the effects remained significant after 12 
months.
104
  
Taken together the results summarized by these two reviews help us understand what 
may be most effective across the types of tailoring most often employed and the direction future 
studies may consider when applying tailoring as a mechanism of behavior change. Although 
comparative results are not available, it appears that a larger effect size may be realized by 
leveraging computer-based tailoring by employing electronic means of message delivery or 
participant interaction. Moreover, multiple contact periods should be considered as should more 
deeply tailored messages—those incorporating multiple behavioral, theoretical, and demographic 
characteristics—both of which are likely most easily accomplished by using the advanced means 
of communication afforded researchers by computers.  
 
Tailoring and Medication Adherence 
 
 A limited number of studies have involved the tailoring of messages aimed at improving 
medication adherence, the vast majority of which having been published in the past decade. 
Table 1.2 summarizes the approaches taken and findings of recent tailoring investigations aimed 
at improving medication-taking in patients with chronic conditions. 
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 The majority of these interventions targeted improving behavior in patients with 
cardiometabolic conditions or AIDS, but asthma and schizophrenia were also represented. Trials 
ranged in length from as little as 12 weeks to as long as 18 months and all involved adult 
patients. Most used standard care as their comparison but educational materials or generic 
feedback was also employed.  
 To produce tailored materials nearly all studies used one or several baseline survey 
instruments; however, interview responses (some motivational) were employed, as was reported 
treatment progress. In some cases, specific, established instruments were used to collect subject 
information, such as the Summary of Diabetes Self-Care Activities,
105
 the Problem Areas in 
Diabetes scale,
106
 the Rapid Estimate of Adult Literacy in Medicine,
107
 the Structured Clinical 
Interview for Positive and Negative Syndrome Scales,
108
 the Barnes Akathisia Rating Scale,
109
 
the Schizophrenia Outcomes Module,
110
 the SF-36,
111
 the CAGE questionnaire,
112
 the Frontal 
Systems Behavior Scale,
113
 and the Perceived Control of Asthma questionnaire.
114
 The direct 
mentioning of framework or theory-driven items being incorporated to the tailoring of messages 
was limited, but several investigations did specifically report the application of behavioral 
theories. Among those that did so, the theories or frameworks applied included: the 
multifactorial framework for adherence in clinical research and clinical care,
115
 the 
Transtheoretical Model,
116
 the Information-Motivation-Behavioral Skills Model,
117
 the Health 
Decision Model,
118
 the Health Belief Model,
119
 Social Cognitive Theory,
120
 Self-Regulation 
Theory,
121
 and the Chronic Care Model.
122
 Other established techniques included Motivational 
Interviewing and Cognitive Adaptive Training.
123,124
 Commonly used collection methods for 
adherence included a 7-day or 14-day self-report, the AIDS Clinical Trial Group-Revised Total 
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Score,
125
 the Morisky Scale,
13
 pill counts, MEMS, metered-dose monitoring, and pharmacy 
claims (either PDC or MPR).  
 By and large, these tailored interventions observed significant differences in adherence as 
a result of the approaches taken. Importantly, those interventions that employed a defined 
technique (Motivational Interviewing or Cognitive Adaptive Training) or an established 
theoretical framework showed almost universal improvement in adherence from baseline, 
increasing adherence, from 4-22%, when specifically reported. Only the Ickovics and Meisler 
framework failed to show a significant difference.
126
 Print,
124,127,128
 in-person,
129-131
 and 
telephone-based
132-134
 approaches showed positive impact; those that incorporated nurse-led 
counseling
130-133
 were also generally associated with improvements in medication taking. These 
results paint a positive picture of the effectiveness of tailoring on improving medication taking in 
patients with chronic disease, particularly when such interventions are rooted in specific theories, 
frameworks, or techniques. Future studies aiming to improve adherence should universally 
employ established models to improve the odds of positive outcomes. 
 Only two of the included studies focused on patients with diabetes and both failed to 
observe statistically significant changes in medication adherence between study arms; however, 
positive improvement was observed in patients taking insulin when directed by a health educator 
over the course of one year.
135
 It should be noted that both of these studies lacked a clear 
theoretical foundation for the tailoring of material, findings that add support for the need to base 
a tailoring intervention in an established model. As a result, future studies aimed at improving 
medication adherence in patients with diabetes should base the tailoring of their materials on a 
well-established theory, particularly one associated with multiple, positive findings (e.g. TTM, 
HBM). These studies may also consider leveraging emerging techniques and technologies to 
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more efficiently reach subjects. The following section describes how the prominence of one 
piece of technology—mobile phones—may be an appropriate and effective means by which 
behavior may be influenced. 
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Table 1.2 Tailoring Interventions to Improve Medication Adherence 
First Author, 
Year 
Study Population Length Intervention Control Tailoring 
Channel 
(framework) 
Adherence Results Limitations 
Grant, 2003 Adults with type 2 
diabetes 
(N=232) 
3 months Drug-specific 
patient 
education, 
identified 
adherence 
barriers, and 
additional 
services 
Standard 
care 
Pharmacist-led 
interviews 
based on 
medications 
and a survey 
Nonsignificant 
differences in 
adherence after 3 
months 
Indirect tailoring, 
limited contact 
Holzemer, 2006 Adults taking 
antiretroviral 
medications 
(N=240) 
6 months Structured nurse 
counseling 
Standard 
care 
Nurse 
counseling 
based on 
survey 
responses 
(Ickovics & 
Meisler 
framework) 
No differences in 
adherence across 
multiple measures 
Dose variation 
Johnson, 2006 Adult members of 
an HMO taking 
antihypertensives 
(N=1,227) 
18 months Stage of change-
based manual 
and tailored 
feedback 
Standard 
care 
Printed 
materials using 
stage-based 
feedback from 
surveys (TTM) 
Significantly lower 
nonadherence at 12 
and 18 months 
Likert-based 
adherence 
measure, high 
dropout 
Johnson, 2006 Adults taking 
cholesterol 
medication 
(N=404) 
18 months Stage of change-
based manual 
and tailored 
feedback 
Standard 
care 
Printed 
materials using 
stage-based 
feedback from 
surveys (TTM) 
Some differences at 
6 months but 
consistently better 
adherence at 12 and 
18 months 
Likert-based 
adherence 
measure, high 
dropout 
Parsons, 2007 HIV positive 
adults taking 
antiretroviral 
therapy (N=143) 
12 weeks Motivational 
interviewing and 
cognitive 
behavioral skills 
training 
Didactic 
health 
education 
Repeated 
counseling 
using MI and 
CBST (IMB, 
MI) 
Improvements in 
percent dose and day 
adherent at  
3months; dissipated 
by 6 months 
Recall bias 
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Bosworth, 2008 Adults with 
hypertension 
(N=636) 
12 months Needs-based 
counseling 
across several 
behaviors; blood 
pressure 
monitoring; both 
Standard 
care 
Telephone, 
nurse-led 
counseling 
using a needs-
based 
assessment 
(HDM) 
Increase in self-
reported adherence 
at 6 months 
Reliance on self-
report 
Hudson, 2008 Adults 
schizophrenia 
patients of VA 
clinics (N=349) 
6 months Adherence 
barriers and 
domain-based 
strategies 
Basic 
education 
Nurse 
counseling 
using interview 
responses 
Significant 
improvement in 
odds of adherence, 
especially if already 
adherent 
Scale used for 
adherence 
Reynolds, 2008 Antiretroviral 
naïve enrollees of 
an AIDS clinical 
trial (N=109) 
16 weeks Structured, 
proactive, nurse-
led phone calls 
Patient 
Education 
Telephone 
nurse 
counseling 
Significant 
improvements over 
64 weeks 
Self-report 
measure 
Velligan, 2008 Recently 
discharged and 
outpatient 
schizophrenia 
patients (N=95) 
9 months Cognitive 
adaptation 
training (all 
behaviors or 
medication-
focused) 
Standard 
care 
Manual-based 
behavioral 
change using a 
series of 
assessments 
(CAT) 
Both interventions 
showed significant 
differences in 
adherence (pill 
counts); no 
difference between 
these groups 
Established 
condition (in 
years), selection 
bias  
Janson, 2009 Adults with 
moderate to 
severe asthma 
(N=280) 
24 weeks Scripted 
sessions with 
asthma 
educators and 
respiratory 
therapists 
Standard 
care 
Nurse 
counseling 
using treatment 
progress 
(HBM, SCT) 
Mean adherence 
remained 
consistently higher 
over time 
Monitoring of 
doses, 
generalizability 
Stacy, 2009 Currently taking a 
statin (N=497) 
Variable Tailored 
feedback from 
interactive voice 
response and 
mailed guide 
Generic 
feedback 
Interactive 
telephone 
based on 
theory-driven 
items (TTM, 
HBM, CCM, 
MI) 
Significantly higher 
adherence rate at 6 
months 
Selection bias- 
subjects opting in 
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Walker, 2011 Adult diabetes 
patients (age>30) 
of a health care 
worker union 
(A1c>7.5%) 
(N=526) 
1 year Calls from 
health educators 
Printed 
educational 
material 
Telephone 
(unspecified) 
Mixed results of 
change in adherence 
due to intervention 
Differential 
dosing, different 
outcomes for 
adherence based 
on measure 
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Mobile Health and Behavior Change 
 
Growth of Mobile Health 
 
 In the past decade, ownership and use of mobile phones in the United States has grown 
from approximately 255 million units to over 326 million units.
136
 Currently, 91% of American 
adults own a mobile phone, up from just under 80% in 2008.
137
 Moreover, roughly $185 billion 
was spent last year on operating mobile phones.
136
 Unlike many technologies, mobile phones do 
not exhibit disparities in ownership across age, race, and socioeconomic status.
137 
While use of these devices was originally dominated by “talk time”, the majority of 
mobile phone use is now dominated by more immediate and brief means of communication, such 
as text messaging and instant messaging. In 2012, more the 2 trillion text messages were sent by 
mobile phone in the United States, a five-fold increase from 5 years earlier.
136
 As of earlier this 
year, 79% of mobile phone owners use their device for messaging, suggesting that there is a 
strong preference for many Americans to communicate by means easier than placing direct 
phone calls.
137 
As this technology has become more popular, the functionality of mobile phones has 
increased dramatically. Most prominently, smartphones—those devices capable of operating and 
exchanging information across web-based applications—have grown in popularity and use: as of 
2013, 56% of American adults own a smartphone, making these devices the most widely owned 
and operated mobile phone on the market.
137
 Considering such widespread use, opportunities 
have emerged to apply mobile phones to the daily conducting of health-related activities. This 
has included applications housing medical information, personal health records, and trackers for 
diet, exercise, and other self-care activities. Additionally, tools have been developed to improve 
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the means by which communication is relayed between patients and providers. As early as next 
year, estimates suggest that the mobile health market will reach $4.6 billion, significantly 
expanding the use of mobile devices in health care and boosting the ability of both patients and 
providers to manage disease and treatment.
138
 As this market continues to grow, it is anticipated 
that mobile phones will also be further introduced as a means to deliver health-related 
interventions; the following sections describe how this has been done to date. 
 
Applications to Behavioral Interventions 
 
 Although still relatively new to the health care field, mobile devices have begun to be 
tested as a means to instill behavior change in patients with a variety of conditions, including 
diabetes, hypertension, obesity, and smoking. Target behaviors of these interventions have 
included medication use, self-care, diet, and exercise, and tested means of altering behavior have 
included education, direct patient-provider communication, reminders, and patient tracking. 
While multiple communication channels using mobile platforms have been applied, text 
messaging has emerged as the most predominant delivery mechanism to date. Results of these 
studies have varied but their findings remain important to our understanding of how mobile 
phones may be used to influence health-related behaviors. 
 Three recent systematic reviews highlighted the results of published studies involving the 
application of mobile phones in behavioral interventions, two of which focused solely on the use 
of text messaging. Krishna and colleagues (2009) reviewed 25 investigations where mobile 
phone communication was used to encourage behavior change; channels included voice, text 
message, Internet, e-mail, and personal devices. Targeted behaviors included smoking cessation, 
medication adherence, appointment keeping, vaccination, and disease management- nine studies 
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specifically focused on diabetes. Nearly all of the reviewed studies employed some level of text 
messaging and relied on one-way communication to do so; when applied, the frequency of 
messaging varied considerably from once daily to once daily, although some were dependent on 
the subjects’ prescribed treatment regimen. The study authors concluded that improvements were 
realized in medication adherence, clinical outcomes, quit rates, and appointments kept.
139
 
Specifically, conditions requiring ongoing support or care, such as asthma, diabetes, and 
smoking cessation, benefitted the most from a mobile intervention. Although positive 
improvement was not universal, these results suggest that mobile device-driven interventions can 
show positive effects; however, trials targeting medication adherence were underrepresented. 
Importantly, all but one of the studies focusing on patients with diabetes showed positive results. 
Fjeldsoe and colleagues (2009) reviewed 14 studies focused exclusively on the effect of 
text messaging in behavior change interventions, seven of which were not included in Krishna’s 
review. Foci of these studies included smoking cessation, physical activity, disease management, 
and medication use; again, diabetes was well represented as seven studies specifically targeted 
patients with this condition. Twelve of the studies applied tailoring techniques to improve the 
individualization of the messages and the majority of these trials (7) utilized two-way 
communication to vary the messages over time to sync with the patients’ ongoing treatment. The 
frequency of messaging varied by study and ranged from weekly to daily, and study length 
ranged from six weeks to one year.  Among the studies reviewed, a majority (8) showed positive 
improvement and nearly all of the remaining studies demonstrated positive trends- the lone study 
that reported null results focused on symptom improvement in patients with bulimia 
nervosa.
140,141
  The evidence presented in this review provides strong support for the application 
of tailoring as nine of the 12 studies using this level of communication observed positive 
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improvements in outcomes, including five studies involving patients with diabetes. However, 
only three studies focused on medication adherence, limiting what may be gleaned about the 
effectiveness of text messaging to encourage this behavior. The review authors concluded that 
the included studies demonstrated the potential that text messaging can have on improving a 
range of health-related outcomes but future trials can improve upon what has been done, 
including the application of more tailoring, larger sample sizes, explicit use of theory, increased 
interaction between patients and providers, and the evaluation of process measures.
140 
More recently, Wei and colleagues (2011) reviewed 24 published studies involving the 
application of mobile phones, specifically using text messaging; 16 of the included studies were 
not summarized in Krishna’s or Fjeldsoe’s publications. Targeted behaviors of Wei’s review 
included smoking cessation, weight loss, disease management, and condition self-monitoring, 
and a larger share of the reviewed trials focused on adherence to medication while five 
specifically targeted diabetes. Similar to what was observed by Krishna and Fjeldsoe, the 
frequency of communication ranged significantly, from daily to monthly, and even mirrored 
dosing schedules. More studies were seen to employ feedback mechanisms and some 
incorporated subject preferences into the messaging. Most of the studies reported positive results 
or trends but a majority of trials involving medication adherence did not observe significant 
improvement, perhaps due to the host of methodological flaws reported by the authors (e.g. 
inadequate sample size, adherence metric, experimental design).
142
 The review authors 
concluded that, by and large, studies to date that have used mobile messaging demonstrate that 
positive change can be realized across a host of behaviors; three of the five studies that included 
patients with diabetes showed positive improvement in outcomes.
142
 However, the varied results 
reinforce the need for further inquiry.  
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Taken together these reviews paint a mostly positive picture of the impact that mobile 
phone interventions can have on particular conditions and behaviors. While positive results were 
observed in numerous studies, the applications to medication adherence were limited. Moreover, 
the main mechanism of behavior change for interventions using text messaging was a simple 
reminder message, which limits the extent to which other reasons for health-related behavior 
may be addressed. Additionally, the application of tailoring was limited- only three of the 42 
studies specifically mention this level of communication. Also, a major limitation of most studies 
was a lack of adequate sample size as many were underpowered to determine statistically 
meaningful differences. Resultantly, opportunities to expand the specificity of messaging remain 
prevalent.  
 
Applications to Medication Adherence 
 
 While still relatively scant, researchers have begun leveraging the utility of mobile 
phones in the pursuit of improving medication adherence. Considering the ubiquitous nature of 
messaging platforms across all types of mobile phones, texting has been a popular channel by 
which messages aimed at changing medication-taking behavior have been relayed. Table 1.3 
summarizes the methods and findings observed across recent investigations aimed at doing so 
which includes several studies previously reviewed but also highlights studies overlooked in 
previous reviews. 
 As can be seen, a majority of published studies to date have been conducted outside of 
the United States and nearly all of which concluded within the past decade, most of which since 
2008. Nearly all studies employed a control group who generally received no message (standard 
care only) although simple beeper messages and real-time monitoring were applied in one case 
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each. In most cases, chronic conditions (two involved diabetes) and associated medications were 
targeted and studies were as short as three weeks and as long as one year. Similar to what has 
been observed in other types of studies, adherence in these investigations was measured in 
several ways: pill counts, visual analog scales, self-report, electronic monitoring, and responses 
to the Morisky scale. Additionally, a majority of studies involved adult patients of both genders 
but pediatric, younger adults, and only females were also specifically enrolled in some cases.  
 Across all studies reviewed the frequency of text messages received by participants 
varied considerably by study. In some cases the number of texts was dependent on the dosing 
regimen of the study subject; other studies sent messages only weekly, two times a week, or, 
most popularly, daily. As many as 12 messages per day
143
 were delivered and one study sent 
subjects messages three times each day.
144
 Interestingly, one study explored the option of 
varying the amount of messaging throughout the 18 weeks of the intervention.
145 
 The studies represented present a dichotomy of approaches to improving medication 
adherence: simple reminders versus tailored content. The majority of studies (n=6) opted to send 
simple reminders, with or without accompanying educational material. Results of these studies 
were mostly positive; improvements in medication-taking were observed in four of the seven 
studies where reminder messages were the focus.
144,146-148
 Texts that were delivered daily were 
mostly effective although weekly messages were shown to outperform them in one instance
148
 
and thrice daily messages also showed positive improvement in adherence,
144
 but the long-term 
implications of this latter approach are yet to be determined. As can be seen, the use of simple 
reminder messages was not universally successful in improving adherence. However, in cases 
where nonsignificant results were observed it is possible that the nature of the medication class 
involved (oral contraceptives)
149
 or the use of active monitoring in the control group
150
 may have 
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contributed to these null results. The latter of these two studies involved patients with diabetes, 
the findings of which were conflicting. What we may glean from this is that simple text 
reminders may not provide added value to patients with diabetes above ongoing monitoring in 
terms of motivating medication-taking behavior. Rather, a deeper messaging channel may be 
required to more adequately influence this population.  
 In four of the reviewed studies, tailoring was also applied to the messaging, improving 
the level of individualization beyond the capability of simple reminders and expanding the extent 
by which other factors affecting adherence may be reached.  Four separate conditions were 
represented in these trials (diabetes, asthma, schizophrenia, and HIV) as were a range of patient 
ages, including children. Feedback from the subjects was employed in two of the investigations 
and texting frequency was different in each of the studies. Importantly, unlike what was observed 
in studies using simple reminders, universal improvement in adherence was realized in each of 
these investigations. 
 The earliest of the studies was an intervention conducted by Franklin and colleagues 
(2006) where a technique called “sweet talk” was tested in a group of pediatric patients (ages 8-
18) with type 1 diabetes. Patients were randomized to one of three groups: 1) conventional 
insulin therapy; 2) conventional insulin therapy and Sweet Talk; and 3) intensive insulin therapy 
and Sweet Talk. The messages were guided by Social Cognitive Theory,
120
 leveraging goal 
setting (established at baseline) and social support, and focused on insulin injections, glucose 
testing, diet, or exercise. A weekly message reinforcing the established goal was sent as were 
daily messages providing tips, information, and reminders related to this goal. Control subjects 
received only the standard care required of all participants. By the end of the study (1 year), 
patients in the Sweet Talk group scored higher in diabetes self-efficacy and demonstrated 
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significant improvement in self-reported adherence (visual analog scale) when compared to 
control.
151
 Additionally, the vast majority of subjects felt the messages helped their diabetes self-
management and nearly all indicated they wanted to continue receiving messages. The frequency 
of messaging was also well received but a chief complaint was the repetition of some messages 
throughout the study. As a first study investigating the viability of tailored text messages to 
improve medication adherence, Franklin and colleagues demonstrated that this channel and level 
of communication can be effective, at least in a particular patient population. 
 In a smaller and briefer investigation, Hardy and colleagues (2008) examined the use of 
tailored messaging, with feedback, in a population of adults with AIDS who had self-reported 
nonadherence to antiretroviral therapy. However, tailoring in this investigation was less defined 
(subjects merely selected, and could change, the theme of their messages) and lacked a 
theoretical foundation- patients selected a timely theme for their messages (e.g. weather, news, 
sports, etc.) that coincided with their reminder. Subjects in the active arm requested feedback 
acknowledging receipt of messages and the frequency of messages was dependent on the 
subjects’ treatment. Comparisons were made to a group of patients receiving a beeper reminder 
over a 6-week period. Results indicated that the use of this messaging system improved 
adherence over six weeks according to multiple measures (MEMS, adherence score, and pill 
counts). This investigation also indicated that a feedback system may not be sustainable over 
time but that the system’s persistence in receiving a response was a main factor in adhering to a 
medication regimen.
152
 Moreover, similar to before, most subjects enjoyed receiving the 
messages and indicated they would continue to use a similar system. While these results also 
paint a positive picture for tailored text messaging, what we may extrapolate from this study may 
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be limited as the methods mirror more of a “preference-based” messaging system rather than true 
tailoring and the small sample size restricts the generalizability of findings. 
 Two additional tailored text messaging studies were published last year, one set in the 
United States and the other in New Zealand. Granholm and colleagues (2012) ran a pilot test of 
tailored messaging in a group of community-dwelling adults with schizophrenia. Over 12 weeks, 
subjects were sent 12 messages per day (6 days per week), randomly distributed, that focused on 
three separate domains: adherence, socialization, and hallucination.  The messages were written 
in a manner to apply cognitive behavioral therapy techniques and were tailored using baseline 
responses and ongoing feedback to multiple choice response messages. No control group was 
employed. The study authors concluded that this tailored text message system was effective at 
improving medication adherence, particularly in those adults with schizophrenia that were living 
independently.
143
 Additionally, there was evidence that, over the course of the study, participants 
increased their belief in their medication to help them stay healthy. Subjects also appeared to be 
receptive to providing feedback as response rates exceeded 80% for all metrics.
143
 While these 
results again support the effectiveness of tailored text messaging they should be taken with some 
caution as the adherence metric employed (prompted, daily, single-item multiple choice 
question) was likely to have been impacted by acquiescence bias and related results were 
dependent on the living situation of the subject; the lack of a control group also limits the 
interpretability of the findings. 
 Focusing on young adults (ages 16 to 45) with asthma, Petrie and colleagues (2012) 
compared messages tailored by patient beliefs to the receipt of no messages to improve 
adherence to controller medications. Tailoring was performed using responses to the Brief Illness 
Perception Questionnaire,
153
 which is theoretically rooted in Leventhal’s self-regulatory 
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model,
121
 as well as medication belief ratings.
154
 Messages were designed to push subjects in a 
target direction based on their baseline responses and the direction believed to be most consistent 
with higher adherence. The frequency of messages varied throughout the study: two per day 
during weeks 1-6, one per day during weeks 7-12, and three per week for weeks 13-18. 
Medication adherence was determined using self-report over the phone at multiple periods. The 
study observed that subjects receiving the tailored messages had an increase in their perceived 
control over asthma and necessity of controller medication as well as held a more chronic view 
of their condition.
145
 Both mean adherence rates and the number of those achieving 80% or 
higher was significantly higher in the intervention group. Moreover, a dissipation of effect was 
not observed even several months after the intervention had ended. This study provides guidance 
on several fronts, mostly providing additional evidence of the effectiveness of theory-driven 
tailored messages but also that their effects can be sustained beyond the time of active receipt. 
However, the varied dose schedule fails to assist future studies in understanding at what 
frequency subjects should be reached.  
 While positive results have been observed in the limited number of studies combining 
tailoring and mobile text messaging, much opportunity exists to better leverage these methods to 
improve adherence, specifically in patients with diabetes. The next section summarizes what 
gaps need to be filled in this area and how the current study was designed to address these needs. 
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Table 1.3 Mobile Text Messaging Interventions to Improve Medication Adherence 
First Author, 
Year (Country) 
Study 
Population 
Length Intervention Control* Text 
Frequency 
Results Limitations 
Marquez-
Contreras, 2004 
(Spain) 
Adult patients 
with 
hypertension 
(N=104) 
4 months Text reminders 
and information 
No messages 2 times per 
week 
All measures of 
adherence 
nonsignificant 
Limited to 
reminders 
Franklin, 2006 
(UK) 
Pediatric 
patients with 
type 1 diabetes 
(N=92) 
12 
months 
Tailored text 
messages with or 
without intensive 
insulin therapy 
Standard care Daily Improved adherence 
with both insulin 
therapy groups 
Visual analog 
scale measure 
Cocosila, 2009 
(Canada) 
Adults willing 
to take Vitamin 
C (N=102) 
1 month Text reminders 
and 
acknowledgement 
No messages Daily Improved adherence 
in both groups; 
correlation between 
acknowledgments 
and adherence 
Single item self-
report question 
Hou, 2010 
(USA) 
Females taking 
oral 
contraceptives 
(N=82) 
3 months Timed reminder No messages Daily No difference in 
missed pills 
Electronic 
monitoring, 
generalizability 
Strandbygaard, 
2010 
(Denmark) 
Adults with 
asthma (N=26) 
8 weeks Daily text 
reminder 
No messages Daily Double digit 
difference in 
adherence rates 
Sample size and 
duration, limited 
to reminders 
Hardy, 2011 
(USA) 
Nonadherent 
adults on 
antiretroviral 
therapy (N=23) 
6 weeks Tailored content 
with feedback 
Beeper 
messages 
Based on 
dosing 
frequency 
Significantly higher 
adherence over 
multiple measures 
Sample size, 
different results 
based on metric, 
unrelated content 
Pop-Eleches, 
2011 (Kenya) 
Adults recently 
started on 
antiretroviral 
therapy 
(N=428) 
12 weeks 1) daily reminder, 
2) daily long 
message, 3) 
weekly reminder, 
4) weekly long 
message 
No messages Daily or 
weekly 
Weekly reminders 
showed higher rate 
of adherers; no 
difference versus 
control in the daily 
groups 
Dropout rates, 
known 
monitoring 
Arora, 2012 
(USA) 
Adults with 
diabetes visiting 
3 weeks Motivational, 
reminder, and 
None 3/ day Improvement in 8-
item Morisky Scale 
Small sample, no 
control 
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the ED (N=23) educational 
messages 
from baseline 
Granholm, 2012 
(USA) 
Community-
dwelling adults 
with 
schizophrenia 
(N=42) 
12 weeks Adherence, 
socialization, and 
hallucination 
messages with 
feedback 
None 12 messages / 
day, 6 days / 
week 
Improved for those 
living independently 
No control, 
unclear 
adherence metric 
Petrie, 2012 
(New Zealand) 
Nonadherent 
young adults 
being treated for 
asthma (N=147) 
18 weeks Beliefs tailored 
text message 
No messages Weeks 1-6: 
2/ day 
Weeks 7-12: 
1/ day 
Weeks 13-
18: 3/ week 
10% increase in 
adherence and 
significant 
difference in percent 
adherent 
Unclear self-
report methods, 
varied dose 
Vervloet, 2012 
(Netherlands) 
Nonadherent 
adults 18-65 
with type 2 
diabetes 
(N=104) 
6 months Real-time 
medication 
monitoring and 
text reminders 
Real-time 
medication 
monitoring 
Dependent 
on dose and 
forgetfulness 
Days without 
medication did not 
differ; texting 
improved dose 
taking within the 
assigned window 
Known 
monitoring, no 
inactive control 
*Control groups included standard care, the same as each active group, unless noted 
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Next Steps 
 
Gaps and Opportunities 
 
 In summary, medication nonadherence continues to be an ongoing issue in patients with 
diabetes and, while progress has been made, much opportunity to improve this problem remains. 
Considering the dramatic growth expected in the incidence and related costs of diabetes in the 
decade ahead,
28
 it is paramount that improved means to alter medication-taking behavior be 
explored so that better adherence can lead to improved disease management.
31,33 
 Over the course of multiple investigations, researchers have observed that patients with 
diabetes are especially influenced by the perceived severity of their condition, their self-efficacy, 
their ability to remember to take their medications, education provided, and their beliefs about 
diabetes;
71
 results have also indicated that understanding the need for ongoing medication use 
can be influential.
73
 Attempts to influence medication-taking in populations of patients with 
diabetes have shown mixed results using a host of approaches, including simple reminders, 
education, and group-based programs; however, leveraging ongoing contact (e.g. provider 
follow-up, adherence support, monitoring) or case management (e.g. disease management, 
counseling, health coaching) showed consistently positive improvement. Such results indicate 
that frequent contact and approaches that incorporate a particular patient’s treatment may best 
improve medication adherence. Moreover, the notion to combine approaches has been voiced for 
over a decade and consideration to do so should be made by future interventions.
93 
 Fortunately, over time our methods of improving medication adherence have been more 
specific. While targeted intervention—those communicating a message to a group sharing 
particular characteristics—have shown some benefit, the results are not conclusive enough to 
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suggest this approach is best suited to instill reliable behavior change. Resultantly, the tailoring 
of interventions has become more prominent and results have been promising, particularly when 
computer-based tailoring is employed.
103,104
 Over the course of its application, we have seen 
limited application of tailoring to medication nonadherence; however, these interventions have 
not always been solidly founded in theory. Evidence from those studies leveraging theory-driven 
has been promising and improvements in adherence have been realized in these cases. Such 
results have further indicated that the most significant improvements have been observed when 
tailoring on at least four to five concepts.
103
 However, a significant gap exists in our 
understanding of how theory-driven tailoring may improve medication-taking behavior in 
patients with diabetes as the evidence has been less conclusive in this population, perhaps due to 
the inadequate application of theoretical methods in these studies. This does not definitively 
indicate that such an approach is inadequate in this population but rather that more robust 
methods of applying tailoring in patients with diabetes is needed, specifically those that leverage 
theory-driven methods. 
 The use of mobile phones in behavioral interventions has become an increasingly popular 
communication channel as the ownership and use of these devices has become widespread. 
Reviews of interventions leveraging mobile communication have shown improvements in the 
management of disease, particularly chronic conditions including diabetes.
139,140
 In recent years, 
we have seen the combined use of mobile phone communication and tailoring become an 
increasingly used mode of delivering behavioral interventions. A limited number of studies have 
explored tailoring mobile interventions in patients with diabetes, using a range of mobile 
communication options, and several have specifically focused on improving medication 
adherence. Results of these investigations have been promising, but several limitations have 
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emerged. Primarily, many interventions have been limited by the use of reminders, the vast 
majority lacked a solid theoretical framework, sample sizes have been relatively small, and 
focusing on medication nonadherence has been underrepresented, although its presence in some 
studies is evidence that the leveraging of mobile devices in medication nonadherence is taking 
place.
139,140,142
 Future interventions can certainly build off of what has already been done keeping 
in mind what has limited the interpretability of previous studies. 
 Across studies using mobile phones, text messaging has emerged as the clear favorite 
among interventional researchers addressing medication nonadherence. However, within this 
area of research, approaches have relied heavily on merely sending reminders to patients and 
some positive results have been observed but change has not been universally realized and 
findings have been conflicting in patients with diabetes. Conversely, when tailored text messages 
have been used, positive improvements in medication-taking have been consistently realized, 
suggesting that this level of communication may be most appropriate when aiming to address 
nonadherence by mobile phone. Moreover, tailored text messages have been shown to lead to 
improved levels of self-efficacy, perceived disease control, perceived chronic nature of disease, 
and medication necessity.
145,151
 Additionally, subjects responded favorably to the receipt of 
messages and nearly all indicated they would like to continue to receive messages; however, 
considering the pediatric population involved and their use of text messaging, acceptance of this 
communication channel in older patients deserves investigating. 
 In spite of these consistently positive results, gaps remain in our understanding of how to 
best apply tailored text messaging. While patients with diabetes have been included in a study 
using tailored texting, it was limited to pediatric patients.
151
 Although still dominated by younger 
Americans, text messaging has shown to be a regularly used communication channel across age 
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groups, and, as such, may be a viable means to reach nonadherent patients regardless of age;
155
 
positive results using such an approach was observed in nonadherent adults with asthma.
145
 
Additionally, the founding of tailored text messaging interventions in sound behavioral theory 
has shown to lead to reliable, positive results, but, as studies have been limited, more research is 
needed.
145,151
 Finally, the frequency of messaging has varied across studies and no reliable 
estimate of what should be sent has been determined. 
 In summary, what we have observed in studies is that tailored text messaging can lead to 
positive improvements in medication adherence. Additionally, the messages used should be 
grounded in theory, not be limited to simple reminders, and include multiple concepts in the 
framing of the messages. What remains to be understood is the applicability of tailored text 
messages to improve adherence in adults with diabetes, how yet untested behavioral theories 
may function in the development of tailored messages, and how adults accept the mobile phone 
into their treatment process as a communication tool.  
To address this we must first consider how theory may be best applied in this context. 
The following section highlights theories that are applicable to adherence and how they guided 
this study. Also, as the use of mobile technology in healthcare is in its infancy, a theory 
explaining how technology may be accepted is applied. Finally, how these theories come 
together to form the conceptual framework is detailed. 
  
Theoretical Considerations  
 
 Considering the positive results observed in the theory-driven studies outlined previously, 
our study will incorporate elements of several established behavioral theories to frame messages 
and assess outcomes. The combination of concepts from the Health Belief Model and Self-
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Determination Theory formed the foundation of the conceptual model guiding this intervention. 
The next section provides an overview of each theory, indicating the rationale for its selection in 
this study. Additionally, a third model is described, elements of which were used asses the study 
population but not applied to the message-development process. Insight gained from including 
this model in the study will focus on how adults with diabetes incorporate the mobile phone into 
their regular care, and the results will provide perspective on the feasibility and demand for 
future mobile messaging projects. 
 
Technology Acceptance 
 
 An extension of the Theory of Reasoned Action, the Technology Acceptance Model 
(TAM) is an information systems theory that attempts to explain the acceptance and use of 
various technologies. Davis and Bagozzi developed this model; the main elements include the 
concepts of perceived usefulness and ease of use. According to Davis (1989), perceived 
usefulness is defined as “the degree to which a person believes that using a particular system 
would enhance his or her job performance”; perceived ease of use refers to “the degree to which 
a person believes that using a particular system would be free of effort.”156 Davis posited that 
these two concepts were fundamental determinants of user acceptance of a particular technology. 
The extent to which the user perceives these concepts influences their attitude toward using the 
technology, which influences their intention to use the technology. This model has been used to 
explain a wide variety of technologies including mobile devices. Kim and Park (2008) applied 
TAM to better understand consumer adoption of short message service (text messages). Their 
findings suggest that perceived ease of use and usefulness are both major factors influencing 
intention to use mobile text messaging.
157
 While these findings suggest that TAM concepts can 
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help us understand the likelihood of text message adoption, their findings were mostly driven by 
younger respondents- a population already understood to readily use such a communication 
channel.
155
 Moreover, the application of mobile phones, particularly text messaging, in the 
context of healthcare delivery has well outpaced the research behind this technology; therefore, 
our understanding of patient perceptions of these messages in the course of their treatment is 
severely limited. As a result, what remains to be better understood is two-fold: 1) how do older 
patients interpret text messaging as easy to use and usefulness and 2) how are these concepts 
perceived in the context of healthcare-related information? Answering these questions is 
paramount to the future development of mobile health-related platforms.  
 
Figure 1.2 Technology Acceptance Model 
 
Health Belief Model 
 
 The Health Belief Model (HBM), first introduced in the 1950s, is one of the most widely 
applied behavioral theories. When originally devised, HBM was designed to predict responses to 
treatment by ill patients; more recently, it has been applied to more general health behaviors. As 
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a result, over the course of the past 40 years, the theory has undergone multiple iterations and 
additional concepts have been inserted over time. Figure 1.3, depicts the components and 
linkages suggested by the most recent version of the theory.
158 
 At its core, HBM posits that a health-related action will be taken if a negative health 
condition can be avoided, a positive expectation of the behavior exists, and that the 
recommended behavior can be successfully taken.
158
 The model suggests that behavior is 
influenced by a combination of factors: 
 Perceived susceptibility: beliefs about the likelihood of an outcome or condition 
 Perceived severity: the seriousness of or consequences of an outcome or condition 
 Perceived benefits: results of actions to reduce threats related to a specific condition 
 Perceived barriers: impediments, perceived or real, to particular behaviors 
 Perceived self-efficacy: personal competency to carry out a particular behavior 
 Cues to action: behavioral triggers that may increase the likelihood of action 
 
It should also be noted, as can be seen in the depiction of the model, that perceived susceptibility 
and severity are often combined to create the concept of perceived threat: the level of risk 
imposed by not acting on the condition. The combination of all of these constructs attempt to 
predict why action to prevent, screen for, or control illness will be taken in a manner that builds 
off of the belief an individual has in each of these concepts. As indicated by the model, 
modifiers, such as age, gender, and ethnicity, may exist differentially impact the predictability of 
a particular behavior in specific populations.
158
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Figure 1.3 The Health Belief Model 
 
When taken into context for medication use, the likelihood of an individual to take their 
medication would be made more likely if they sense they are susceptible to a specific condition, 
believe that condition would have serious potential consequences, believe that taking the 
medication would reduce the probability or severity of a condition, and understand that these 
benefits outweigh any costs of or hindrances to taking the medication. Additionally, the 
likelihood of taking the medication would be increased if the individual believed in their ability 
to take the medication as directed and may also be improved if triggers to taking the medication 
(such as symptoms or encouragement) are introduced.  
Across conditions and health-related behaviors the Health Belief Model has been 
rigorously tested or applied, this has included investigating the role of this model in treatment 
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adherence. Becker and colleagues (1978) were one of the first to show that perceived severity, 
susceptibility, benefits, and barriers observed in mothers were each found to be significantly 
associated with both measures of adherence to asthma medications assessed in their children.
159
 
In 1985, Becker and Janz reviewed applications of HBM to patients with diabetes. Results from 
reviewed studies indicated that positive associations between HBM components and insulin 
treatment exist, some reaching statistical significance: severity and barriers.
160,161
 These findings 
suggest that components of the model may be predictive of adherence but the model as a whole, 
to this point, may not have empirical support.
162,163
 A recent meta-analysis highlighted the 
association between perceived disease severity threat—the combination of perceived 
susceptibility and severity—and adherence (not limited to medication use). DiMatteo and 
colleagues (2007) observed a significant and positive association between adherence and 
perceived disease severity threat across 27 studies. The authors further suggested that these 
findings are suggestive of the need for improved health education, the building of patient-
centered health messages, and the assisting of patients to recognize when disease threats are most 
severe.
164 
Taken together, the results of studies incorporating elements of the Health Belief Model 
provide guidance on how this model may help us predict adherence as well as the constructs that 
are most likely to be associated with improved medication use. Considering the complexity of 
medication adherence, specifically the range of identified influencers, it may not be particularly 
surprising that the entire HBM framework would be supported empirically.
165
 However, its 
individual constructs have shown to be predictive of levels of medication adherence, particularly 
perceived susceptibility and severity. Such support suggests that health messages should consider 
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the role that health beliefs play in ongoing medication use when seeking to encourage improved 
adherence. 
 
Self-Determination Theory 
 
 Developed by Deci and Ryan, Self-Determination Theory is a theory of motivation, 
suggesting that people are driven by three essential needs: competence, relatedness, and 
autonomy.
166
 The pursuit of these needs is reflected in a continuum of motivation, ranging from 
amotivation, or a complete lack of motivation resulting from the absence of value in an activity, 
to intrinsic motivation where one is completely self-determined.
168
 The theory focuses on 
identifying specific types of motivation within this range as a compilation of five mini-theories 
that evaluate the continuum:
166,168,169 
 Cognitive Evaluation Theory addresses the social contexts of intrinsic motivation and 
highlights the roles of competence and autonomy supports.  
 Organismic Integration Theory is focused on extrinsic motivation and specifically 
outlines the continuum of internalization and the relationship this has with autonomy. 
 Causality Orientations Theory differentiates between three types of orientations 
(autonomy, control, and amotivated) based on individual tendencies. 
 Basic Psychological Needs Theory addresses the basic tenet of SDT that well-being and 
functioning are influenced by autonomy, competence, and relatedness, and that support of 
these needs should impact wellness. 
 Goal Contents Theory dichotomizes goals by their extrinsic and intrinsic natures and how 
they are individually related to wellness. 
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Figure 1.4 Self-Determination Theory 
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With these sub-theories in mind, Self-Determination Theory operates under the 
assumption that humans are active organisms that interact with and are either socially supported 
or thwarted to achieve particular needs. The theories then attempt to explain motivational-related 
behavior observed across investigations. On one end of the continuum, intrinsic motivation 
describes the internal tendency to seek challenges but it has been observed that unsupportive 
conditions can inhibit this state.
166
 Resultantly, maintenance of this state by social and 
environmental factors, such as positive feedback, is needed;
168
 however, it is important to 
remember that this level of motivation will only be reached for things that hold intrinsic value for 
them.  
In the middle of the continuum we see a range of regulation types that define extrinsic 
motivation which aide in the understanding of motivation when applied to activities lacking 
intrinsic value. Motivation for performance of these activities lies in some definable outcome, 
and Organismic Integration Theory helps explain the differences in types of motivation that are 
extrinsically driven, varying in the extent of autonomous regulation.
166
 Here, external regulation 
is that controlled by an outside force or influence beyond the control or cause of the subject. 
Next, introjected regulation includes those activities performed to avoid guilt or anxiety and done 
so with only partial, personal acceptance of the behavior.
166
 More plainly, these activities may be 
performed to demonstrate worth to others or to enhance one’s ego which demonstrates ability but 
also the external nature of the motivation.
170
 The third form of extrinsic motivation—identified 
regulation—is one in which the individual consciously values a behavior and sees it as 
personally important. This demonstrates some development toward more autonomous, yet still 
extrinsic, motivation. Finally, integrated regulation is when the behavior has been fully accepted 
by the individual as being completely compatible with their values and needs but are yet still 
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motivated by some defined outcome. While demonstrated across a continuum, Deci and Ryan 
(2000a) do not suggest that the process of improved autonomy occurs in defined stages but rather 
that internalization may increase over time through facilitation- providing support for autonomy 
furthers the process of transforming values from an external source to individual ownership.
166
 
However, it is important to remember that all three needs require servicing to facilitate greater 
internalization and integration as has been observed by the theory’s authors.166 Therefore, 
support for autonomy must also be met with reinforcement of competence and the personal 
relatedness of the behavior. 
 In the context of medication taking, SDT may assist us in understanding the motivation 
one may or may not have for ongoing adherence to a prescribed regimen. The theory suggests 
that motivation to take a particular medication may either by driven internally, if one has 
established intrinsic value for the medication, or by an external force against which the 
individual places the medication’s value. Beyond this, the degree to which motivation is driven is 
related to how competent one feels they are in adhering to the regimen and how closely related 
the taking of the medication is to the values of the individual. Efforts to promote medication-
taking using SDT as a framework should consider all three of these needs in its design and also 
recall that changes in motivation may be driven over time by addressing the individual’s source 
of motivation and guiding them in a desired direction. 
Applications of SDT have been led by Williams and the results of the integration of this 
theory to the taking of medication have important implications for future studies. Williams’ 
earlier investigation applying SDT (1998) did so in a population taking prescription medications 
for at least 3 months; diagnoses varied considerably between subjects (31 in sum) but the vast 
majority were diagnosed with either hypertension, symptoms of menopause, or hyperthyroidism. 
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The objective was to assess the relationship between autonomous support and medication 
persistence. Medication adherence was assessed using two pill counts separated by two weeks. 
Results indicated that autonomous motivation was related to and directly predicted medication 
adherence at least when accounting for it by self-report.
171
 Moreover, autonomy support was 
found to indirectly affect adherence; motivation was seen to mediate this relationship.
171
 Other 
significant findings provided support for HBM, through a negative correlation between 
adherence and perceived barriers, and the suggestion was made that autonomy may mediate the 
relationship between barriers and adherence. Overall, these results indicate that motivation, 
support, and barriers play a role in adherence, but, given the cross-sectional and short duration of 
follow-up, a deeper analysis was necessary.  
A more robust analysis was conducted by Williams (2009) in patients with diabetes. The 
purpose of this study was to further explore the application of SDT to adherence by extending a 
hypothesized model to include other constructs of the theory to this particular behavior. Both 
self-reported and medical claims data were used to assess medication adherence, the Treatment 
Self-Regulation Questionnaire was given to assess self-regulation and support, and the Perceived 
Competence Scale was used to assess the subjects’ perception of their ability to manage their 
diabetes.
172
 The authors concluded that their hypothesized model showed adequate fit: support 
related positively to regulation, which related positively to competence, which related positively 
to medication adherence.
173
 Moreover, these results provided support for earlier findings that 
indicated these same SDT constructs may play an important role in diabetes management.
174 
Taken together, these applications of SDT to medication adherence provide evidence that 
autonomous support and regulation as well as competence are important factors in the decision to 
take medications. Strong evidence in support of the application of this theory to diabetes was 
61 
 
observed and the suggestion made that motivation be addressed in clinical encounters to improve 
the odds of better self-management, an aim in line with recommendations made by the American 
Diabetes Association.
173,175
 Additionally, the Treatment Self-Regulation Questionnaire and 
Perceived Competence Scale were both tested and shown to be significantly relevant to 
medication adherence in patients with diabetes, evidence that the concepts inherent to these two 
instruments should be considered by future interventions. 
 
Conceptual Framework 
 
 Our basic conceptual framework for the study is detailed in Figure 1.5 which describes 
how the elements of each theory coordinate to explain and contribute to medication adherence, 
how personal elements aid the message development and delivery process, and how the process 
of message receipt is ultimately intended to lead to behavior change. Using responses to items 
related to HBM
176
 and SDT (Treatment Self-Regulation Questionnaire;
177 
Perceived Competence 
Scale
172
), each included concept (perceived severity, susceptibility, benefits, and barriers, and 
sources of motivation, autonomy, and perceived competence) is evaluated to determine the 
perceived level of each concept in individual subjects and then the impact that these constructs 
may have on treatment adherence. These theories were chosen based on the evidence, such as 
that highlighted above, that showed the concepts described by these models were related to 
medication-taking behavior and were appropriate for an intervention to address.
160,161,164,171,173,174
 
By including these concepts, we aim to address the perceived level of health belief or attitude  
with the intent of shifting these beliefs and attitudes in a direction known to increase the 
likelihood of medication adherence. For instance, increased perceived susceptibility and severity
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Figure 1.5 Conceptual Framework 
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have been found to be associated with an improvement in medication-taking;
164
 by encouraging 
an understanding of the importance of these concepts in the treatment process over time the aim 
is that improved adherence will ultimately be observed. Additionally, recognizing the need to 
guide subjects over time toward a target belief level, messages incorporate a developmental 
element, assuming that progress will be made as a result of the message content.
166
 Thus, Self 
Determination Theory is shown to apply to both how its concepts explain the target behavior as 
well as how a gradual progression may be incorporated.  
The eventual result of addressing HBM and SDT concepts over time is hypothesized to 
be improved levels of health beliefs and attitudes, which have been supported by previous 
research in this area and by the proposed means. Ultimately, our goal is to relate the changes in 
beliefs and attitudes to changes in behavior, in this case the levels of medication adherence, 
adding to our understanding of how concepts of HBM and SDT relate to medication-taking in 
patients with diabetes  
 
Aims and Hypotheses 
 
 The overall objective of this project is to test the effectiveness of individually tailored 
messages delivered by mobile phone text messaging in a sample of patients with diabetes. The 
central hypothesis is that tailored text messages will improve treatment-related beliefs and 
adherence to the prescribed treatment regimen beyond that observed in adult patients with 
diabetes receiving only standard care. This central hypothesis, as highlighted by the conceptual 
framework, will be tested by the following three specific aims: 
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1. Construct a library of and successfully deliver condition and treatment-related tailored 
text messages that can be used to influence medication-taking behavior using theory-
driven approaches among patients with diabetes. 
2. Assess the effect of tailored text messages on health beliefs related to treatments, 
conditions, and technology acceptance in patients with diabetes. 
3. Analyze changes in diabetes medication adherence between patients receiving tailored 
text messages and patients with only standard care. 
 
With these aims in mind, we have hypothesized the following: 
H1: The assessed beliefs and attitudes will be significantly and positively changed in patients 
receiving tailored text messages compared to patients with standard care and that mobile 
phone-based messaging will be perceived as a useful and easy to use healthcare tool. 
H2: Medication adherence will be significantly and positively changed in patients receiving 
tailored text messages when compared to subjects receiving standard care only. 
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CHAPTER II. PAPER 1: DEVELOPMENT AND DELIVERY OF TAILORED TEXT 
MESSAGES 
 
 
Abstract 
 
Background: Medication nonadherence remains a significant public health problem, and efforts 
to improve adherence have shown only limited impact. The tailoring of messages has become a 
popular method of developing communication to influence specific health-related behaviors but 
the development and impact of tailored text messages on medication use is poorly understood. 
 
Objectives: The aim of this paper is to describe an approach to developing theory-based tailored 
messages for delivery via mobile phone to improve medication adherence among patients with 
diabetes. 
 
Methods: Kreuter’s five-step tailoring process was followed to create tailored messages for 
mobile phone delivery. Two focus group sessions, using input from 11 people, and expert review 
of message content were used to adapt the survey instrument on which the messages were 
tailored and edit the developed messages for the target population.  
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Results and Conclusions: Following established tailoring methods a library of 168 theory-driven 
and 128 medication-specific tailored messages were developed and formatted for automated 
delivery to mobile phones. Concepts from the Health Belief Model and Self-Determination 
Theory were used to craft the messages and an algorithm was applied to determine the order and 
timing of messages with the aim of progressively influencing disease and treatment-related 
beliefs driving adherence to diabetes medication. The process described may be applied to future 
investigations aiming to improve medication adherence in patients with diabetes and the 
effectiveness of the current messages will be tested in a planned analysis. 
 
Background 
 
 A variety of interventions have been developed using communication theory to promote 
health behavior change. Many of these interventions have used targeted messaging whereby a 
particular patient population (defined by their age, disease, etc.) received the same type of 
message aimed at eliciting a particular behavior based on that group’s shared characteristics.1 
Over time, methods have become more focused, narrowing the emphasis from population-level 
factors to tailoring according to characteristics that reflect more proximate determinants of health 
behaviors, such as beliefs about the risks and benefits of treatment. By tailoring, behavioral 
interventions may highlight condition and treatment-specific influences that are most personally 
relevant to each subject with a clear, personalized goal in mind. 
 The general approach to tailoring health communication is to create messages that are 
individualized for each recipient based on information collected about that user via survey.  This 
information can be used to create original messages or can be added to pre-existing material. 
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Common survey elements used to tailor health communication include the participant’s name, 
age, gender, race, family structure, and details related to the outcome of interest (e.g. potential 
consequences of inadequate disease management and the benefits of adhering to self-
management plans). These characteristics are strategically placed into a message with the aim of 
influencing behavior by creating a piece of communication that appears to be relevant only to the 
recipient.  
The foundation for tailoring messages rests on information processing theory, which 
suggests that people are more likely to process information thoughtfully when they perceive that 
information to be personally relevant.
2
 A prominent example of such a theory, the Elaboration 
Likelihood Model (ELM) posits that separate routes of information processing (peripheral and 
central) influence how information is managed and is based on the individual’s need for 
cognition and motivation.
2
 The benefits of more elaborated processing include longer message 
retention and an increased likelihood of permanent attitude change.
3
 Therefore, applying ELM, 
the benefit of tailoring health communication is the improved odds of capturing users’ attention 
through individualization that will increase the likelihood of thoughtful consideration of message 
content and ultimately a greater impact on health behavior. 
 Message tailoring has shown promise as a mechanism for effectively promoting 
individual health behavior change. Reviews of tailored health interventions have concluded that 
tailoring is useful in a variety of areas including smoking cessation, physical activity, dietary 
change, and preventative screening.
4-16
 Tailoring has also been applied successfully to the 
problem of medication nonadherence: the inability to take medications as prescribed by a 
healthcare provider, which may be either intentional (due to motivational or perceived issues) or 
unintentional (forgetfulness). Positive applications of tailoring to medication adherence have 
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been observed among patients with hypertension, schizophrenia, hyperlipidemia, and asthma.
17-23
 
However, the vast majority of these studies were conducted using either print or computer-based 
materials, limiting their reach and effectiveness. Adherence problems are also common among 
people with diabetes, resulting in inadequate physiological control and a higher risk of 
complications.
24-26
 Unfortunately, interventions focused on improving diabetes medication 
adherence have had only limited success.
27
 Effective interventions for diabetes medication 
adherence support likely require an individualized approach addressing each patient’s array of 
health beliefs and other limitations- a problem for which tailored health communication may be 
ideally suited. 
Recently, mobile phone messaging has been increasingly used in tailoring studies. 
Mobile phones are nearly ubiquitous and could be an effective channel for improving self-
management support between face-to-face interactions with clinicians.
28
 Most studies focused on 
improving medication adherence using mobile phones have been limited to improving 
unintentional nonadherence through reminder messages, and results of these investigations have 
been mixed in terms of the effect on medication use.
29-34
 However, a limited number of studies 
have incorporated the tailoring of health messages into interventions focused on medication 
nonadherence. Petrie and colleagues (2012) showed improved medication adherence to 
controller inhalers among adult patients with asthma by text messaging subjects from 1 to 3 
times daily over 18 weeks.
35
 Several recent studies have combined mobile phone adherence 
reminders and tailored messages addressing patients’ beliefs associated with intentional 
nonadherence. For example, using an intervention called “Sweet Talk”—a tailored text 
messaging support system for patients with type 1 diabetes—Franklin and colleagues (2006) 
observed improvements in self-reported adherence to diabetes medications after 12 months.
36
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Such results suggest that tailored text communication could improve diabetes-related adherence, 
but additional testing is necessary to confirm and expand on our understanding of how this 
messaging channel may be most effectively applied. The aim of this paper is to describe an 
approach to developing theory-based tailored messages that can be delivered by mobile phone to 
improve medication adherence among patients with diabetes.  
 
Methods 
  
Kreuter’s five-step process of tailored message development was used to produce a 
library of messages addressing various contributing factors to nonadherence and an algorithm for 
individualizing each patient’s series of messages while customizing this approach for mobile text 
messaging delivery.
5
 This process included the following steps as suggested: problem 
identification, assessment tool creation, message creation, message storage, and tailoring 
algorithm development (Figure 2.1).
5
 The following section describes the processes taken to 
fulfill these steps for developing the message library for a diabetes adherence support 
intervention. This study was approved by the Institutional Review Boards at both the University 
of Michigan and Mercy Health Partners (Muskegon, MI). 
 
Problem Identification 
  
 Recognizing that diabetes medication nonadherence was an important contributor to poor 
outcomes, Lakeshore Health Network (“Network”), a physician hospital organization with over 
300 primary care and specialty physicians, began exploring potential solutions in 2011, including 
a community-wide medication adherence awareness campaign focusing on consumer 
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engagement. The Network prioritized strategies using information technology in order to 
improve self-management support in a way that would be potentially cost-effective. Tailored 
health communication supporting adherence and delivered via text messages appealed to the 
community’s health leaders, who partnered with researchers at the University of Michigan to 
develop such an approach. 
 To clearly define the problem, it was critical to first understand the specific factors 
impacting diabetes patients’ adherence behavior. Two theories of health behavior were chosen to 
establish a framework for understanding the processes determining diabetes medication use. 
Self-Determination Theory (SDT) suggests that people are driven by 3 essential needs:  
competence, relatedness, and autonomy. The pursuit of these needs is reflected in a continuum of 
motivation, ranging from amotivation to intrinsic motivation, where the latter is completely self-
determined.
37
 Evidence suggests that the likelihood of long-term maintenance of behavior 
change is increased if one is intrinsically motivated rather than influenced by external forces.
38, 39
 
For example, individuals may take medications initially because physicians tell them to do so. 
Over time, continuing to take medications is likely a decision based on internal motivation that 
includes an implicit balancing of benefits and costs to the user. Ultimately, medication taking 
may become habit; however, adoption of such a behavior may be a process for some and, as 
such, requires that messages encouraging the behavior guide the patient along the way rather 
than forcing change upon them. Applied to medication-taking, Self-Determination Theory 
concepts have been found to be related to this behavior: evidence suggests that autonomous self-
regulation and perceived competence each play an important role in the ongoing taking of 
medication.
40 
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The Health Belief Model (HBM) has been extensively applied to a variety of health 
behaviors including medication adherence. Using the model, studies of adherence have identified 
numerous barriers that contribute to inadequate medication use and several health beliefs 
(perceived susceptibility, severity, and benefits) have been predictive of this behavior.
18, 41, 42
 At 
its core, HBM posits that a health-related action will be taken if a person believes that a negative 
health condition can be avoided through that action, the behavior is likely to result in a positive 
outcome, and they can successfully execute the intended behavior.
43
  In the context of 
medication use, the likelihood of an individual taking their medication may then be increased if 
they believe that they are susceptible to a specific condition, believe that condition would have 
serious potential consequences, believe that taking the medication would reduce the probability 
or severity of the condition, and understand that these benefits outweigh any costs of or barriers 
to taking the medication. Additionally, the likelihood of taking the medication would be 
increased if the individual believed in their ability to take it as directed and may also be 
improved if triggers to taking the medication (such as symptoms or encouragement) are 
introduced. Multiple studies have observed the role that HBM constructs may play in the 
medication-taking process, suggesting that levels of each of the incorporated concepts may be 
predictive of resulting adherence or nonadherence.
44-49
 Applying this model allows the crafting 
of messages to be based on the particular constellation of beliefs for individual patients and the 
level of belief individuals have in each construct 
 
 
Assessment Tool Creation  
 
Initial concepts and items in the assessment tool 
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 The first step in message development is the selection of a proper survey to capture 
patient characteristics that can guide the tailoring process. In the current study, the tailoring 
process was guided by instruments incorporating Self-Determination Theory and the Health 
Belief Model. (Figure 2.2)  
 Concepts related to Self-Determination Theory were captured using the Treatment Self-
Regulation Questionnaire (TSRQ) and the Perceived Competency Scale. The concepts of 
motivation and support as measured in the TSRQ have acceptable internal consistency 
(Cronbach’s α > 0.80) and validity has been verified in diabetes.50, 51 Perceived competence was 
measured using items from the Perceived Competence Scale, allowing messages to be based on 
initial competence that can be adjusted over time. Cronbach’s α for this scale is 0.94 and support 
for its construct validity has been demonstrated.
52
  
The extensive application of Health Belief Model (HBM) to health behaviors has 
produced validated survey instruments specific to conditions and modes of treatment. We used a 
diabetes-specific instrument developed by Given (1983), and then by Becker and Janz (1985), to 
capture diabetes and treatment-related health beliefs.
53,41
 The Cronbach’s α ranged from 0.70 to 
0.89 depending on the domain of the scale and content validity was verified by a separate 
study.
53, 54
 Using this instrument, 4 HBM concepts were assessed including perceived disease 
severity, susceptibility to negative outcomes, benefits of medication use, and barriers to 
medication use.  
  In addition to these theory-driven items, 2 other domains of questions were added to the 
instrument to more deeply tailor the messages. The subject’s name was used in every message 
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and their age was used sporadically. In addition, we included details about the subject’s current 
diabetes medications, including the name of the medications (as written on the bottles), number 
of times taken each day, number of pills taken at each dose, and time of day the medication was 
to be taken. This information was used to time text message delivery and craft messages that 
would be specific to each subject’s treatment (benefits, safety, and mechanism of action). The 
name of medications was also included in some theory-driven messages.  
 
Assessment tool adjustment 
 
 To incorporate specific perspectives from the target population in the message design, 2 
focus groups were held on separate days including patients with diabetes from the Muskegon, MI 
area. These sessions were led by the study’s primary investigator and guided by questions 
focused on issues related to diabetes treatment adherence and mobile phone use. The goal of the 
focus groups was to uncover any medication-taking problems specific to this community and not 
already considered in our theories, as well as inform the study on how adults in the area use their 
mobile phones to text message and access health-related information. Recruitment was done with 
advertisements in area physician offices, pharmacies, and community health practices using 
flyers and word-of-mouth. The target population for these sessions was intended to represent the 
population of interest for the larger, proposed study: adults with diabetes currently under 
treatment for diabetes and who had an active mobile phone. Basic demographic information on 
the participants was collected by an anonymous survey given at the end of each session. Sessions 
were audio recorded, dictated by a research assistant, and lasted approximately an hour each.  
Transcriptions were analyzed by the principal investigator following each session.  Emerging 
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themes and concepts were noted and used to inform potential changes to the proposed 
assessment tool and the message development process.  
Two sessions were held including 11 people with diabetes. All but 3 of the participants 
were female, most were Caucasian, and most had been diagnosed with type 2 diabetes (Table 
2.1). Most participants reported that they have been treated for diabetes for 5 years or less. 
Participants’ ages ranged from 48 to 69 and the number of medications being taken for diabetes 
ranged from 0 to 4.  
Several themes were identified from the focus groups.  First, participants reported that 
their mobile phone use was relatively limited. Most indicated that they used their phone for basic 
functions, generally talking to family members or for emergencies, and if other functions were 
used it tended to be text messaging. When texting, many subjects indicated that it was mostly for 
communicating with family members, 1 person specifically mentioned that they “liked the 
texting because it is faster.” For those utilizing texting functions, estimates of the number of 
messages per day ranged from 1-2 to 9-10. However, not all participants viewed texting 
favorably: “I don’t like reading information on text messages…texting is for the younger 
people.” One subject specifically mentioned that the size of the text in the message made them 
too difficult to read. Members of both groups reported even more limited use of smartphone 
applications. 
 Several participants indicated that they already used their mobile phone to access health-
related materials, mostly to gather information about symptoms and treatments. However, the 
majority of participants indicated that the computer remains their primary source of health-
related information, “to see what’s wrong, you know symptoms that I have. I just Google it.” 
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Patients who sought health information online did so with varying frequency, some as often as 
weekly and others less than once every few months. When asked how valuable they would view 
receiving personalized health-related information on their phone, participants reported mixed 
feelings. Generally, those already using their phones on a more regular basis reported more 
favorable interest; however, more consistent support was garnered for receipt of similar 
information if delivered by “snail mail…a couple times a month.” 
 Participants indicated that adherence to their prescribed diabetes treatment was generally 
good: “I don’t see a challenge, just follow the rules. They say just take it 2 times a day and that’s 
what I do”.  When given explicit directions from their physician, these subjects indicated that 
they were better able to follow the protocol, knowing what the consequences of inaction would 
be. Moreover, if doses were missed, respondents indicated that these were only on occasion.  
 However, 1 point was raised by members of both focus groups. When beginning a new 
medication, participants said that they would have benefitted from learning more about potential 
side effects of new treatments. Multiple participants mentioned unexpected side effects that were 
brought on by new medications that were not mentioned by their providers. Specifically, the 
participants suggested that these details could have been better described to them by pharmacists: 
“As soon as they gave [it to] me I wish they had told me I would feel tired. It’s three o’clock in 
the evening and I’m trying to go do something and I was knocked out. They didn’t tell me that 
right away.” 
Based on the information from the focus groups, changes to the assessment tool were 
deemed unnecessary, as other challenges to the medication use process in this population were 
not identified. However, 1 item from the original survey was removed as it was specific to 
changing eating habits rather than medication use; altering this item to fit the study’s aims was 
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deemed inappropriate. The final assessment tool included 3 sections (a medication list, the 
theory-based items, and demographic details) and 34 items, 29 of which were used for tailoring 
(Appendix).  
 
Message Creation  
 
 Based on the items in the assessment tool, text message stems were drafted using each 
theoretical concept survey item, and the range of answer options for each item was used to 
develop different messages tailored to the specific response on that item. The assessment tool 
included Likert-type items with response options ranging from “strongly disagree” to “strongly 
agree” for HBM constructs and from 1 to 7, ranging from “not at all true” to “very true”, for 
SDT items. For Health Belief Model items, messages were written for responses deemed “high” 
or “low”. This was determined using a survey response to each item where responses of “agree” 
or “strongly agree” (“disagree” or “strongly disagree” for those reverse coded) indicated “high” 
and responses of “uncertain”, “disagree”, or “strongly disagree” would indicate “low” 
(“uncertain”, “agree”, or “strongly agree” for those reverse coded). For Self-Determination 
Theory items, messages were drafted for “low”, “medium”, and “high”, corresponding to 1 and 
2, 3 to 5, and 6 and 7 responses, respectively, or the opposite if reverse coded. For example, a 
response of “2” to the first item related to competence, “I am confident that I can take care of my 
diabetes” would suggest that this subject had a low level of this construct and that the individual 
would then receive a “low” message. 
 Messages within each level were framed with the goal to improve or make more positive 
the concept/attitude, and the intention of the messages was to guide rather than force change 
from a less desirable to a more optimal level.
38
 Practically, this means that those starting at “low” 
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or “medium” would receive messages intended to guide them toward a higher level of either 
“medium” or “high”. This approach may include recognizing the challenges of their treatment or 
condition, acknowledging the frustrations that may be introduced by external pressures, 
recognizing small victories, or valuing gradual progress. Conversely, subjects starting at “high” 
would only receive messages that reinforced this level of the intended concept. These messages 
were framed with maintenance and recognition in mind to keep subjects at the target level. Each 
message had a singular theme aligned with the corresponding survey item (Table 2.2). This eased 
the manner by which subjects may be guided toward more optimal levels of beliefs and self-
determination. Two to 3 separate messages per item-level were drafted because of the number of 
messages required for the study. Consequently, 96 Health Belief Model messages (16 items and 
2 levels) and 84 Self-Determination Theory messages (12 items and 3 levels) were created. 
 Drafts of the message stems were reviewed by an expert panel of health behavior 
researchers for readability (appropriate reading level), content (matching of the material to the 
concept), and tone (matching of the messages to the response level). Suggested revisions 
centered on appropriately structuring messages that included the subject’s age—to avoid 
inadvertent stereotyping—as well as simplifying the language to an 8th grade reading level. The 
study team recognized that the medication-specific messages detailed the benefits of each 
treatment, and the inclusion of medication tailoring in benefits-based messages was redundant. 
As a result, only 2 messages per item-level focusing on “perceived benefits” were included in the 
library. After this review, substantive changes were applied to 55 of the theory-based items. 
Following these changes, a total of 168 potential, theory-based messages were included in the 
final library.  
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 Messages were also developed that included tailoring based on diabetes treatment with 
messages addressing medication efficacy, safety, mechanism of action, and reminders. These 
messages were crafted for 10 therapeutic classes of medications, including 5 combination 
products and 3 insulin categories, and did not vary for individual products available in each 
class; however, combination medications were handled by including information about both 
therapeutic classes. Separate messages were created for short, intermediate, and long-acting 
insulin. Based on feedback from focus groups, several messages were drafted that focused on 
communication with providers, specifically pharmacists, to encourage patients to ask for 
medication-specific information. Up to 3 messages per category were developed resulting in a 
total of 128 possible messages; a clinical pharmacist reviewed initial drafts for clarity and 
accuracy. Two of the 128 potential messages were revised and all messages were deemed 
appropriate for inclusion in the final library.  
 Finally, messages were edited to limit their length to approximately 160 characters to 
allow for the inclusion of the subject’s age, name, and medication names. Such limitations 
allowed the messages to be properly delivered by a single mobile phone text message.  
 
Message Storage 
 
 The final library was maintained in a Microsoft Excel spreadsheet, which served as the 
primary tailoring engine for the larger study. The file was programmed to automatically 
concatenate the subject’s name with the appropriate message stem after all stems (both 
medication and theory-based items) were pulled from the library.  
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Tailoring Algorithm 
 
The tailoring algorithm provides the logic to link the messages with survey responses and 
places them in a predetermined way that is established by the investigator. Tailored messages for 
each subject were constructed in a step-wise fashion. First, raw survey information (name, 
medications, and item responses) was entered into coded worksheets. These responses created 
coded output that concatenated information based on survey item number and leveling. For 
instance, a response to the first item indicating “low” competence on the baseline survey would 
retrieve the appropriately leveled message stem from the library creating a list of the specific 
theory-based messages for this item (3 in total). This process is then repeated for each survey 
item until all theory-based messages are created using baseline measures and the message bank is 
populated for each user. Concurrently, medication codes retrieved all of the medication message 
stems from the library based on the subject’s reported treatment plan, and all message stems 
were automatically concatenated with the subject’s name and a randomly selected greeting (e.g. 
Hello, Hi, Good [morning, afternoon, evening], etc.) Finally, the subject’s age and/or 
medications were manually imputed to select, randomly determined messages. These additions 
increase the specificity of the message to the individual, creating a message that is tailored on 
upwards of 5 characteristics (name, timing, treatment, age, and beliefs). For instance, a subject 
(Jane) with a baseline competence level of “low” (response equaled “1” or “2”) would receive 
the following message related to competence: “Hello, Jane. Building confidence in being able to 
take care of your diabetes takes time. But you make progress every day by following your 
treatment plan.” 
 The ordering and delivery of messages was based on several constraints. First, the 
associated intervention lasted 90 days with participants receiving 1 tailored message per day. 
 90 
This allowed for 78 theory-driven messages for each subject; 12 tailored, medication-specific 
messages were added in order to total 90 messages.   
Second, the leveling of items had to be considered as the delivery of messages was 
intended to guide subjects from lower to higher levels of the concepts over the 90-day 
intervention. The system was designed so that subjects would receive 2 Self-Determination 
Theory messages from their baseline level and 1 message from the next higher level with both 
sets drawn randomly from the available messages in each level. As an example, a subject with a 
baseline level of “low” for a competence item would receive 2 messages from the “low” 
category and then their third message would be from the “medium” category. Subjects whose 
baseline response was high for any item would receive 3 messages from the “high” category in 
order to maintain their self-reported level. Messages for subjects beginning at “low” for Health 
Belief Model items—meaning baseline survey response indicated a limited understanding of or 
belief in their disease severity or susceptibility—would first receive 2 messages to encourage 
understanding of these concepts and then change to messages focusing on reinforcement as they 
progressed through the intervention. Following this approach, subjects who were low for any 
HBM construct would receive 2 messages from the “low” category and then 1 message from the 
“high” category. For instance, a subject deemed “high” for an item related to severity may 
receive a message with the following text: “You know how serious diabetes can be. Taking your 
medications as directed will help you control this condition and improve your health.” 
Finally, as stated earlier, medication messages were incorporated into the algorithm to fill 
the gap created by the number of theory-driven messages and the 90-day study period. All 
subjects received the same number of medication-specific messages and these were received on 
defined days that were identical for each subject; however, the mix of the types of medication 
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messages (efficacy, mechanism of action, and potential side effects) was dependent on the 
number of medications for each subject. All messages were timed for delivery based on the time 
of day at which the first dose of any medication was reported to be taken.  
 The order of messages was pre-determined to alternate between theories and their 
individual concepts, but an identical scheme for each subject for the order of messages was used 
(Figure 2.3). The final algorithm specified that theory-driven messages alternated between those 
based on HBM and SDT until all messages were exhausted. Using the baseline level for each 
item, messages began with the first message for the baseline level of each corresponding item, 
cycling through the first message, then the second, and (if applicable) the third item.  
 Once placed in chronological order, message stems were automatically combined with 
the subject’s name and a randomly assigned greeting. The addition of subject medication and age 
were completed manually prior to message delivery. Following these steps, the resulting 
combination of messages was stored in individual worksheets (1 per subject) and formatted to 
meet the needs for server-based delivery to each subject’s mobile phone.  
 
Discussion 
 
 Tailored messaging has become an increasingly used means to encourage health-related 
behaviors, including medication adherence. Only recently has this approach been modified to 
communicate with patients by mobile phone text messaging. Building effective messages that are 
sufficiently tailored and formatted for mobile phone delivery poses unique challenges. A 
repository of theory-driven messages is vital to the success of mobile phone-based and tailored 
adherence support services. Applying the library of messages built by the methods described 
here will contribute both broadly, by adding available messages to the architecture of tailoring, 
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and specifically, by demonstrating how tailored text messages may impact medication 
adherence. 
The applied methods were similar to prior efforts although there were some important 
differences. Applying “Sweet Talk”, Franklin and colleagues targeted pediatric patients with 
type 1 diabetes using messages that were informed by Social Cognitive Theory but their 
approach had a more universal focus on self-management behaviors (e.g. exercise and glucose 
self-testing) rather than a specific targeting of medication use.
36
 Moreover, as an intervention 
targeting children, “Sweet Talk” involved the use of ‘texting jargon’—the shortening of 
particular words—that likely improved the resonance of the messages with this younger 
population. 
More recently, Petrie and colleagues focused on improving asthma treatment adherence 
in young adults.
35
 The basis for their messages was a validated Illness Perceptions 
Questionnaire.
55
 Messages were crafted around each illness perception item in order to change 
beliefs over the course of the intervention. This was accomplished using responses to the 
instrument’s 11-point scale; messages were tailored to match baseline patient beliefs for those 
higher or lower than the mean reported values. However, those within the standard deviation of 
the mean responses for a particular item did not receive a message tailored for that belief and it 
was unclear whether these messages were replaced with others. It was also not clear to what 
extent individual patient characteristics were used in message tailoring. In contrast, our message 
delivery was designed to reach all participants for all concepts of each theory, regardless of 
baseline values, so that all elements studied were tailored to and studied.  
The current methods have limitations. Both the type and number of messages were 
limited to 2 health behavior theories and daily delivery, respectively. While evidence suggests 
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that such a “dose” of messages is acceptable to subjects, a truly individualized approach would 
incorporate patient preferences for the number of messages into the design.
35
 Moreover, a host of 
health communication and behavior theories (e.g. Theory of Planned Behavior, Trans-theoretical 
Model, Regulatory Focus Theory) could apply to the message creation process, particularly 
expanding on the role of need for cognition as defined by the Elaboration Likelihood Model. 
Additionally, messages did not consider the effect of present versus future oriented subjects 
when framing messages from either a loss or gain perspective- a previous study highlighted the 
impact that this type of framing may have on medication adherence.
56
 Similarly, messages were 
drafted without specific subject input to the process and content; future studies should 
incorporate this step into the message-creation process to improve the specificity and content of 
each message as well as to increase the use of patient preferences. Also, while the theories 
applied to the current messages supplied sufficient concepts for tailoring, they may not be 
comprehensive in addressing all factors that influence medication use. Specifically, the cost of 
medications was not addressed and the concern for side effects, while acknowledged by our 
medication-specific messages, was not applied extensively in this study. As previous research 
has suggested the role that these concerns may play in motivating adherence to medication, 
future studies involving theory-driven messaging should consider including these issues in the 
message development process.
57
 
The process described by Kreuter and demonstrated herein is a practical approach to 
tailoring messages aimed at changing a specific behavior. This study’s methodology applied 
such an algorithm with the goal of delivering tailored messages by mobile phone- one of the first 
studies to do so. The result of this integration is a process that similar studies may duplicate so 
that further theory-driven tailoring of text messages may be applied to improving medication 
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adherence and other health-related behaviors. The current library of messages will be tested in a 
future study among patients with poorly controlled diabetes. Specifically, this will quantify the 
impact of tailored text messages on patients’ beliefs regarding diabetes treatment and their 
disease as well as the impact of the intervention on users’ acceptance of mobile technology and 
medication adherence.  
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Table 2.1 Focus Group Subject 
Characteristics 
 
 
 
 
 
 
 
 
Total n = 11 
 
 
 
 
 
 
 
 
  
Characteristic Frequency (n) 
Gender  
Male 3 
Female 8 
Race  
Caucasian 6 
African American 4 
Hispanic 1 
Diagnosis  
Type I Diabetes 4 
Type II Diabetes 7 
Treatment Years  
<1 4 
1-3 2 
3-5 1 
5-10 2 
>10 2 
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Table 2.2 Message Themes  
Concept        Themes Example Message Stems 
Severity  Condition progress and control 
 Daily effort to manage diabetes 
 Role of medications in reducing the risk of future 
complications 
 Serious nature of diabetes, now and in the future 
 Low: even if your diabetes isn’t controlled today, taking your medications, 
exercising, and eating right will help you reach your goal  
 High: sounds like you are making progress with controlling your diabetes. Keep 
up the good work! 
Susceptibility  Treatment adherence even when feeling well 
 Potential for future health problems 
 Symptoms of illness 
 Chronic nature of diabetes treatment 
 Low: even when you start to feel better, be sure to stick with the diabetes plan 
your doctor and you agreed upon. It’ll pay off in the long-run  
 High: recognizing that there is more to treating your diabetes than just feeling 
ok is a great way to approach your health. Keep it up!  
Barriers  Adjusting daily habits/routines to fit medication-
taking needs 
 Means to ease the process of taking medications 
 Understanding prescribing directions 
 Low: your normal activities don’t have to be affected by your treatment. Pair a 
daily activity with taking your medications to easily fit them in  
 High: sounds like your doctor gave you great direction on your diabetes 
medications. Be sure to put that plan in action every day  
Benefits  Belief in self-efficacy 
 Adjunct therapy to medication 
 Symptom relief 
 Tailored treatment plan 
 Low: your medications can go a long way in controlling your diabetes. The plan 
your doctor outlined is tailored to meet your needs and improve your health  
 High: believing in the power of your medications is great, taking them as 
directed will show you how much you can control your condition  
Competence  Confidence in self-treatment 
 Making daily progress toward treatment goals 
 Acknowledging and managing treatment 
challenges 
 Low: controlling diabetes can be challenging but there’s a lot in your control, 
like following your medication schedule and eating well  
 Medium: meeting the challenges of controlling your diabetes takes time, but 
taking your medications as directed moves you closer every day  
 High: thinking you can meet the challenges of your diabetes head on is a 
powerful attitude. Stay strong and keep up with your treatment 
Motivation  Importance of medications 
 Incremental impact of medications 
 Taking responsibility for own health 
 Indirect effects of medication taking 
 Low: it may be tough to see but taking your diabetes medications is vital to your 
health. Taking them as directed may help you see their value  
 Medium: many things are important for your health when you have diabetes. 
Taking your medications as directed is one of them. See for yourself  
 High: you’re right. Taking your diabetes medications is one of the best things 
for your health. So, keep taking them as directed to reach even better health  
Support  Limiting external pressure(s) 
 Upsetting others 
 Proving self-efficacy 
 Approval for managing treatment 
 Low: when it comes to health the only approval you need is that of your body 
when it gets the benefit it needs from medications to treat your diabetes  
 Medium: by focusing on your treatment plan you are gaining the only approval 
you need: that of your body. Your medications are designed to help with this 
 High: you’re right, the only approval you need is your own and that of the 
benefit of the good health you’ll see from sticking to your treatment plan  
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Figure 2.1 Kreuter’s Five-Step Tailoring Process 
  
Adapted from process detailed in Kreuter, 1999
5
5. Algorithm Development 
Decision rules for message element combination Test final message combinations 
4. Developing a Database 
Create item response data field Code all response options 
3. Creating Tailored Messages 
Map potential respontial tailored approaches Construct message library 
2. Developing an Assessment Tool 
Select existing survey items Develop original items, if necessary 
1. Analyzing the Problem 
Determine a target behavior Consider potential factors or relevant models 
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Figure 2.2 Framework for Message Development   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Self-Determination Theory 
Demographics/Individualization 
Message Content Message Delivery 
Regulation Competence 
Treatment and condition-
related health beliefs 
Perceived Benefits 
Perceived Severity 
Perceived Susceptibility 
Perceived Barriers 
Motivation 
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Figure 2.3 Tailoring Process and Algorithm
Survey Responses 
Personal Details Theory-Based Items Medications 
Age Name 
Establish baseline 
response level 
Pull all needed messages 
from library 
Order by message code and 
scheme 
Determine message 
scheme 
Populate 
medication 
list 
Pull all potential 
messages from library 
Determine needed 
medication messages 
1. Severity1_Msg1 
2. Competence1_Msg1 
3. Susceptibility1_Msg1 
4. Motivation1_Msg1 
5. Barriers1_Msg1 
6. Support1_Msg1 
7. Medication_Msg1 
8. Severity2_Msg1 
9. Competence2_Msg1 
10. Susceptibility2_Msg1 
11. Motivation2_Msg1 
12. Barriers2_Msg1 
13. Support2_Msg1 
14. Medication_Msg2 
15. Benefits1_Msg1 
Repeat at baseline level for 
Third iteration sends message   
Automated merging 
Randomized 
greeting 
Manual entry 
Completed messages 
Concatenate 
16. Severity3_Msg1 
17. Competence3_Msg1 
18. Susceptibility3_Msg1 
19. Motivation3_Msg1 
20. Barriers3_Msg1 
21. Support3_Msg1 
22. Medication_Msg3 
23. Severity3_Msg1 
24. Competence3_Msg1 
25. Susceptibility3_Msg1 
26. Motivation3_Msg1 
27. Barriers3_Msg1 
28. Support3_Msg1 
29. Medication_Msg4 
30. Benefits2_Msg1 
second message per item. 
at next highest level per item. 
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Appendix. Tailoring Survey Instrument Items 
 
Section Category Item 
Medication Use
a 
Diabetic regimen Name of medication 
Number of pills 
Times taken per day 
Time(s) of day taken 
Health Beliefs
b
 Severity My diabetes is well controlled. 
My diabetes would be worse if I did nothing about 
it. 
I believe that my medications will help prevent 
complications related to diabetes. 
Diabetes can be a serious disease if you don’t 
control it. 
Susceptibility My diabetes is no problem to me as long as I feel 
alright. 
My diabetes will have a bad effect on my future 
health. 
My diabetes will cause me to be sick a lot. 
I believe I will always need my diabetes 
medications. 
Benefits I believe I can control my diabetes. 
I believe that my medications will control my 
diabetes. 
My medicine makes me feel better. 
Barriers I would have to change too many habits to follow 
my medications. 
It has been difficult following the medications 
prescribed for me. 
I cannot understand what the doctor told me about 
my medications. 
Taking my medications interferes with my normal 
daily activities. 
Self-Determination
c
 Competence I am confident that I can take care of my diabetes. 
I can handle my diabetes now. 
I can do my own routine diabetes care now. 
I can meet the challenge of controlling my diabetes. 
Motivation Taking my diabetes medication is very important 
for being as healthy as possible. 
I personally believe that taking my diabetes 
medications is the best thing for my health. 
I feel that I want to take responsibility for my own 
health. 
I have carefully thought about it and believe taking 
my medications is very important for many aspects 
of my life. 
Support I feel pressure from others to take my diabetes 
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medications. 
Others would be upset with me if I didn’t take my 
diabetes medications. 
I want others to see that I can take my diabetes 
medications. 
I want others to approve of me. 
Demographics Age
d 
Subject age 
Gender
e 
Subject gender 
Marital status
e 
What best describes your current marital status? 
Race
e 
What race best describes you? 
Income
e 
Total household income? 
Inhabitants
d 
With how many people do you currently live? 
a
 Responses were written in by the subjects in the space provided; time of day was indicated among given options. 
b
 5-item Likert scale responses, ranging from “Strongly Disagree” to “Strongly Agree” 
c
 7-item Likert scale responses, ranging from “1 (Not at all true)” to “7 (Very true)” 
d
 Open-ended response 
e
 Categorical options given 
 
 106 
 
 
 
CHAPTER III. PAPER 2: USE OF MOBILE PHONES AND PERSPECTIVES ON 
TAILORED TEXT MESSAGES IN ADULTS WITH DIABETES 
 
Abstract 
 
Background: Mobile phone text messaging has become an increasingly popular means to 
exchange information. Little is known about the preferences for and acceptance of text messages 
by patients. 
 
Aims: To evaluate the use of mobile phones, acceptance of text messaging, and perspectives on 
receiving tailored text messages in adults with uncontrolled diabetes. 
 
Methods: A total of 48 subjects were recruited into a randomized controlled study to improve 
medication adherence; 21 individuals provided responses on technology acceptance and 12 
personal telephone-based interviews were conducted. Following 90 days of receiving tailored 
text messages, subjects in the intervention arm were surveyed on technology acceptance and 
interviewed to obtain personal perspectives on the receipt of tailored materials and preferences 
for the use of mobile phones during the treatment process. 
 
Results: Text messaging was relatively limited (<10 per day) among most participants and those 
texting more frequently tended to be younger and own a smartphone. Acceptance of text 
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messaging in the treatment process, in terms of usefulness and ease of use, was high; only 
perceived competence and barriers were found to have significant relationships with either 
acceptance concept. Subjects felt that receiving one message per day was appropriate and 
generally benefitted from the content but indicated that messages tended to still serve as 
reminders.  
 
Conclusions: Acceptance of tailored text messages was high in adults with diabetes and subjects 
felt they could benefit from receiving similar messages in the future.  
 
Introduction 
 
Mobile phones are a nearly ubiquitous piece of technology, the use of which has 
increased dramatically in the last two decades. Between 1992 and 2012, wireless phone 
subscriptions in the United States grew from just over 11,000,000 to over 326,000,000.
1
 
Currently, an estimated 91% of American adults own a mobile phone, up from 78% five years 
ago.
2
 Most of these devices are now smartphones (56%), the ownership of which has increased 
dramatically, growing by over 20 percentage points in the past two years and penetrating all 
socioeconomic levels.
2
 A higher percentage of American adults now own mobile phones than 
report using the Internet.
3
 Moreover, while minutes of talk time have remained relatively stable, 
the estimated number of text messages exchanged between devices has more than doubled since 
2008: over two trillion messages were sent last year, the majority of which among younger 
populations.
1,4
  
Capitalizing on widespread ownership and advanced connectivity, the healthcare 
community has begun to leverage mobile phones in the delivery of care. As of 2012, nearly one-
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third of cell phone owners reported using their phone to search for health or medical information, 
the percentage of which having nearly doubled from two years prior and is well distributed 
across socioeconomic levels. Moreover, nearly one in five adults now own health-related 
applications on their phone to assist in the tracking or management of their condition.
5
 
Considering the penetration of mobile applications and operability in the healthcare market, 
researchers have employed mobile technology in the conducting of behavioral interventions.  
To date, text messaging has been the most popular mobile channel used by interventions 
but direct calling, Internet, and e-mail functions have also been applied.
6
 A variety of conditions 
and behaviors have been targeted across these studies, including smoking cessation, appointment 
keeping, physical activity, diabetes, hypertension, and asthma.
6-8
 Medication nonadherence has 
also been addressed, primarily using reminder messages to encourage the proper taking of 
medications, mostly in chronic conditions.
9-14
  
Estimates suggest that less than 10% of American adults receive updates or alerts by text 
message and over 80% of the mobile Internet usage is in adults 49 years of age and younger.
5
 
Importantly, several studies evaluated the receipt of messages in their subjects to better 
understand the acceptance of such a system. In these studies, acceptance of and satisfaction with 
receiving text messages focused on medication adherence was high, and this was observed in 
investigations with a variety of dosing schemes ranging from one to three daily and even in those 
employing an adjusting dose.
11, 13-17
 However, if mobile platforms such as text messaging and 
smartphone applications, focused on health and medicine, are to be more widely accepted, more 
must be understood about the use of cell phones, and their capabilities, as well as the needs and 
preferences in certain patient populations. 
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The Technology Acceptance Model, an extension of the Theory of Reasoned Action, 
suggests that the fundamental determinants of acceptance of a technology are its perceived ease 
of use and perceived usefulness (Figure 3.1).
18, 19
 Specific to mobile phones, research has 
suggested that these two concepts are major factors influencing the intention to use mobile text 
messaging.
20
 While several investigations have considered the influence of external variables on 
perceived ease of use and usefulness, our understanding of how patients perceive and accept 
mobile messaging, in the context of healthcare delivery, is severely limited.  Considering the rate 
by which text messaging is used by the general population, it may be assumed that many would 
adopt this communication channel as a healthcare tool. However, while differences in use by age 
have been observed, it is possible that condition-related factors may also influence text message 
use and a better understanding of potential influencers would aide practitioners and developers in 
the pursuit of improving the exchange of information with patients. As part of an intervention 
focused on improving medication adherence in adults with diabetes, this research aimed to better 
understand how patients actually use and perceive using their mobile phone in the treatment 
process. The objectives of this paper were to describe general mobile phone use, illustrate 
personal responses related to the receipt of tailored text messages, and evaluate mobile phone 
acceptance in a population of patients with diabetes. These findings provide insight to the 
characteristics, health beliefs, and motivations that may influence the acceptance and eventual 
use of text messaging during the treatment process. 
 
Methods 
 
Design 
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Mobile phone use and acceptance in adults with diabetes were evaluated as part of a 
randomized, controlled intervention using tailored text messages to address medication 
nonadherence. The intervention employed theory-based individualized text messages focused on 
condition and treatment-related beliefs as well as medication-specific information over a period 
of 90 days. The message development and delivery process is described elsewhere.
21
 Participants 
in the active arm received their daily message at the same time each day in conjunction with the 
time of day at which the first medication was taken; control arm subjects received a monthly 
“thank you” message throughout their 90-day period. Institutional Review Board approval was 
received from both the University of Michigan and Mercy Health Partners (Muskegon, MI) for 
all study components. 
 
Subjects 
 
Subjects for the intervention were recruited from a community-based primary care 
network in western Michigan. Eligible subjects for the randomized study included those 
diagnosed with diabetes, taking at least one antidiabetic medication, and having a hemoglobin 
A1c of at least 8.0% (according to their most recent test). Patients were excluded if they had 
experienced a stroke or heart attack, been diagnosed with congestive heart failure, or did not own 
and operate a mobile phone. Following screening and informed consent, eligible subjects were 
randomized (using a random number generator) to a study arm where they would receive either 
one tailored text message per day for 90 days or standard care only. All subjects were then 
mailed a survey and were considered enrolled once this was completed and returned; a similar 
survey was mailed after the 90 days of the intervention. All subjects, regardless of study arm, 
were compensated $50 for their participation.  
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The intervention ran from December 15, 2012 through September 24, 2013, and 2,230 
study-related messages were sent and 94.3% were delivered properly as scheduled according to 
the system. Most interruptions in message delivery were isolated incidences (e.g. one missed 
day, received later in the day) with one exception where a phone was disconnected.  
Subjects in the tailored text messaging arm were asked to participate in a brief phone 
interview (10-15 minutes) at the end of the study to capture perspectives on the receipt of 
tailored text messages. Subjects were randomly selected until half of the cohort had participated, 
and oral consent to participate was obtained from each subject prior to participating. All subjects 
were compensated $10 for being interviewed. 
 
Data Collection 
 
At entry to the intervention, all enrolled subjects (regardless of study arm) were surveyed 
on general mobile phone utilization and ownership. Items focused on the type of phone owned, 
including service provider, frequency of texting, and monthly service costs. Among those 
subjects in the intervention group, technology acceptance was evaluated after 90 days of 
receiving tailored text messages. Four items guided by the Technology Acceptance Model were 
included in the endpoint survey and adapted for patients with diabetes from an instrument used 
to investigate SMS (text) messaging employed previously by Kim and colleagues.
18, 20
 The 
included items surveyed subjects on perceived usefulness and perceived ease of use (two items 
for each concept), the degree of which, according to the model, influences the user’s attitude 
toward a particular technology and, ultimately, their intention to use the technology.
18
 Seven-
point Likert scales were used for this study, ranging from 1 (strongly disagree) to 7 (strongly 
agree). Scale reliability for perceived usefulness and perceived ease of use were demonstrated 
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previously to be 0.77 and 0.91, respectively.
20
 Additionally, subjects were surveyed on their 
health beliefs and level of self-determination (according to concepts related to the Health Belief 
Model and Self-Determination Theory) using items from three established sets of instruments, 
the details of which have been described previously.
21 
 Questions in the personal interviews focused on opinions of the messages in terms of 
content, their role in the treatment process, frequency, and their anticipated use of mobile phones 
for diabetes management in the future. The primary investigator conducted all interviews and 
notes were recorded on a standardized form for each response item.  
 
Analysis 
 
For analysis, responses to baseline survey items were combined with demographic 
characteristics reported by each subject and descriptively reported using t-tests or Fisher’s exact 
tests for continuous and categorical variables, respectively. To summarize responses for 
Technology Acceptance Model concepts, mean values were determined using scores from both 
items within each concept; descriptive statistics and comparisons were made using Mann-
Whitney tests.
22
 To determine if differences in acceptance varied by or potential relationships 
existed between subject characteristics or beliefs, mean values for both Technology Acceptance 
Model concepts were compared between categorical variables by Mann-Whitney tests and 
among continuous variables by Spearman rank correlation.
23
 In cases where multiple categories 
existed, groups were combined to form dichotomous variables of more balanced cell values to 
accommodate for the small sample size: low texting (1-10 texts per day) versus high texting (11+ 
texts per day), lower income (≤$50,000) versus higher income (>$50,000), and White versus 
minorities (African American, Hispanic, Native American, or multiple). These categories were 
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also applied to Technology Acceptance Model items among interview participants, due to the 
reduced sample size, in order to examine potential characteristics among those with relatively 
lower technology acceptance. 
 
Results 
 
Subject and Mobile Phone Characteristics 
 
The final study sample included 48 individuals that were randomized equally at baseline 
into the two study arms. At baseline, the average age was 47 years, but half of the subjects were 
aged 50 years and older. Also, nearly all subjects were Caucasian or African American, and just 
over half were married. Income tended to increase with age but no significant differences were 
observed between races or genders. Among all subjects, approximately two diabetes medications 
were taken on average and were being taken across four doses per day; at endpoint the number of 
medications remained unchanged but the average daily dose dropped below four per day (mean = 
3.9, SD: 1.56). The two study arms were well balanced according to the characteristics surveyed 
(all p>0.05). 
Daily texting, type of phone, and phone bill were examined by demographics. Overall, 
participants reported limited text messaging: two-thirds of the population indicated texting 10 
times or fewer per day. Of those texting on a more regular basis (11 times or more per day), a 
significant majority (p<0.01) were 49 years of age and younger; nearly all of these subjects were 
aged 39 years or younger. In this population, more frequent texting was observed in women than 
men (p<0.05) and was more likely to have been done among those owning smartphones 
(p<0.05). No differences in text messaging were observed across income categories, races, or 
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between service providers; spending on service was no different between low and high text 
messaging subjects. At baseline, no difference in texting frequency was observed between study 
arms (p=0.682) and all other mobile phone characteristics were similar.  
Smartphones were the dominant phone type, and a majority was owned by subjects 49 
years of age and younger (72%). Also, a larger share of subjects who reported annual household 
incomes of $50,000 or less (62%) owned these devices. Differences in ownership of the two 
types of phones were not observed by race or gender. 
The average monthly bill for mobile services was approximately $100 and roughly 80% 
obtained service through a major provider. While the average bill for subjects with smartphones 
($112.90, SD: 14.55) was observed to be higher than those with basic devices, the difference did 
not reach statistical significance. Those in the lowest income bracket reported the lowest average 
monthly bills ($59.14, SD: 28.33) and were significantly lower than the averages of those in the 
next highest income category as well as those making over $50,000—no difference was observed 
between these latter two groups. Additionally, no significant relationships were observed 
between the number of medications taken or daily dose and mobile phone ownership, spending, 
or use.  
 
Technology Acceptance 
 
Endpoint surveys captured intervention arm subjects’ responses to items intended to measure 
acceptance of mobile phones in the diabetes treatment process. By and large, acceptance was 
high in this population in terms of perceived ease of use and usefulness of mobile text 
messaging. Mean values were 6.33 (SD: 0.885) and 5.67 (SD: 1.38) for ease of use and 
usefulness, respectively. Only two subjects indicated some level of disagreement to the 
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usefulness items; only one subject did so for the items measuring ease of use. All three of these 
subjects reported low daily texting, contracted with major carriers, were male, over the age of 50, 
and taking their diabetes medications at least six times per day. 
Among all subjects, 76% moderately or strongly agreed to both ease of use items; just 
over half (52%) had this level of agreement for both perceived usefulness questions. Those 
subjects reporting such high acceptance to all items (42%) were similar to the characteristics of 
all respondents except that they tended to be slightly older than average and reported lower than 
average monthly mobile phone bills. No significant differences or relationships in either 
acceptance concepts were identified across subject characteristics, including age, race, income, 
and gender, or among treatment regimens, including the number of medications or type of 
regimen (oral medication alone versus other regimens). Similarly, mean values for usefulness 
and ease of use were comparable for subjects regardless of texting frequency or phone type 
(Table 3.2).  
  Responses for usefulness and ease of use were also compared to each of the seven health 
beliefs and self-determination concepts surveyed. Correlation analysis indicated that only ease of 
use was observed to have a significant relationship with other theory-driven concepts, 
demonstrating strong, positive association with perceived competence (ρ = 0.6, p < 0.01) and 
perceived barriers (ρ = 0.43, p = 0.05). In this population the two Technology Acceptance Model 
concepts trended toward a significant relationship but did not reach statistical significance (ρ = 
0.39, p=0.07); correlation between perceived usefulness and daily doses of diabetes medications 
also trended toward significance (ρ = -0.385, p = 0.08). 
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Perspectives on Treatment and Condition-Tailored Messages 
 
Twelve (50%) of the subjects in the intervention arm were interviewed over the phone after they 
had completed the study. The average interview lasted 12.25 minutes (range: 7—43) and most 
responded to 17 questions. Characteristics of those interviewed, including daily texting, phone 
type, and both technology acceptance items, were similar to those intervention subjects not 
interviewed except that those asked and willing were nearly all Caucasian and twice as many 
males participated than females. Specifically, two-thirds reported texting 10 times or fewer per 
day, slightly more than half owned a smartphone, and all income categories were represented.  
All but one of the subjects interviewed indicated that they enjoyed receiving a daily 
tailored text message; the objection was financially driven as that individual specified the 
messages were, “not worth the cost.” Subjects commonly suggested that they enjoyed the 
messages because they served as reminders, provided encouragement, or gave helpful 
tips/information. Most (n=9) reported that they found the information in the messages helpful; 
specific comments indicated the information was “educational”, “encouraging”, and a “little bit 
of a confidence booster” or a “pep talk.”  The remaining three subjects felt that the messages 
could have been better tailored to their specific needs or that the information provided was not 
relevant to their current point in the treatment process. One subject suggested that “[the 
messages] would have been more handy if based on checking sugars. I struggle with that every 
day. So, a reminder about sugars would have been helpful.” However, all but one person 
indicated that the tailoring was appropriate and that the individualization made them more likely 
to read and consider each message since they, “liked knowing [the message] was for me, not just 
generic.” Another subject noted, “I could tell they were tailored for me because they mentioned 
the medications I am on. Made me more likely to take them.”  
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In terms of the impact of the messages, a majority indicated the messages made them 
more confident about managing their diabetes (n=8) and more likely to take their medication 
each day (n=8). However, the most commonly mentioned motivation for taking each dose was 
the timing of the message serving as a reminder.  
 The messages focused on motivational and health belief factors and gave medication-
specific information tailored to subjects’ responses. Those interviewed most commonly indicated 
that content focusing on motivation was most helpful. One subject commented, “The type that 
gave encouragement, those ones [were the most helpful]. By remembering to take my meds, like 
I am supposed to, I can live a longer life. Gave me encouragement to take my meds.” The 
messages focused on medication education were also well-received; comments included, “liked 
the information about what your medications do, how they react, and why I should take them” 
and “learned more about my Levemir; how it works throughout the day.” No types of messages 
were specifically identified as bothersome or unhelpful. All subjects indicated that it was 
convenient for them to receive these messages by mobile phone and that receiving one message 
per day was sufficient; however, some felt that the messaging dose could be individualized (e.g. 
additional messages to match dosing schedules) based on demand without being bothersome. 
 Subjects were also asked about what they would like to see out of a similar, future 
message-based system. Suggestions varied but were generally suggestive of either increased 
specificity and/or the inclusion of feedback mechanisms. Participants felt that they would benefit 
from messages that focused on other ways to control their condition (e.g. diet, exercise), 
individualization around self-identified areas of difficulty (e.g. checking sugars), and more 
technical medication information. For example, one subject who was taking two insulins 
mentioned, “I don’t know if the benefits or synergies were discussed. A lot of programs lack 
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giving an understanding of what the short and long-term insulins are doing together. Need more 
messages about understanding how the medications are working together- don’t think that gets 
addressed.” The ability to relay information back to a provider was commonly suggested to 
“keep in touch with the doctor” or even finding a way to receive “feedback on sugars: these were 
my sugars, these were my activities, my insulin doses, and recommendations on what I could 
do.” All but one subject indicated they would want to participate in a tailored messaging 
program, similar to this one, if available in the future.  
In addition to simple messaging, other functions of mobile phones that could be used for 
health-related purposes were mentioned. The most frequently mentioned functions were the 
ability to track disease progression, specifically the recording of tests, and the scheduling of 
reminders. Only one-third of interviewees indicated that they plan to, or already, use their phone 
to research diabetes-related information. If subjects mentioned they would like to interact with a 
provider (n=8) they tended to specify this would be with their physician; however, the desire to 
interact with a pharmacist was indicated. In this case, the pharmacist was specified “because of 
insurance status, especially about cost.” 
 
Discussion 
 
As part of a randomized controlled study, this investigation sought to better understand to 
what extent adults with diabetes use and accept mobile phone text messaging during their 
ongoing treatment. In the population studied, messaging was relatively limited and younger 
subjects were observed to text more frequently; however, even limited levels of messaging were 
seen across ages. Importantly, acceptance of using this form of communication in the treatment 
process was high, in terms of ease and usefulness, after 90 days of receiving a daily tailored 
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message, and was consistent across ages. Following what has been suggested by theory such 
high acceptance of mobile messaging would indicate a high intention to use this particular 
technology.
18
 While no continuous messaging system similar to what was examined is regularly 
used in practice, the responses of interviewed intervention arm subjects indicating nearly 
universal interest in using a similar, individualized system suggests that future tailored messages 
aimed at improving treatment adherence would be accepted and used. As suggested, such a 
system may be more highly accepted if it deepened the tailoring to specific treatment needs (e.g. 
checking sugars, lifestyle management) and the stage of therapy.  
A key issue across studies of text messaging interventions focused on medication 
adherence has been the determination of an appropriate message dose, meaning the desired level 
of contact the subject has with the system. To date, investigations have employed a variety of 
dosing strategies; these have included sending messages weekly or twice per week as well as 
sending messages up to 12 times per day.
9, 10, 24
 Approaches have also included varying the 
number of messages sent either based on the subject’s medication dose frequency11, 15 or by 
stepping down the number of messages from twice daily to approximately one every other day.
25
 
However, the most popular dose used in text-based adherence studies has been sending one 
message per day.
10, 12-14, 16
 Our study found that a daily message was an appropriate level for our 
subjects, corroborating the earlier findings, while also discovering that subjects would be open to 
variable levels of messaging as at least one other study had determined previously.
14
 Moreover, 
our subjects also voiced interest in continuing to use such a message-based system in the future, 
a sentiment voiced in previous studies as well.
15, 16 
Several types of messages were applied in this study, adding to our understanding of the 
most appropriate content for patients with diabetes. In our population, respondents in the 
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intervention arm were split between finding the medication education and motivational messages 
most helpful- those preferring medication-specific messages tended to be slightly younger and 
were taking more diabetes medications, and more often, on average. Overall, this suggests that 
tailoring could be improved by focusing messaging on either type of message, rather than both, 
based on patient preferences—something that would need to be done at the outset of any 
intervention. Such an approach may then be more likely to result in positive behavior change and 
serve as more of an adjunct to therapy and less like a simple reminder. Interestingly, a strong, 
positive relationship was observed between perceived ease of use and the theory-driven concepts 
of perceived competence (diabetes-specific) and barriers—the only external variables to do so. 
This suggests that those finding text messaging relatively free of effort are also likely to be those 
who perceive themselves as able to successfully meet the challenge of controlling their condition 
and those who feel that relatively few barriers exist to effectively manage their diabetes. Future 
research should investigate how best to leverage mobile tools, such as text messaging, in those 
with a higher level of competence and with few perceived barriers to reinforce behaviors and 
further improve the odds of positive health outcomes. Similarly, a deeper investigation into what 
characteristics may be related to higher levels of acceptance is needed in order to better 
understand the adoption of mobile messaging and the subsequent influence it may have during 
the treatment process. 
This study was limited in several ways. The sample size for this investigation was 
relatively small and only a fraction of those who participated were surveyed on technology 
acceptance and interviewed to obtain personal perspectives. While the responses given provide 
guidance on how adults with diabetes use their mobile phones and how text messaging studies 
may be structured, the views reported may not be representative of the general population of 
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adults with diabetes. Moreover, while half of those receiving tailored messages were interviewed 
to obtain a representative set of responses and their characteristics were similar to those not 
interviewed the opinions of subjects within the intervention arm may have differed significantly. 
Additionally, only a limited set of messages was sent to the subjects throughout the study; the 
mix of messages may have influenced the extent to which each individual was impacted by and 
their perception of the usefulness of the messaging program. Furthermore, the subjects recruited 
could also have had either type 1 or type 2 diabetes and may have had their condition for any 
number of years; however, the messages were not drafted with either type of diabetes or stage of 
treatment in mind. Resultantly, the messages used may not have been appropriate for all subjects 
within the study. The intervention also assumed that individual medication regimens were static 
for the three months of the study. While only three subjects within the intervention arm reported 
a change in medications over the 90-day period, the inability to alter medication messages after 
baseline limited the extent to which these messages could have been tailored, resulting in some 
inappropriate messaging for those placed on a new medication.  Finally, while the system used to 
deliver all messages could report that a message was sent properly it could not confirm whether 
the recipient read a message. 
Conclusions 
 
This study found that adults with diabetes are accepting of using text messaging during 
their treatment process and that a daily message focused on behavioral motivations, health 
beliefs, or medication education was appropriate. The use of a similar system may be of benefit 
to many adults with diabetes or other chronic conditions and future investigations should 
evaluate how best to leverage tailored material delivered by mobile phones. Such potential 
systems should consider individual patient preferences in terms of messaging content and dose, 
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the relaying of feedback, and direct communication between patients and providers in order to 
improve the odds of both patient utilization and improved health outcomes. 
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Table 3.1 Tailored Messaging Cohort Demographics 
Characteristic 
Active Group 
N (%) 
N 24 
Age* 46.4 (11.57) 
 
Age Group  
21-29 3 (12.5) 
30-39 3 (12.5) 
40-49 6 (25.0) 
50-59 9 (37.5) 
60-64 3 (12.5) 
 
Female 12 (50.0) 
 
Marital Status  
Single 3 (12.5) 
Living Together 3 (12.5) 
Married 12 (50.0) 
Separated/Divorced 6 (25.0) 
 
Race  
Caucasian 14 (58.3) 
African American 8 (33.3) 
Native American 1 (4.2) 
Latino 1 (4.2) 
 
Household Income  
$0-25,000 7 (29.2) 
$25,001-50,000 7 (29.2) 
$50,001-75,000 8 (33.3) 
$75,001-100,000 1 (4.2) 
>$100,000 1 (4.2) 
 
Daily Diabetes Medications* 
 
2.3 (0.85) 
Daily Doses* 
 
4.5 (1.64) 
Daily Texting  
0-10 16 (66.7) 
11-20 5 (20.8) 
21-30 2 (8.3) 
31+ 1 (4.2) 
Phone Type  
Basic 10 (41.7) 
Smart 14 (58.3) 
Average Monthly Bill* 98.27 (70.36) 
**Presented as mean (+/-SD) 
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Table 3.2 Technology Acceptance by Category 
Characteristic 
Ease of Use  Usefulness 
p-value mean (SD) p-value mean (SD) 
Age Group  0.109  0.886 
21-49 6.7 (0.67)  5.9 (0.77)  
50-64 6.0 (0.99)  5.5 (1.78)  
Gender  0.590  0.427 
Female 6.5 (0.71)  5.7 (0.67)  
Male 6.2 (1.01)  5.6 (1.77)  
Race  0.326  0.186 
Caucasian 6.5 (0.92)  6.0 (0.97)  
Minority 6.2 (0.84)  5.5 (0.50)  
Income  0.313  0.762 
<$50,000 6.2 (0.93)  5.5 (1.57)  
≥$50,001 6.6 (0.79)  5.9 (0.93)  
Texting Frequency  0.226  0.850 
≤10 per day 6.2 (0.93)  5.6 (1.60)  
≥11 per day 6.6 (0.75)  5.8 (0.91)  
Phone Type  0.218  0.914 
Basic 6.2 (0.75)  5.4 (1.93)  
Smart 6.5 (0.99)  5.8 (0.83)  
Treatment Regimen  0.961  0.145 
Oral alone 6.4 (0.75)  6.4 (0.95)  
Combination therapy 6.3 (0.93)  5.5 (1.44)  
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Figure 3.1 Technology Acceptance Model 
 
 
 
 
 
 
 
Adapted from Davis (1989)
19
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CHAPTER IV. PAPER 3: THE IMPACT OF TAILORED TEXT MESSAGES ON 
HEALTH BELIEFS AND MEDICATION ADHERENCE IN ADULTS WITH DIABETES 
 
Abstract 
 
Background: Inadequate medication adherence plagues health outcomes and can lead to 
increased costs, particularly in patients with diabetes. Efforts to date have resulted in limited 
effects; approaches leveraging mobile technology have emerged but their focus has mainly been 
limited to simple reminder messages. 
 
Objectives: To test the effectiveness of tailored messages delivered by mobile phone on 
improving medication adherence and health beliefs in adults with diabetes. 
 
Methods: Adults, aged 21-64, with uncontrolled diabetes, and taking at least one antidiabetic 
medication were recruited from a western Michigan health system and randomized into two 
study arms. Using responses from a baseline survey, intervention arm subjects received a tailored 
text message once daily for 90 days; control subjects received only standard care. Changes in 
theory-driven health beliefs and attitudes were assessed by comparing baseline and endpoint 
survey responses, and the impact on medication adherence was evaluated using pharmacy claims 
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by calculating the percent of days covered (PDC) prior to, during, and following the active study 
period. 
 
Results: A total of 48 subjects were randomized into 2 equal study arms. Mean PDC values at 
baseline were comparable between active and control subjects (84.4% and 87.1%, respectively; 
p>0.05). Declines in adherence were observed in both groups over time but no significant 
differences were observed between groups or from baseline to the end of the active study period. 
A trend toward significant improvement in perceived competence was observed in the 
intervention cohort, and unadjusted tests suggested that both perceived benefits and competence 
might have improved over the course of the intervention. An effect size for detecting an impact 
on health beliefs ranged from 0.0 to 0.047 and was 0.035 for adherence to diabetes medications. 
 
Conclusions: The tailoring of mobile phone text messages is a novel way to address medication 
nonadherence and health beliefs but further investigation to this combined technique is needed to 
better understand the impact it may have on behavior change in adults with diabetes. 
 
Introduction 
 
 Nonadherence to chronic medications is a prevalent public health issue in the United 
States, contributing to added costs and detrimental health outcomes. The extent of this issue 
varies by condition with estimates of nonadherence to long-term medication regimens ranging 
from 20% to 83%.
1
 The landscape of nonadherence is especially problematic in patients with 
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diabetes and is prevalent in those taking either oral medications or insulin. In this patient 
population, while adherence may be as high as 98%, estimates have been observed to be as low 
as 31% for oral medications while insulin regimens were found to have been adhered to only 
two-thirds of the time, on average.
2,3 
The implications of such suboptimal adherence include a 
worsening of health status, as indicated by higher levels of hemoglobin A1c, as well as increased 
hospitalizations and all-cause mortality.
4,5
 
 Approaches aimed at improving adherence have evolved over time. Common methods 
have included provider follow-up,
6-10
 patient education and coaching,
11-17
 case 
management,
12,18,19
 and reminders.
15,20,21
Across these intervention strategies, improvements in 
medication adherence have been realized, but consistent change has not been observed among 
similar strategies and no dominant approach has emerged. Recently, mobile technology has been 
increasingly used as a means to target improved medication adherence, most commonly 
leveraging text message reminders to reach patients.
22-27 
While improvements in adherence have 
been realized by solely focusing on such cues to action, this technology affords the medical 
community the opportunity to relay messages to patients beyond simple reminders and focus on 
other medication-taking barriers.  
Having shown positive results in health-related behaviors, such as smoking cessation and 
dieting, tailored messaging may be an approach to influence patients with diabetes to better 
adhere to their regimens based on added influences.
28,29
 Tailoring identifies and then focuses 
communication on individual barriers and behavioral factors observed to impact a particular 
behavior. Studies using tailoring techniques aimed at improving medication adherence have 
shown mostly positive outcomes, such results having become more consistent in recent years.
30-
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39
 However, in studies involving patients with diabetes, the results have been mixed, suggesting 
the need for further inquiry.
40,41
 
  Recognizing the potential of both tailored communication and text messaging, a limited 
number of studies have investigated the combined effect that these two channels may have on 
medication adherence and have provided promising results.
42-44
 Focusing on type 1 diabetes, 
Franklin and colleagues examined the use of tailored text messages in pediatric and adolescent 
patients; results demonstrated that this level of communication was accepted and could be 
effective in improving self-reported adherence.
45
 What remains to be seen is whether the 
combined approach of tailoring and mobile phone message delivery can be an effective mode of 
behavior change in older and more diverse populations of patients with diabetes. 
 As a pilot study, the purpose of this investigation was to test the effectiveness of tailored 
text messages on influencing patients’ health beliefs and attitudes toward their condition and 
treatment which in turn could lead to improved medication adherence in adults with uncontrolled 
diabetes. We hypothesize that the sending of daily messages focusing on either theory-driven 
concepts known to influence medication or specific medication knowledge will lead to increased 
subject beliefs about their condition and treatment and result in improved adherence to therapy. 
 
Methods 
 
Design   
This pilot study was conducted as a randomized controlled investigation using two 
parallel arms: an active cohort that received a daily tailored message and a control arm that 
received standard care only. Approval to conduct this investigation was granted by an 
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Institutional Review Board at the University of Michigan and Mercy Health Partners (Muskegon, 
MI), and patients gave informed consent to participate after being briefed on the study. 
 
Study Population 
Using electronic health records, adults (aged 21-64) with diabetes and a hemoglobin A1C 
of at least 8.0% (according to their most recent reading) were recruited from a western Michigan 
health system. Potentially eligible subjects were drawn from the health system’s electronic health 
record system, contacted by mail, and given the option to opt out of being further contacted and 
considered. Those not opting out were contacted by phone, introduced to the study, and screened 
for eligibility, if interested. Subjects were also recruited at a local diabetes health fair during 
which the study was introduced and interested subjects were screened and consented, if eligible. 
In order to be eligible, subjects needed to have been diagnosed with diabetes, been taking at least 
one antidiabetic medication, reported missing at least one dose within the past 30 days, used a 
mobile phone able to receive text messages, and reported pharmacy coverage through either one 
of two payer partners or the health system’s assistance program. Subjects were excluded if they 
had suffered a heart attack or stroke, been diagnosed with congestive heart failure, or if English 
was not their primary language. Once eligible, all subjects were randomized into either the 
intervention or control arm using a random number generator. Regardless of study arm, all 
subjects were compensated with a $50 debit card for their participation at the end of the study.  
 
Intervention 
 Using responses to a baseline survey, subjects in the intervention arm received one 
tailored message by mobile phone each day for 90 days. Content for each message was based on 
 133 
either concepts of the Health Belief Model or Self-Determination Theory or focused on the 
medication regimen of the subject. To achieve a more deeply tailored message, subject name and 
the time of day delivered (e.g. morning, afternoon, evening) was always used; age and 
medication name were used sporadically or when coinciding with a medication-focused message, 
respectively. The intent of the messages was to increase patient education, provide motivation, 
and reinforce existing levels of condition and treatment-related beliefs. Messages were timed to 
be received at the time of day coinciding with the subject’s first dose, and delivery of each 
message was confirmed by the system used to automate the process- the entire message creation 
and delivery process has been described elsewhere.
46
 Subjects in the control arm received 
standard care only and a monthly check-in message.  
 
Data Collection 
 At enrollment, subjects were mailed a survey to capture baseline values related to Health 
Belief Model and Self-Determination Theory constructs as well as information on demographics, 
mobile phone operation, and medication use. Established instruments were used to evaluate the 
theory-driven concepts of perceived severity, susceptibility, barriers, and benefits as well as 
autonomous motivation, perceived competence, and external regulation. Health Belief Model 
constructs were captured using a diabetes-specific instrument developed by Given
47
 and then 
altered by Becker and Janz
48
, maintaining the original Likert-type response options. Cronbach’s 
α for this instrument ranged from 0.70 to 0.89 depending on the domain of the scale and content 
validity was verified by a separate study.
47,49 
Individual items were scored and summed to create 
a composite score for each of the four model concepts; higher scores indicated a higher 
perceived belief in each concept. 
 134 
Two separate instruments evaluated items surrounding Self-Determination Theory: the 
Treatment Self-Regulation Questionnaire (TSRQ) and the Perceived Competency Scale (PCS). 
As measured in the TSRQ, the concepts of autonomous motivation and external regulation have 
acceptable internal consistency (Cronbach’s α > 0.80) and validity has been verified in 
diabetes.
50,51
 Perceived competence was measured by items of the PCS; Cronbach’s α for this 
scale is 0.94 and support for its construct validity has been demonstrated.
52
 Similar to the Health 
Belief Model concepts, a summed score was created for each of the three constructs with a 
higher score indicating a higher level of each concept. 
Subjects were also asked to provide a complete list of medications currently being taken 
for diabetes. This included providing the following details: medication name, time of day taken, 
pills or units per dose, and times taken per day. 
 To evaluate medication adherence, pharmacy claims were collected from a health 
insurance company as well as the participating health system. Claims were collected over three, 
90-day periods to establish a baseline, study period, and follow-up level of adherence to diabetes 
medications. The proportion of days covered (PDC) was calculated for each subject, and for each 
medication being taken, to form an overall composite PDC.
53
 For each subject, the first fill date 
for each medication during the 90-day look-back period served as the index date. For this initial 
period the number of days between index and the end of the period determined the denominator; 
the study and follow-up periods each had 90-day denominators. Using the days supply, a count 
of the number of days each medication was on hand determined the numerator; overlapping fills 
occurring before the end of a previous fill’s days supply were not counted until after the previous 
fill’s supply was exhausted.  PDC was calculated as the ratio between total days covered and the 
days in the period.   
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Analysis 
 Subject characteristics, including demographics, medication use, and mobile phone 
operation, were described using means and standard deviations or frequencies and proportions, 
and evaluated using t-tests for continuous variables and Fisher’s exact tests for categorical 
variables in order to account for small cell sizes. The proportion of days covered and responses 
to theory-driven items for each time period were described by means and standard deviations and 
compared across cohorts by t-tests and Wilcoxon signed-rank or rank sum tests, respectively.  
 Comparable to a previous, similar study, differences in medication adherence across the 
entire study period were evaluated using repeated measure ANOVA, assessing between and 
within group differences as well as a group by time interaction.
44
 ANCOVA analyses were also 
run in order to control for baseline PDC values in examining potential changes from baseline to 
the end of the intervention. Comparisons were also conducted to evaluate the proportions of 
subjects attaining a PDC ≥ 80% between treatment and control groups using Fisher’s exact tests.  
Changes in Health Belief Model and Self-Determination Theory constructs throughout 
the study, between and within groups, were compared using ANCOVA on those subjects 
returning the endpoint survey. Pearson correlation coefficients were calculated to describe 
potential relationships between demographic characteristics and particular theory-driven 
concepts. Survey data were analyzed using only those who completed both the baseline and 
endpoint assessments.  
The primary outcome measure was change from baseline in medication adherence 
following 90 days of daily tailored messaging. Effectiveness of the intervention was defined a 
priori as providing an improvement in adherence comparable to previous studies aiming to 
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impact medication-taking and health beliefs using mobile phones. Power calculations indicated 
that 28 subjects in each cohort would allow for 80% power to detect at least a 15% difference 
(SD: 20%) in medication adherence, which would be comparable to an earlier study examining 
the impact of text messaging on adherence and treatment beliefs.
44
 For all comparisons, a p-value 
of ≤0.05 was considered to be significant, and STATA 11.0 (College Station, TX) was used for 
all analyses. 
 
Results 
 
Subject Demographics 
 A total of 75 individuals were eligible and consented verbally across both recruitment 
methods; ultimately, 48 subjects returned the baseline surveys and were randomized equally into 
the study arms at baseline (Figure 4.1). After the 3-month study period, 43 subjects completed 
and returned endpoint surveys. During the study, one subject was lost to follow-up due to death 
and the remaining four failed to return the endpoint survey after multiple attempts; no surveys 
were returned due to a change of address. Three of the four non-responders were control subjects 
(limited interaction during the study period); baseline characteristics were similar to the average 
study subject and no outlying values for health beliefs and attitudes were observed. Similarly, no 
baseline characteristics of the lone active arm, non-responding subject were suggestive of a cause 
for not completing the study and all beliefs and attitudes values were similar to the average study 
subject.  
Cohorts were well balanced by all included characteristics although some marginal 
differences in demographic features were observed in some categories; distribution by gender 
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was equal and similar by race and age groups (Table 4.1). Mean ages were not significantly 
different between groups (p=0.734) and the average across the entire study population was 47.0 
years (SD: 11.7). Just over half were married and nearly all subjects were either African 
American or White. Also, nearly all participants reported an annual household income of 
$75,000 or less with the vast majority reporting a value of $50,000 or less.  
 Study cohorts were also well balanced by subjects’ mobile phone characteristics. Two-
thirds of all subjects reported text messaging 10 times or less each day and a majority were 
owners of smartphones. Smartphone owners and those more regularly text messaging were more 
likely to be 49 years of age and under (both p<0.01) and basic cell phone owners reported 
significantly less daily texting (p=0.037). No significant differences were observed in phone 
ownership or operation across other demographic characteristics. Across all subjects the average 
monthly cell phone bill was $100 (SD: 72.3). Considering all baseline subject characteristics, the 
randomization was successful in creating well-balanced cohorts. 
 
Medication Use 
 At baseline, a majority of patients (70%) were taking one or two antidiabetic medications 
and the distribution of the number of diabetes medications taken each day was nearly identical 
across cohorts. On a daily basis, the average number of doses was approximately four and this 
was no different between study groups (p=0.637). The single most common medication being 
taken was metformin (62%); however, both rapid (e.g. lispro, aspart) and long-acting (e.g. 
glargine, detemir) insulin were well represented (49% and 58%, respectively). Nearly all subjects 
(87%) were on oral medication only, insulin only, or a combination of oral and insulin therapy; a 
near equal distribution was observed between these types of regimens. While medication 
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regimen characteristics were fairly similar between cohorts, more than twice as many subjects in 
the active arm were on an oral and insulin regimen. Among all subjects, the number of doses per 
day tended to decrease with age (r = -0.31, p = 0.036); those on an oral only regimen tended to 
be aged 50 years and older while a majority of those on either insulin or both insulin and oral 
medications tended to be 49 years old and younger. (Table 4.2) 
 
Health Beliefs and Attitudes 
 At baseline, no significant differences existed between treatments groups for any of the 
included beliefs and attitudes (all p>0.05). Within both cohorts, average scores were highest for 
perceived severity and autonomous regulation for HBM and SDT constructs, respectively, and 
were maintained in the follow-up period. No differences in any mean levels were observed 
between genders while a negative relationship was observed between the number of medications 
and perceived barriers (r = -0.42, p = 0.004). Additionally, values for external regulation tended 
to increase with age (r = 0.429, p = 0.002) but no significant relationship was found between this 
construct and the number of reported cohabitants (p = 0.194) or by relationship status (p = 
0.231). Also, in spite of the observed differences in mean values, significant relationships 
between scores for autonomous motivation and external regulation were not seen at baseline.   
No significant differences between cohorts in all beliefs and attitudes following the study 
period were observed after adjusting for baseline values (Table 4.3); effects on perceived 
competence trended toward significance (p=0.077). However, unadjusted tests indicated that 
some significant improvement in perceived benefits (p = 0.02) and perceived competence (p = 
0.033) was experienced in active arm subjects; comparisons between cohorts for endpoint values 
of these constructs did not reach statistical significance (not shown). Analyses using mean value 
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replacement and last value carried forward were also conducted but no appreciable differences in 
results were observed. 
 
Medication Adherence 
 Complete pharmacy records over the three time periods were available for 20 subjects 
(10 in each cohort). At baseline, the mean PDC values were 84.4% (SD: 18.8) and 87.1% (SD: 
19.8) for subjects in the intervention and control arms, respectively, and most subjects in both 
cohorts had achieved a PDC of at least 80%- no statistically significant differences were 
observed for either metric. Over the course of all three periods the mean PDC for all subjects was 
77.2% (SD: 0.276).  
For both groups, mean PDC values declined between the three study periods; mean 
change from baseline to the end of the intervention was -5.7% and -12.4% for active and control 
subjects, respectively. ANOVA analysis showed a significant overall time effect (F(1,18) = 0.03, 
p=0.012), a non-significant cohort effect, and a non-significant cohort by time effect (Figure 
4.2). Individual tests indicated that the significant difference in mean PDC values occurred for 
both groups between values at baseline and at follow-up (both p<0.05), but no significant 
differences were achieved between groups at any time point. ANCOVA analysis showed an 
adjusted but non-significant difference in PDC values between groups from baseline through the 
active study period of 5.5% (p=NS); the resulting effect size was 0.035. Between groups, 
significant differences in mean PDC values over the entire three study periods were also not 
observed. Over time, the number of adherent subjects in the intervention arm did decline but not 
to a statistically significant degree. 
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Discussion 
 
 The tailoring of messages is a novel method by which behavior change may be driven 
and their delivery by mobile phone leverages a nearly ubiquitous communication channel that 
expands our ability to reach and engage patients. This study sought to pilot test sets of theory-
driven and treatment-specific tailored messages in a cohort of adults with uncontrolled diabetes 
from a single health system in western Michigan over a period of three months. Specifically, we 
aimed to improve adherence to diabetes medications and alter condition and treatment-specific 
health beliefs and attitudes by focusing message content on individual treatment regimens and 
baseline health belief levels. 
 Results suggested that the methods used by this intervention did not lead to significant 
success in altering either adherence or health beliefs and attitudes. However, some notable 
findings were observed that will be helpful in guiding future interventions. Compared to and 
controlled for baseline values, intervention subjects’ mean values for perceived competence 
trended toward significant improvement versus what was observed in control subjects. This 
observation may be the result of the overarching themes of the theory-driven messages employed 
by the intervention: the majority of the content focused on reinforcing diabetes self-management 
and the internalization of the motivation to do so. As perceived competence has been suggested 
to facilitate goal attainment and provide individuals with need satisfaction, it may be 
hypothesized that this individual finding may be reflective of the universal effect of the tailored 
messages used across concepts in spite of their being a lack of significant change in each 
concept.
54
 Since unadjusted, within-group results suggested that some improvement was realized 
in the intervention arm, further inquiry to how perceived competence may be incorporated into 
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and altered by tailored text messages, specifically by the means employed, should be considered 
in future, larger investigations.  
Similarly, results suggested that subjects’ perceived benefits might be impacted by 
focusing some messages on either medication-specific information or theory-driven content with 
an emphasis on the benefits of treatment adherence. When considering the bulk of content 
delivered, one in five messages sent to each subject focused on the benefits of treatment; 
resultantly, we may have expected to see a more dramatic change in mean values from baseline. 
However, in spite of limited statistical inference, this finding should be taken into consideration 
by future studies that may more precisely tailor medication information to each patient’s 
regimen, specifically the point at which they are in their treatment and to any changes made over 
time.  
To our knowledge, this was the first study to leverage theory-driven tailored text 
messages with a specific focus on improving medication adherence in adults with diabetes. 
While multiple studies have investigated the impact that text messages and tailoring can have on 
adherence, the combined use of these two methods has been limited and either failed to 
individually tailor or did not fully describe how tailoring was accomplished. Importantly, this 
study adds both a precise description of how tailoring was achieved as well as an analysis of the 
intervention’s impact;46 the results add to a body of literature demonstrating mixed effects from 
employing text messaging in encouraging medication adherence.
55,56
 Such a demonstration, in 
spite of clearly significant results, can help guide future studies aiming to employ similar 
methods. However, investigators should also consider the approaches taken by recent studies that 
demonstrated positive improvements in medication adherence,
42-45
 specifically those that focused 
on adults with diabetes.
57
 Considering the extent of nonadherence, myriad reasons for this 
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behavior, and lack of consistency in what has proven to be effective, future studies may benefit 
from an individualized yet multifaceted approach that builds off of what has been observed to 
date. 
 
Limitations 
 
 Most notably, this study was limited by its small sample size, similar to many mobile 
health investigations to date, as several subjects were lost to follow-up and less than half had 
reliable pharmacy claims data, further reducing the sample size for analysis. A post-hoc analysis 
indicated that, for the distribution of data observed, the study would have needed at least 339 
subjects per arm to have at least 80% power to detect a statistically significant difference in mean 
values for health beliefs and adherence (atα=0.05). As a pilot study, the aim of this research was 
to examine the potential for several types of messages to influence health beliefs and medication-
taking, and while the sample size limits statistical interpretation the results still provide guidance 
on how particular tailored text messages may be used during the diabetes treatment process.  
Additionally, the types of messages employed were constructed based on the influence 
their related theory-driven constructs have been observed to have on adherence while also 
providing education on reported medications. However, research on medication taking has 
uncovered myriad reasons for nonadherence, only several of which were the focus of this 
investigation. Resultantly, the influence of the tailored messages used in this study may have 
been limited if their focus did not match the needs of the enrolled population. The influence of 
the messages may have also been impacted by how long each subject had been treated for 
diabetes: more established patients might have not benefited as much as those who were recently 
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diagnosed. Also, the intervention only lasted three months and may not have been long enough 
to make a significant impact on either health beliefs or adherence. 
To examine adherence, pharmacy claims data were used to track the refilling of diabetes 
medications; however, a significant discrepancy existed between the medications being taken as 
listed by each subject and those for which a claim was observed. Considering the wide 
availability of generic medications through pharmacies offering discount programs, it is likely 
that many oral medications were filled in this manner and, therefore, could not be tracked by 
insurance claims data. As a result, the impact of the intervention on the taking of some 
medications could not be measured. Similarly, the use of PDC as an adherence metric, while 
widely used and accepted, is an indirect measure of medication-taking behavior: this method 
cannot confirm that a prescription filled led to medication being taken by each subject. 
Additionally, adjustments to insulin dosing may not be accurately measured by PDC, leading to a 
bias in how adherence was measured for subjects taking this class of medication. Finally, the 
study population consisted of mostly insured subjects; therefore, the results may not be 
generalizable to populations lacking or with dissimilar coverage. 
 
Conclusions 
 
 The tailoring of treatment and condition-specific text messages remains an area of 
opportunity to improve medication adherence, increase patient knowledge, and provide 
motivation to patients with diabetes and other conditions. Future research should be certain to 
improve the exchange of information between patients and providers, seek to enroll large cohorts 
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of subjects, and improve the tailoring of the messages to further individualize the intervention, 
advance patient engagement, and, potentially, lead to significant behavior change over time. 
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Table 4.1. Baseline Study Population Characteristics 
 
Characteristic 
Tailored Subjects (N=24) Control (N=24) 
p-value Count % Count % 
Demographics      
Age (years)* 47.54 12.1 46.38 11.57 0.734 
Age Group (years)     1.000 
21-29 3 12.5 3 12.5  
30-39 3 12.5 3 12.5  
40-49 6 25 6 25  
50-59 8 33.3 9 37.5  
60-64 4 16.7 3 12.5  
Female 12 50 12 50 1.000 
Relationship Status     0.204 
Single 5 20.83 3 12.5  
Living Together 0 0 3 12.5  
Married 13 54.17 12 50  
Widowed 2 8.33 0 0  
Separated/Divorced 4 16.67 6 25  
Race/Ethnicity     0.406 
African American 8 33.33 8 33.33  
Hispanic 0 0 1 4.17  
Multiple 2 8.33 0 0  
Native American 0 0 1 4.17  
White 14 58.33 14 58.33  
Household Income     0.559 
$0-$25,000 6 25 7 29.17  
$25,001-$50,000 11 45.83 7 29.17  
$50,001-$75,000 5 20.83 8 33.33  
$75,001-$100,000 2 8.33 1 4.17  
>$100,000 0 0 1 4.17  
Cohabitants (persons)* 2.25 1.67 2.79 2.11 0.329 
Mobile Phone Use      
Daily Texting (messages)     0.682 
1 to 10 16 66.67 16 66.67  
11 to 20 5 20.83 3 12.5  
21 to 30 2 8.33 2 8.33  
31 or more 1 4.17 3 12.5  
Phone type     0.768 
Basic phone 10 41.67 9 37.5  
Smart phone 14 58.33 15 62.5  
Average monthly bill ($)* 98.27 70.36 101.9 75.48 0.867 
*Presented as mean +/- standard deviation 
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Table 4.2. Baseline Medication Use 
 
Characteristic 
Tailored Subjects 
(N=24) 
Control  
(N=22)* 
p-value Mean SD Mean SD 
Diabetes Medications per Day 2.25  0.85  2.09 0.87 0.805 
Daily Doses of Diabetes Medications 4.5  1.83 4.24 2.05  0.637 
Diabetes Therapy**     0.421 
Oral medication only 6  25.0 7 31.8  
Insulin only 7 29.2  7 31.8  
Oral medication and insulin 9  37.5 4 18.2  
Other combinations 2  8.3  4 18.2  
Percent of Days Covered (PDC) 0.84 0.18 0.87 0.33 0.756 
*Includes only those completing the self-reported medication list 
**Presented as frequency and % 
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Table 4.3. Subject Health Beliefs and Attitudes 
 
 
Theory Construct 
Tailored  Control Adjusted 
Difference 
p-
value Baseline Endpoint Baseline Endpoint 
Health Belief 
Model 
Perceived 
Severity 
4.0  
(0.53) 
4.3 
(0.44) 
4.3  
(0.44) 
4.2  
(0.43) 
0.10 0.447 
Perceived 
Susceptibility 
3.7  
(0.58) 
3.7  
(0.57) 
3.6  
(0.73) 
3.6  
(0.53) 
0.01 0.968 
Perceived 
Benefits 
3.6  
(0.59) 
3.9  
(0.34) 
3.8  
(0.48) 
3.8  
(0.61) 
0.20 0.169 
Perceived 
Barriers 
3.6  
(0.83) 
3.8  
(0.63) 
3.8  
(0.68) 
3.8  
(0.79) 
0.09 0.646 
Self-
Determination 
Theory  
Perceived 
Competence 
4.5  
(1.51) 
5.3  
(1.14) 
4.9  
(1.52) 
5.0  
(1.53) 
0.57 0.077 
Autonomous 
Motivation 
6.2  
(1.17) 
6.5  
(0.49) 
6.6  
(0.43) 
6.3  
(0.70) 
0.17 0.363 
External 
Regulation 
3.3  
(1.32) 
3.7  
(1.63) 
3.8  
(1.48) 
3.6  
(1.46) 
0.36 0.406 
Values are listed as mean (+/-SD) 
At endpoint, 23 tailored subjects and 20 controls responded to survey items 
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Figure 4.1. Subject Recruitment and Enrollment 
 
  
Initially eligible based on 
EHR values (N=400) 
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(N=24) 
Completed 
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(N=20) 
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Figure 4.2. Intervention Impact on Medication Adherence 
 
 
Values represent mean PDC for each time period 
20 subjects with complete pharmacy records for all time periods were analyzed 
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CHAPTER V. DISCUSSION 
 
 As one of the first studies focused on adult patients with diabetes to combine tailoring 
with text messaging, this pilot study sought to create, deliver, and then test the effectiveness of 
tailored text messages to improve medication adherence. Additionally, this investigation aimed 
to assess the extent to which these messages altered subjects’ condition and treatment-related 
beliefs by focusing message creation on theory-driven and medication-specific concepts. Finally, 
we collected personal responses from participants on their mobile phone use and acceptance as 
well as impressions from intervention subjects on their experiences with receiving a daily, 
tailored text message. 
 
Summary of Study Aims  
 
Aim 1 
 Using theory, medication-specific information, and insight from adults with diabetes, a 
library of 296 messages was created and formatted for delivery by mobile phone messaging. In 
combination with self-reported characteristics (age, gender, medication, etc.), all messages were 
individually tailored and prepared for use in the intervention using baseline responses to a survey 
instrument. This method allowed us to create deeply tailored messages that corresponded to each 
subject’s level of health beliefs, motivation, competence, and regulation, and deliver subsequent 
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messages aimed at directing individuals toward a target attitudinal level. Such an approach was 
in accordance with what previous research has shown in terms of a gradual change in health 
beliefs or behavior change over time rather than trying to create an abrupt alteration.
1
 
Additionally, this approach may be easily replicated for similar, future studies and is perhaps the 
first investigation to provide such transparency on how tailoring may be wed with mobile phone 
delivery in an attempt to improve medication taking in adults. Earlier studies using 
individualized texting have provided some details on either their approach (instruments, message 
derivation, etc.) or listed example messages, but not to the extent given herein.
2, 3 
 This study also demonstrated how established survey instruments could be leveraged to 
design message content. While many tailoring studies opt to create original instruments, the use 
of tested questions, when appropriate items are available and reliable, improves the efficiency by 
which an investigation may be conducted. For our purposes, items based on two well-established 
theories were used in order to further test their applicability to medication adherence and to 
introduce to the literature example messages based on the Health Belief Model and Self-
Determination Theory. Such an approach proved to ease the manner by which question items 
could be used to develop message stems and responses translated into scaled messages. 
Considering the myriad reasons for nonadherence, the use of these theories limited the concepts 
that were addressed but participants’ reception of the messages is important for researchers 
interested in conducting theory- and communication-based interventions.
4
 To this end, interview 
responses indicated that the theory-based messages were motivational and could be of added 
value for recently diagnosed patients with diabetes. Additionally, while not formally tested, 
personal responses from intervention subjects indicated that education on medications being 
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taken for diabetes was helpful and could even be increased in the future, particularly for different 
types if insulin in order to better connect patients with their individual treatment regimen.  
Similar to the dearth of guidance in tailoring text messages, the literature is similarly 
lacking insight to how an intervention using mobile phones as a communication channel may be 
successfully delivered and managed. Over the course of this intervention, a total of 2,230 
messages were relayed to mobile phones by an automated server, 94.3% of which were received 
as planned; when interruptions occurred they were generally brief (received later in the same day 
or on the next day) and most often due to message coding interfering with the server’s automated 
process. Such a demonstration is indicative of the ease by which automated messages, even when 
individualized, can be introduced to the care process in order to reach and engage patients. While 
this study developed its own engine to produce tailored materials, it is likely that the introduction 
of tools specifically designed to tailor electronic messages will ease this process and improve the 
means by which patients may be reached. Furthermore, a standard logarithm for message 
delivery was used where all subjects received the same order and number of messages based on 
survey responses from one period in time. This approach provides a blueprint for interventions 
seeking to have a defined treatment period with a static dose; however, post-intervention 
interviews, suggested that alterations in this algorithm might be more appropriate. Specifically, it 
was suggested that additional messages be sent per day to correlate more closely with each 
treatment regimen, and changes in the mix and types of messages could be made to more closely 
match the needs of patients based on their baseline beliefs and needs. Furthermore, changes to 
the mix of messages over time could be made to parallel changes in need over time. Overall, this 
study was successful in delivering the intervention as planned and defined, adding valuable 
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methods to the scant literature on the conducting of a tailored text message program primarily 
focused on changing medication adherence. 
 
Aim 2 
 In terms of concrete outcomes, this study sought to understand the extent to which 
tailored messages could impact treatment and condition-related health beliefs and attitudes, 
specifically some of those previously observed to be related to the medication-taking process. 
Results indicated that minimal changes in the included concepts were realized; however,  some 
differences should be highlighted irrespective of statistical significance. Of note, the receipt of 
messages focused on perceived competence and benefits as well as those with specific 
medication information translated into some differences in mean values from baseline in the 
intervention group. These results are promising considering the focus of a majority of the 
messages, the relatively brief period over which the intervention was run, and the adult 
population recruited. While more evident improvements in particular diabetes-specific attitudes 
were observed in a younger population by an earlier study, our results provide some guidance on 
what may be accomplished in older patients over a shorter period of time.
5
 Moreover, our results 
should be of particular interest to researchers focusing on populations with a specific need to 
improve perceived competence in adults with diabetes and may be considered for those with a 
low perceived benefit of treatment. For these purposes, the use of messages with a focus on 
competence and benefits may show significant effects over a longer treatment period and may be 
most appropriate for those having been recently diagnosed with diabetes. While complete 
support for the application of concepts related to the Health Belief Model and Self-
Determination Theory was not provided by this study, value was still realized by subjects in the 
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intervention as the conceptual messages were well received. Such insight is useful to 
investigators wishing to apply other theories of health behavior to the tailored text messaging 
process when specifically targeting medication nonadherence. 
 Of equal importance to the intervention’s impact on health beliefs were the impressions 
of study participants on the acceptance of mobile phone messaging and the receipt of a tailored 
message during the treatment process. While mobile phone use and mHealth capabilities have 
grown exponentially in recent years, relatively little is understood about what patients want out 
of these devices and how they would prefer to use these tools as accessories to their medication 
regimen.
6
 Results suggested that technology acceptance, in terms of ease of use and usefulness, 
was high in adults with diabetes when considering the receipt of a tailored text message. 
Importantly, acceptance remained high regardless of mobile phone type and texting frequency, 
suggesting that smartphones and regular texting were not barriers to accepting mobile messaging 
as a value-added service to patients. Additionally, subjects found a once-daily message to 
appropriately meet their needs but some could have benefited from a system that mimicked their 
treatment regimen; therefore, we may reasonably assume that a truly individualized system, and 
one that may lead to significant behavior change, may be one that matches the message dose 
with specific patient needs. This information will be useful to health systems, payers, and 
providers interested in developing and implementing a messaging service as an interactive 
feature for their patients. In terms of specific content, subjects found both medication-specific 
information and theory-based messages to be useful, in spite of still serving as a regular reminder 
to take medication. The majority of those interviewed indicated interest in continuing to receive 
tailored messages by mobile phone and would welcome even more interaction with a messaging 
system or providers in the future (e.g. relaying blood sugar or receiving ongoing medical advice). 
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These findings echo what previous studies have found, suggesting that patients have great 
interest in being more engaged in their therapy.
5, 7
 Moreover, such positive receipt is encouraging 
for the implementation of messaging systems that go beyond simply relaying reminder messages, 
particularly considering the adult population from which impressions were gathered.  
 
Aim 3   
 Primarily, this study aimed to evaluate the impact of tailored text messages on adherence 
to diabetes medications in adults. While the tailoring of text messages has been applied in other 
conditions and younger populations with diabetes, this is one of the first studies to investigate 
this approach in adults with diabetes. Over the course of the three-month intervention, results 
indicated that mean adherence levels (using proportion of days covered) declined from baseline 
in both those receiving a tailored text message and those having standard care only. Additionally, 
the proportion of those already adherent (PDC>80%) also declined from baseline levels, 
suggesting a lack of benefit from the intervention. While differences did not reach statistical 
significance, we originally hypothesized and anticipated that tailoring would lead to 
improvements in medication-taking by focusing messaging on factors previously observed to 
relate to adherence, or at the very least would result in levels of adherence higher than those in 
the control group. However, these results should be taken with caution as less than half of the 
subjects involved were able to have their medication use analyzed due to the methods employed 
to assess adherence; resultantly, the study was underpowered to determine reliable differences in 
mean values between groups.  
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 It was also the aim of this study to assess the fit of the conceptual framework as outlined 
by the specific aims. Using individual-level data, we observed that the methods used to create 
our tailored messages led to minimal statistically significant changes in health beliefs; however, 
as the majority of changes for intervention subjects (except for perceived susceptibility) were in 
the intended direction we may infer that the messages used may be impactful in terms of altering 
patients’ perceived health beliefs. Resultantly, it is reasonable to suggest that the outlined 
framework to construct and deliver tailored text messages may be appropriate for interventions 
seeking to alter patients’ diabetes-related beliefs. Unfortunately, inferences beyond these 
conclusions cannot be made due to a lack of individual-level pharmacy claims data on study 
subjects. Therefore, conclusions related to the entire framework, specifically whether the 
messages employed led to changes in health beliefs and then, ultimately, whether these 
alterations led to changes in medication adherence, must be reserved for a future, larger 
investigation with sufficient data. 
 As a pilot study, this investigation sought to better understand the applicability of tailored 
text messages in affecting adherence to diabetes medications. Therefore, the findings, in spite of 
statistical inference, have value to the research community in terms of evaluating methods that 
may effectively address the myriad reasons for nonadherence. Elsewhere, tailored text messaging 
has shown benefit to some adults with diabetes;
2
 presently, these messages may have proven 
beneficial to the medication-taking process to subjects in this study but were unobserved. It is 
important to note that, mean values for many health beliefs were at or near target levels prior to 
the intervention and the majority of adherence inference was made on claims for insulin. 
Therefore, this population may not have been ideally suited to benefit from the chosen concepts; 
other theoretical constructs or adherence barriers may have been more appropriate and resulted 
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in significant change. Moreover, the analytic methods employed may not have accurately 
captured actual medication possession considering the high prevalence of claims for insulin- due 
to the nature of dosing for these products medication use may have been dramatically different 
than what was determined. As research continues in this area and tailored text message libraries 
grow, studies may benefit from expanding the options of message concepts available for testing 
in order to more precisely target barriers to adherence.  The approach taken is just one method by 
which tailoring may be applied to mHealth interventions in a theory-based manner and may be 
easily replicated by researchers interested in further evaluating potential impacts on adherence in 
particular populations.  
Health systems and payers seeking to increase engagement with their patients may also 
easily duplicate the methods employed in a potentially cost-effective manner. While a formal 
cost analysis was not performed as part of this study, direct costs to reach all involved 
participants were approximately $250 over the course of the entire investigation (including both 
reaching and interacting with the subjects in both arms)- roughly $1.30 per active subject per 
month on average. Considering the relatively low cost per message charged to the patient, the 
relaying of individual information by text message might provide all entities a cost-effective 
communication channel and one that will continue to decrease in price. Policymakers, 
particularly those focused on reducing the high administrative costs of care, may be especially 
interested in the use of tailored messaging to improve the flow of information between patients, 
providers, and payers. Moreover, the tailoring of mobile-based messages may also be of value as 
adjunct services to reach newly diagnosed patients or those beginning new and unfamiliar 
treatment regimens as a means to improve patient engagement and knowledge at critical times of 
therapy and between encounters with providers. However, prior to implementation by payers or 
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suggestion being made by policymakers, a better understanding of related indirect costs, such as 
the time required to capture patient information and build original messages, must be better 
understood. Should these costs prove to be manageable and the exchange of tailored material 
demonstrate correlation with consistently and measurably improved health outcomes, the costs to 
the patient may be worthy of coverage by payers and included as regular services. 
  
Limitations 
 
 Similar to other studies involving mobile health interventions, the most prominent 
limitation of this study was the sample size enrolled. Over one-third of those recruited and 
consented were lost prior to the beginning of the study, severely limiting the analytic power to 
detect differences in adherence and health beliefs and attitudes as well as conduct sub-group 
analyses. Additionally, the loss of follow-up data due to unreturned surveys further limited our 
interpretability. Moreover, reliable and consistent pharmacy claims data were only available for 
less than half of all subjects, providing only a glimpse of what the intervention may have done to 
alter medication-taking in the study population. However, the intention of this study was to pilot 
a particular approach to tailored messaging and, in spite of a small sample, effect sizes and 
interpretations were determined and the results will serve to guide future, similar investigations. 
Although comparable to other similar studies, the length of the intervention (three 
months) may not have been long enough to adequately address the target behavior or state of 
health beliefs in all subjects. As subjects were enrolled having diabetes for a variable length, the 
dose of the intervention may not have been appropriate to result in behavior change for those 
with advanced disease or having been diagnosed many years ago; conversely, if newly diagnosed 
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patients were involved then a noticeably higher change may have been realized. Determining an 
appropriate intervention length—in order to lead to long-standing change—is a challenge for all 
investigations and this study, while relatively brief, provided insight on what may be achieved 
over three months of daily messaging. Moving forward, studies may benefit from longer 
intervention periods and may even consider comparing across variable lengths of time used to 
encourage change. 
 The methods behind the messages employed also introduced some limiting factors. It is 
possible that the application of concepts beyond what was employed may have impacts on 
adherence and health beliefs in adults with diabetes beyond what was observed herein. As one of 
the few studies using a theory-based approach to tailored text messaging, the results will aid 
future studies but a deeper understanding of the most appropriate theoretical applications is 
needed. 
 Secondly, the recruitment process may have inadvertently removed those with an 
unfavorable view of text messaging, thus biasing the results related to technology acceptance. As 
well, the reception of certain messages may not have been appropriate for all subjects and the 
impact of the messages may have been limited by each subject’s stage of treatment and disease 
severity.  
 Also, input from potential subjects to the content of the proposed set of messages was 
relatively limited. No pre-testing of the message set was conducted in a representative group of 
potential subjects that may have benefited the construction process by identifying areas of the 
diabetic treatment process that could have been the focus of some messages (e.g. lifestyle 
modification, checking sugars). Moreover, this final study population was not assessed for 
literacy or numeracy levels which may have varied dramatically between subjects.  
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 The manner by which medication taking was assessed in this study also has its 
limitations. The use of claims data only allows for the tracking of medication refills once a claim 
is generated; therefore, any medications filled through a discount generic medication program—
those that would not be reported to the patient’s payer—were not able to be accounted for and 
analyzed. In this study, the distinct discrepancy between the lists of subject-reported medications 
and those for which a claim existed suggests that such a phenomenon may impact studies 
involving conditions for which a large number of generic medications are available and regularly 
used. Specific to this study, adherence could only be calculated among medications for which a 
claim was generated, limiting our interpretability of the intervention’s impact on overall 
medication use in some subjects. Additionally, the proportion of days covered, as an adherence 
metric, is an indirect measure of medication taking. While the refilling of medications implies 
use, there is no guarantee that a medication filled led to it being taken as directed. Similarly, the 
days supply field is used to generate the numerator to calculate adherence during a defined 
period, and this assumes that the amount supplied was intended to be taken for the number of 
corresponding days. However, certain products, such as insulin, may be dosed on a variable scale 
and the number of days provided might not equate to the number of days over which the 
medication was taken. In such cases, the level of adherence would be biased in either direction 
depending on how the insulin was dosed on a daily basis. 
 Finally, the reading of each message could not be confirmed. Therefore, it is difficult to 
assess whether a message sent resulted in a message read and understood by each subject.  
 
Future Directions 
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This investigation was one of the first to analyze the feasibility, implementation, and 
impact of tailored messages delivered by mobile phone aimed at improving medication 
adherence in adults with diabetes. While several key findings were taken from this study, much 
remains to be understood about how such an approach can impact the ongoing taking of 
medications. Considering the expected growth in mHealth applications in the coming years, such 
improved understanding has great potential to leverage mobile health into playing a pivotal role 
in the improving of health outcomes. 
Moving forward it will be imperative to construct studies that enroll a larger number of 
subjects from diverse backgrounds, including adolescent and adult patients of varying 
socioeconomic levels, races, and ages. This should also include expanding the focus to subjects 
with other chronic conditions that require regular, ongoing medication use; hypertension, 
hypercholesterolemia, and asthma are diseases that may benefit from the combination of 
tailoring and text messaging- an expanded investigation involving diabetes should also be 
planned. In so doing, direct health outcomes related to these conditions should also be included, 
such as blood pressure, hemoglobin A1c, and hospitalizations, to corroborate the need for and 
impact of improving adherence to medication. Resultantly, investigations will need to expand 
well beyond three months in order to capture sufficient outcomes and properly assess how a 
messaging system can be more fully integrated into the ongoing care process. Furthermore, 
longer interventions will provide needed information surrounding the adequate length of a 
messaging program that most successfully leads to longstanding behavior change and positive 
outcomes. 
Comments made by participants of this study provided significant direction for 
expanding the capacity and capabilities of a future messaging system. While this study targeted 
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several established factors influencing medication-taking behavior and disease management, 
other important health behaviors such as testing sugars, proper diet, and adequate exercise were 
only minimally included or absent. Moving forward, tailoring on the complete treatment 
regimen, rather than simply focusing on medication, should be included, and such an approach 
could easily be replicated in other conditions requiring treatment beyond medicinal therapy. 
Such improved tailoring should also include the expansion of medication-specific messages to all 
medications being taken rather than limiting them to the class or condition of interest. More 
individualized tailoring should also accommodate how often each subject would like to interact 
with the system. While several studies, including this one, have investigated the dose by which 
messages should be relayed, perhaps the most appropriate approach is one that is set by each 
subject rather than the investigators. Additionally, consideration for the stage of disease (i.e. time 
since diagnosis) should also be included in the content of each message and adjust over time, as 
patient’s needs change. This could be accomplished by incorporating feedback mechanisms into 
the messaging program either by the surveying of subjects at multiple points or by direct 
interaction with subjects through the messaging system. To accomplish the latter, exchanges 
could include asking subjects to respond to quality of life items, supply clinical markers (e.g. 
blood pressure readings and blood glucose), send updates on diet and exercise, and provide any 
changes to medications being taken that could be relayed to physicians or pharmacists to better 
understand their patients’ condition. Effectively, this will increase the patient’s involvement over 
time and bring them closer to their care and providers. Furthermore, this will contribute to the 
constructing of a self-sustaining, robust messaging system that could be integrated to electronic 
health records and, eventually, be used for more direct interaction with patients. Such level of 
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communication could contribute to more efficient care and would certainly improve the ease by 
which health-related information is shared among interested parties. 
As a pilot study, this investigation sought to establish the effect that tailored text 
messages have on medication adherence and health beliefs in adults with diabetes, and did so by 
comparing a tailored approach to standard care alone. However, since the majority of studies to 
date have investigated the impact of reminder messages on adherence, there is a need to 
understand how tailored messages may compare to the effect that simple reminder messages 
have on medication-taking behavior. As larger and longer studies are constructed, they should be 
developed to include multiple comparison groups, which at a minimum, should include tailored 
and reminder cohorts. 
Finally, the sending and receiving of text messages involves some costs. If any mobile 
messaging system, particularly one that involves tailoring, is going to be fully integrated to the 
care process then its cost-effectiveness must be established. Future studies utilizing a tailored 
technique to relay text messages should capture the costs of creating and delivering these 
messages and model these against the health-related impact they are associated with throughout 
the study period. 
 
Conclusions 
 
 Nonadherence, particularly in patients with diabetes, remains a prevalent public health 
issue, and improved means to curb this problem are needed. The tailoring of messages delivered 
by a nearly universally owned device affords researchers the opportunity to further engage 
patients and encourage the following of prescribed treatments. While results of this study 
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indicated that adherence was not improved by delivering theory-based and medication-specific 
tailored messages to adults with uncontrolled diabetes, the methods employed were well-
accepted by the population and showed promise in altering condition and treatment-related 
health beliefs. An effect size for detecting an impact on health beliefs ranged from 0.0 to 0.047 
and was 0.035 for adherence to diabetes medications. 
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APPENDICES 
 
APPENDIX A 
A. Tailoring Survey Instrument 
The following questions are about your current medications and how you take them. Please list all of the 
prescription medications (including any samples) you are currently taking for diabetes. If you are not sure 
the medication is for your diabetes, please add it to the list. For each medication, please list the name, 
number of pills taken each time, number of times you take them each day, and check when you take them. 
For your reference, please see the attached list of medications to help fill out this form.  
 
 
Medication    # of Pills       Times/Day     Time of Day (check all that apply) 
 
__________________      ___             _____        ○ morning ○ midday ○ afternoon ○ evening ○ night 
 
__________________      ___             _____      ○ morning ○ midday ○ afternoon ○ evening ○ night 
 
__________________      ___             _____      ○ morning ○ midday ○ afternoon ○ evening ○ night 
 
__________________      ___             _____        ○ morning ○ midday ○ afternoon ○ evening ○ night 
 
__________________      ___             _____      ○ morning ○ midday ○ afternoon ○ evening ○ night 
 
__________________      ___             _____      ○ morning ○ midday ○ afternoon ○ evening ○ night 
 
__________________      ___             _____        ○ morning ○ midday ○ afternoon ○ evening ○ night 
 
__________________      ___             _____      ○ morning ○ midday ○ afternoon ○ evening ○ night 
 
__________________      ___             _____        ○ morning ○ midday ○ afternoon ○ evening ○ night 
 
__________________      ___             _____      ○ morning ○ midday ○ afternoon ○ evening ○ night 
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The following 15 questions are about your diabetes and the medications you take for it.  Please CIRCLE 
the ONE answer that best describes how you think or feel about your diabetes or your prescription 
diabetes medications. 
 
1. My diabetes is well controlled. 
 
Strongly 
Agree 
Agree Uncertain Disagree Strongly 
Disagree 
 
 
2. My diabetes would be worse if I did nothing about it. 
 
Strongly 
Agree 
Agree Uncertain Disagree Strongly 
Disagree 
 
 
3. I believe that my medications will help prevent complications related to diabetes. 
 
Strongly 
Agree 
Agree Uncertain Disagree Strongly 
Disagree 
 
 
4. Diabetes can be a serious disease if you don’t control it. 
 
Strongly 
Agree 
Agree Uncertain Disagree Strongly 
Disagree 
 
 
5. My diabetes is no problem to me as long as I feel alright. 
 
Strongly 
Agree 
Agree Uncertain Disagree Strongly 
Disagree 
 
 
6. My diabetes will have a bad effect on my future health. 
 
Strongly 
Agree 
Agree Uncertain Disagree Strongly 
Disagree 
 
 
7. My diabetes will cause me to be sick a lot.  
 
Strongly 
Agree 
Agree Uncertain Disagree Strongly 
Disagree 
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8. I believe I will always need my diabetes medications. 
 
Strongly 
Agree 
Agree Uncertain Disagree Strongly 
Disagree 
 
 
9. I believe I can control my diabetes. 
 
Strongly 
Agree 
Agree Uncertain Disagree Strongly 
Disagree 
 
 
10. I believe that my medications will control my diabetes. 
 
Strongly 
Agree 
Agree Uncertain Disagree Strongly 
Disagree 
 
11. My medicine makes me feel better. 
 
Strongly 
Agree 
Agree Uncertain Disagree Strongly 
Disagree 
 
 
12. I would have to change too many habits to follow my medications. 
 
Strongly 
Agree 
Agree Uncertain Disagree Strongly 
Disagree 
 
 
13. It has been difficult following the medications prescribed for me. 
 
Strongly 
Agree 
Agree Uncertain Disagree Strongly 
Disagree 
 
 
14. I cannot understand what the doctor told me about my medications. 
 
Strongly 
Agree 
Agree Uncertain Disagree Strongly 
Disagree 
 
 
15. Taking my medications interferes with my normal daily activities. 
 
Strongly 
Agree 
Agree Uncertain Disagree Strongly 
Disagree 
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For the next 12 questions, please check how true you feel each statement is. For each item, 1 means not at 
all true and 7 means very true. 
 
 
16. I am confident that I can take care of my diabetes. 
 
1 
Not at all True 
 
2 3 4 5 6 7 
Very True 
 
17. I can handle my diabetes now. 
 
1 
Not at all True 
 
2 3 4 5 6 7 
Very True 
 
 
18. I can do my own routine diabetes care now. 
 
1 
Not at all True 
 
2 3 4 5 6 7 
Very True 
 
19. I can meet the challenge of controlling my diabetes. 
 
1 
Not at all True 
 
2 3 4 5 6 7 
Very True 
 
20. Taking my diabetes medication is very important for being as healthy as possible. 
 
1 
Not at all True 
 
2 3 4 5 6 7 
Very True 
 
21. I personally believe that taking my diabetes medications is the best thing for my health. 
 
1 
Not at all True 
 
2 3 4 5 6 7 
Very True 
 
22. I feel that I want to take responsibility for my own health. 
 
1 
Not at all True 
 
2 3 4 5 6 7 
Very True 
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23. I have carefully thought about it and believe taking my medications is very important for many 
aspects of my life 
 
1 
Not at all True 
 
2 3 4 5 6 7 
Very True 
 
24. I feel pressure from others to take my diabetes medications. 
 
1 
Not at all True 
 
2 3 4 5 6 7 
Very True 
 
25. Others would be upset with me if I didn’t take my diabetes medications. 
 
1 
Not at all True 
 
2 3 4 5 6 7 
Very True 
26. I want others to see that I can take my diabetes medications. 
 
1 
Not at all True 
 
2 3 4 5 6 7 
Very True 
 
27. I want others to approve of me. 
 
1 
Not at all True 
 
2 3 4 5 6 7 
Very True 
 
 
 
Please provide a few final details about yourself. 
 
28. Age___________ 
 
29. Gender :   
_____ Male  
_____ Female 
 
30. What best describes your current marital status? 
 
_____ Single, Never Married  
_____ Living Together, Not Married 
_____ Married  
_____ Widowed  
_____ Separated   
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31. What race best describes you? 
_____ African American  
_____ Asian-Pacific Islander 
_____ Hispanic   
_____ Multiple Races  
 _____ Native American 
_____ White  
_____ Other 
32. Total household income: 
_____ $0-25,000  
_____ $25,001-50,000   
_____ $50,001-75,000 
 _____ $75,001-100,000  
_____ More than $100,000 
33. With how many people do you currently live:_________ 
 
Response Scoring: 
 
Items 1 through 15 constituted questions related to the Health Belief Model while items 16 through 27 
measured responses to concepts of Self-Determination Theory. Each HBM item was scored from 1 to 5 in 
the pre-determined target direction as some items were reverse scored based on the phrasing of these 
items. The distribution of HBM questions by scoring was as follows: 
 Scored 1 (Strongly Disagree) to 5 (Strongly Agree): items 1-4 and 6-11 
 Scored 1 (Strongly Agree) to 5 (Strongly Disagree): items 5 and 12-15 
Similarly, SDT items were scored from 1 to 7 in the pre-determined target direction to accommodate 
reverse scoring. The distribution of SDT questions by scoring was as follows: 
 Scored 1 (Not at all True) to 7 (Very True): items 16-23 
 Scored 1 (Very True) to 7 (Not at all True): items 24-27 
Mean values were produced for each item and were then averaged across items for each corresponding 
theoretical construct. For purposes of message construction, break points were created for each item based 
on their scoring. For HBM items, responses corresponding to scores of ‘1’, ‘2’, or ‘3’ were categorized as 
‘low’ while responses corresponding to ‘4’ or ‘5’ were considered ‘high’. For SDT items three categories 
were created: responses scored ‘1’ or ‘2’ were considered ‘low’; responses corresponding to ‘3’, ‘4’, or 
‘5’ were considered ‘medium’; and scores of ‘6’ or ‘7’ were deemed ‘high’. 
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APPENDIX B 
 
B. Endpoint Survey Technology Acceptance Model Items 
The next 4 questions are about your phone and text messaging over the past 3 months. Please consider the 
messages that you received from the study when answering these questions. CIRCLE how much you 
agree or disagree with the following statements. 
 
1. Using text messaging as part of my diabetes treatment increases my chances of achieving things 
that are important to me. 
 
Strongly 
Agree 
Moderately 
Agree 
Somewhat 
Agree 
Uncertain Somewhat  
Disagree 
Moderately 
Disagree 
Strongly 
Disagree 
 
 
2. Using text messaging as part of my diabetes treatment helps me accomplish things more quickly. 
 
Strongly 
Agree 
Moderately 
Agree 
Somewhat 
Agree 
Uncertain Somewhat  
Disagree 
Moderately 
Disagree 
Strongly 
Disagree 
 
 
3. I think learning how to use text messaging as part of my diabetes treatment is easy for me. 
 
Strongly 
Agree 
Moderately 
Agree 
Somewhat 
Agree 
Uncertain Somewhat  
Disagree 
Moderately 
Disagree 
Strongly 
Disagree 
 
 
4. I find text messaging as part of my diabetes treatment easy to use. 
 
Strongly 
Agree 
Moderately 
Agree 
Somewhat 
Agree 
Uncertain Somewhat  
Disagree 
Moderately 
Disagree 
Strongly 
Disagree 
 
Scoring: 
Mean values for each item were produced by applying numeric values to each response. Values ranged 
from 1 (Strongly Disagree) to 7 (Strongly Agree). Items 1 and 2 were combined to produce a mean value 
for Perceived Usefulness; items 3 and 4 were combined to produce a mean value for Perceived Ease of 
Use.    
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APPENDIX C 
 
C. Mobile Phone Use Survey Items 
The following 4 questions relate to your use of mobile phone text messaging. If you own and operate 
more than one mobile phone, please answer them based on your primary phone only. If you do not know 
exact numbers, please estimate as best as possible. Place your answer in the space provided. 
 
 
1. In a typical day, how many text messages do you send and receive? 
_____1-10  
_____11-20 
_____21-30 
_____31 or more 
 
2. What best describes the type of phone you own? 
_____Smartphone 
_____Basic phone 
 
 
3. To which of the following service providers do you subscribe? 
_____Verizon 
_____AT&T 
_____Sprint 
_____T Mobile 
_____Cricket 
_____MetroPCS 
_____Other 
 
4. On average, what is your monthly bill for mobile phone services? 
$________________ 
 
_____Don’t know 
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APPENDIX D 
 
D. Focus Group Questions 
1. Icebreaker  
a. What feature of your cell phone do you like the most? 
2. Mobile phone use questions 
a. Could you please describe how you use your mobile phone on a daily basis in terms of 
talking, texting, app use, and/or browsing? 
b. How many text messages would you estimate you send and receive on a typical day? 
c. How often would you say you use your phone to access health-related material? 
d. How comfortable would you be with receiving personalized diabetes-related information, 
such as details of your medication and tips on improving your condition, in a text 
message sent to your phone? 
e. If so, how often would you prefer to receive these messages? (Provide ranges of options 
from which to choose) 
3. Medication use questions 
a. What challenges, if any, do you face in taking your diabetes medications as directed by 
your physician and/or pharmacist? 
b. What have you done to help you take your medication more regularly? 
c. How clearly did your physician and/or pharmacist describe the treatment you are on, in 
terms of how to take it and what to expect? 
d. Is there anything that you wish your physician and/or pharmacist would have told you 
about your diabetes or treatment at your last visit that would have been helpful? 
4. Wrap-up 
a. Is there anything else about taking your diabetes medications that you would like to 
mention? 
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APPENDIX E 
 
E. Post-Intervention Interview Guide 
1. Did you enjoy receiving messages on your phone specific to your condition and treatment? 
a. Yes: What specifically did you enjoy? 
b. No: Why were these messages not enjoyable to receive? 
i. Potential follow-up: Was this due to the content of the message? 
ii. Potential follow-up: Was this because it was received on your phone? 
2. Did you find the information in these messages helpful in your ongoing treatment? 
a. Yes: What did you find most helpful? 
b. No: Why do you feel these messages were not helpful? 
3. You received several types of messages over the course of these 3 months. Could you describe 
the ones that you found to be the most helpful, interesting, or educational? 
4. Similarly, could you also describe the types of messages you found to be the most distracting, 
unhelpful, or bothersome? 
5. If you were to continue to receive messages on your phone about your treatment and/or condition, 
what topics or material should these messages focus on? 
6. You received one message each day for 90 days. Was this too much, too little, or about right? 
a. Potential follow-up: How often and how many messages would you prefer to receive? 
7. Was it convenient for you to receive these messages on your phone? 
a. Yes: Is this your preferred method of receiving health-related information? 
b. No: How else would you prefer to receive health-related information? (Suggested 
sources: online, e-mail, mail.) 
8. The messages you received were created specifically for you, meaning they were tailored to your 
treatment and current condition. Did this make you more or less likely to read, consider, and act 
on each message? 
9. After receiving these messages for 90 days, do you feel more confident about managing your 
diabetes than you did before the study began? 
10. When you received these messages did it make you more or less likely to take your prescribed 
medication for the day?  
a. Yes: What made you more likely to do so? 
b. No: What aspect of the messages made you less likely to do so? 
11. In the future, how could we make a message-based system, similar to this one, more effective in 
terms of providing individual information and support? (Suggested topics: types of messages, 
interaction, timing.) 
12. In the future, would you consider receiving tailored messages on your phone throughout the 
course of your treatment, similar to what you have for the past 3 months? 
13. After receiving health-related information on your phone for 90 days, how likely are you to use 
your mobile phone for other health-related activities, such as tracking your condition, interacting 
with a healthcare provider, or looking up information? 
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APPENDIX F 
 
F. Focus Group Demographic Survey 
 
Participant Information 
 
Age:___________    Gender:_________________ 
 
Race: Caucasian__________  Asian__________ Native American__________ 
  African American__________ Hispanic__________ Other__________ 
 
Diagnosis: Type 1 Diabetes (insulin-dependent)__________ 
  Type 2 Diabetes__________ 
 
Years since being diagnosed with diabetes: Less than 1 year_________ 1-3 years__________ 
      3-5 years__________  5-10 years__________ 
      More than 10 years__________ 
 
Number of diabetes medications you currently take: 1__________  2__________ 
       3__________  4__________ 
       5 or more__________ 
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APPENDIX G 
 
G. Focus Group Guide 
 Introduction 
o Study overview 
o Focus group logistics and format 
 Icebreaker question 
o What feature of your cell phone do you like the most? 
 Mobile phone use questions 
o Could you please describe how you use your mobile phone on a daily basis in terms of 
talking, texting, app use, and/or browsing? 
o How many text messages would you estimate you send and receive on a typical day? 
o How often would you say you use your phone to access health-related material? 
o How comfortable would you be with receiving personalized diabetes-related information, 
such as details of your medication and tips on improving your condition, in a text 
message sent to your phone? 
o If so, how often would you prefer to receive these messages? (Provide ranges of options 
from which to choose) 
 Medication use questions 
o What challenges, if any, do you face in taking your diabetes medications as directed by 
your physician and/or pharmacist? 
o What have you done to help you take your medication more regularly? 
o How clearly did your physician and/or pharmacist describe the treatment you are on, in 
terms of how to take it and what to expect? 
o Is there anything that you wish your physician and/or pharmacist would have told you 
about your diabetes or treatment at your last visit that would have been helpful? 
 Wrap-up 
o Is there anything else about taking your diabetes medications that you would like to 
mention? 
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APPENDIX H 
 
H. Theory-Driven Message Library 
Concept Level Message Stem 
Perceived 
Severity 
High sounds like you are making progress with controlling your diabetes. 
Keep up the good work  
great to know your diabetes is well controlled. You must have a good 
plan so stick with it and keep it controlled  
even if your diabetes is controlled be sure to keep taking your INSERT 
MEDS as directed so you can keep making progress  
knowing that diabetes takes work goes a long way to improving your 
health. Every step matters, even at AGE, keep it up  
recognizing that you have to work to control your diabetes is a 
winning attitude. Keep making strides every day  
INSERT MEDS are powerful ways to help treat your diabetes, taking 
them as directed is a big step you're taking every day  
seems like you know how helpful your medications can be in helping 
avoid complications with diabetes. Eating well and exercising help 
them do more  
your medications certainly go a long way to preventing complications 
at AGE but be sure to eat well and exercise to further improve your 
diabetes  
your INSERT MEDS are doing their part to help you avoid 
complications. Be sure to also eat well and exercise to help them do 
more  
it seems like you know how serious diabetes can be even when you're 
AGE. Following the plan your doctor and you agreed upon is key to 
your health  
you know how serious diabetes can be. Taking your medications as 
directed will help you control this condition and improve your health  
even though uncontrolled diabetes can lead to serious problems, taking 
INSERT MEDS as directed will help you stay healthy and avoid issues  
Low even if your diabetes isn't controlled today, taking your medications, 
exercising, and eating right will help you reach your goal  
controlling diabetes can be tough but your doctor has given you a great 
plan. Stick to it and you will see results  
taking INSERT MEDS is one of the easiest ways to control your 
diabetes. Be sure to keep taking them as directed by your doctor  
having diabetes can be challenging but a lot of it is in your control. 
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Even small efforts each day, even when you're only AGE, can be 
helpful  
every day matters when trying to control diabetes. Even a small step 
can have a big impact. Make today count  
it may not seem like much but taking your INSERT MEDS does a lot 
to improve your diabetes. Every dose makes a big difference  
diabetes can lead to many complications but taking the medications 
your doctor suggests can help you avoid additional problems at AGE  
not taking your diabetes medications as directed by your doctor can 
double your risk of ending up in the hospital  
taking your INSERT MEDS is a simple way to avoid diabetes 
complications, both at age and in the future. Be sure to take them as 
directed  
diabetes requires careful attention in order to avoid future problems. 
Controlling it now, at AGE, can lead to better tomorrows  
it may not seem like a big deal now but problems due to diabetes can 
develop over time. Work on controlling your diabetes now to avoid 
future issues  
INSERT MEDS have been prescribed for you to help avoid long-term 
serious issues. Taking them is key to controlling your diabetes  
Perceived 
Susceptibility 
High recognizing that there is more to treating your diabetes than just 
feeling ok is a great way to approach your health. Keep it up  
you know that diabetes can be an issue even at AGE. Even if you are 
feeling well, be sure to keep checking your blood sugar and seeing 
your doctor  
you know that diabetes can cause problems even if you feel ok. Taking 
your INSERT MEDS is key to staying healthy and feeling well  
it's true that diabetes can lead to complications but you have the tools 
and ability to manage your treatment and stay healthy  
you're right, having diabetes can lead to poorer health, but it is up to 
you to do things every day to stay healthy, like taking your meds  
taking your INSERT MEDS as directed will go a long way to 
improving your health, today, at AGE, and every day in the future  
having diabetes may mean you'll be sick a lot, but remember it is up to 
you to manage your treatment every day to avoid this  
with diabetes, how you feel each day is up to you. Do something today 
to help avoid feeling sick later, like taking your meds and eating well  
one of the best ways to make sure you don't feel sick due to diabetes is 
to take your INSERT MEDS as directed. Keep it up  
even at AGE recognizing that diabetes needs to be treated for a 
lifetime is important. It may be tough but every day matters, so make 
today count  
sounds like you know you need to take your diabetes medications for a 
long time. That may sound tough, but you can do it and you'll see 
results, too  
you may need to take INSERT MEDS for a lifetime but doing so will 
lead to better health today, at AGE, tomorrow, and years to come  
Low even when you start to feel better, be sure to stick with the diabetes 
plan your doctor and you agreed upon. It'll pay off in the long-run  
even if you feel alright at AGE, diabetes can be difficult. Taking your 
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medications is a great way to treat your condition and feel better  
taking your INSERT MEDS may be helping you feel better but be 
certain to stick to your entire treatment plan to avoid problems  
it's tough to realize but diabetes can have bad effects on your future 
health, like vision problems. Taking your meds helps you avoid them  
at AGE it may be tough to see how diabetes can lead to more issues 
but taking your medications, eating right, and exercising can do a lot 
to help  
one of the best ways to make sure your diabetes doesn't affect your 
future health: take your INSERT MEDS as directed  
it may be hard to see, but uncontrolled diabetes, even when you're only 
AGE, can make you feel sick. Following your treatment will help  
even if you feel well now, diabetes can make you feel sick in the 
future if you don't work at controlling it. Taking your meds can help  
you may not realize it but diabetes can make you feel sick but your 
INSERT MEDS were prescribed to help. So take them as directed  
treating diabetes takes time, even at AGE, but every day matters. 
Make today count by taking your medications as directed and keep it 
going tomorrow  
today, tomorrow, and beyond, every dose matters. So, be sure to take 
your medications as directed so you can be in control of your diabetes  
every dose matters when treating diabetes. So, take your INSERT 
MEDS according to the plan your doctor and you discussed  
Perceived 
Benefits 
High thinking you have the tools and ability to control your diabetes is a 
great attitude that will help you see results. Keep it up  
believing in your ability to control your diabetes will go a long way in 
improving your health. Turn that attitude into action every day  
as you know, your medications are designed to help control your 
diabetes, and taking them as directed is the only way to know that  
believing in the power of your medications is great, taking them as 
directed will show you how much you can control your condition  
it's great that your medicine makes you feel better today. Keep taking 
them as directed and this will be just the start of even better health to 
come  
your medicine should help you feel better. Happy to hear that that they 
do. Keep taking them and it can lead to even better health  
Low there is a lot you can do to get control of your diabetes. It starts with a 
healthy diet and exercising regularly  
controlling your diabetes is within reach. Your doctor and you have 
devised a great plan but it is up to you to follow it. You can do it  
your medications can go a long way in controlling your diabetes. The 
plan your doctor outlined is tailored to meet your needs and improve 
your health  
you may not feel the effects but your medications are working hard to 
improve how your body controls your diabetes. Keep taking them, 
results will come  
even though you may not feel it, your diabetes medications are 
working hard to help improve your health. Keep taking them and 
you'll see results  
your diabetes medications may not make you feel much better today 
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but your body is thankful. It runs much better when you take them  
Perceived 
Barriers 
High way to go. You're proof that taking your diabetes medications can be 
an easy habit to adopt and follow. Keep it up  
sounds like you have found a way to add taking your diabetes 
medications to your everyday rituals. It's a habit worth keeping  
you've made taking your INSERT MEDS a regular ritual. Make taking 
them, eating well, and exercising habits you can't break  
sounds like you have found a way to closely follow your treatment 
plan.  Keep up the good work and keep taking your medications  
we know following your treatment plan isn't always easy, but you 
seem to be handling it well. Way to go, keep it up  
seems like you are having no problem taking your INSERT MEDS. Be 
proud of being able to make them a part of your everyday life  
sounds like your doctor gave you great direction on your diabetes 
medications. Be sure to put that plan in action every day  
understanding how to follow your treatment is a key step toward 
improving your health but it is up to you to execute your plan every 
day  
sounds like your doctor or pharmacist made it easy to understand how 
to take your INSERT MEDS. Turn that understanding into action each 
day  
sounds like you have found a way to make taking your diabetes 
medications a regular routine. Way to be committed to your treatment  
seems like taking your diabetes medications has been easy to fit into 
your schedule. Don't forget about that even when you travel  
nice job fitting your INSERT MEDS into your daily activities. Doing 
that every day will bring you closer to better health  
Low taking your diabetes medications as directed doesn't have to change 
your life that much. Just make taking them one of your habits  
we all have habits and some of them are tough to break. Try to make 
taking your diabetes medications one of those rituals you can't shake  
taking your INSERT MEDS can be your newest habit. Start with 
making them a part of today and you'll see how easily it can be done  
taking medications regularly isn't always easy. Take a few minutes 
today and think about how you can easily follow your diabetes 
treatment plan  
adding medications to your daily life can be hard. But it doesn't have 
to be. If you are having trouble, give your doctor or pharmacist a call 
sounds like you may be having trouble taking your INSERT MEDS. It 
may be time to talk to your doctor about how to make this easier  
knowing how to take your medications is important. Sounds like you 
may need to have a chat with your doctor or pharmacist to know 
exactly what to do 
not knowing enough about your medications can be tough. Talk with 
your doctor or pharmacist to get a better understanding  
understanding how to take you INSERT MEDS is vital to your 
treatment. Talk with your doctor or pharmacist, they can help  
taking your diabetes medications doesn't have to be a burden. Think 
about today and how you can find a minute or two to easily take them  
your normal activities don't have to be affected by your treatment. Pair 
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a daily activity with taking your medications to easily fit them in  
think about today and how you can most easily fit in taking your 
INSERT MEDS. Then try and make it a daily routine  
Perceived 
Competency 
High you should be confident, you can take care of your diabetes. It starts 
with taking your medications as directed and includes eating well each 
day  
keep that confidence going strong. You can definitely take care of 
your diabetes. Following your treatment plan as directed is strong 
proof 
being confident is one thing but showing you can take care of your 
diabetes by taking your INSERT MEDS is even better  
thinking you can handle your diabetes is a great attitude. Turn that into 
action every day and stick to your treatment plan to see results  
you're right, you can handle your diabetes. But remember there's more 
to it than just believing, you have to take action, too  
believing you can handle your diabetes and taking your INSERT 
MEDS is a powerful combination. Keep it up, and remember to eat 
well, too  
managing your routine care is tough, but you found a way. Way to go. 
Just be sure that includes taking your diabetes medications as directed  
being able to handle your routine diabetes care is essential to 
improving your health. Never forget: that includes your medications, 
too  
being able to handle your routine diabetes care puts you closer to 
improved health. Taking your INSERT MEDS will help even more  
thinking you can meet the challenges of your diabetes head on is a 
powerful attitude. Stay strong and keep up with your treatment  
sounds like you are meeting the challenge of controlling your diabetes. 
Prove it by taking your medications and eating well every day  
remember that controlling your diabetes includes eating well, 
exercising, and taking your INSERT MEDS as directed every day  
Medium building confidence in being able to take care of your diabetes takes 
time. But you make progress every day by following your treatment 
plan  
taking your INSERT MEDS may not seem like much but it should 
give you confidence in being able to take care of your diabetes  
you should be confident, you can take care of your diabetes. It starts 
with taking your medications as directed and includes eating well each 
day  
you're on the way to being able to better handle your diabetes. You 
may not be there yet, but every day you follow your treatment, you get 
closer  
you may still be a bit unsure about being able to handle your diabetes, 
but taking your INSERT MEDS is proof that you can  
thinking you can handle your diabetes is a great attitude. Turn that into 
action every day and stick to your treatment plan to see results  
it can take time to figure out your own diabetes care, but each day you 
take your medications you are making progress. Keep it up  
each day you take your INSERT MEDS you make progress in 
managing your own care, controlling your diabetes, and improving 
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your health  
managing your routine care is tough, but you found a way. Way to go. 
Just be sure that includes taking your diabetes medications as directed  
meeting the challenges of controlling your diabetes takes time, but 
taking your medications as directed moves you closer every day  
one of the ways to make controlling your diabetes easier is by taking 
your INSERT MEDS as directed. It goes a long way  
thinking you can meet the challenges of your diabetes head on is a 
powerful attitude. Stay strong and keep up with your treatment  
Low you may not believe it yet, but you can take care of your diabetes. One 
of the things you can do every day to prove it: take your medications  
gaining confidence in your ability to take care of your diabetes starts 
with taking your INSERT MEDS as directed. You can do it  
building confidence in being able to take care of your diabetes takes 
time. But you make progress every day by following your treatment 
plan  
handling your diabetes doesn't always happen overnight. Hang in there 
and follow your plan, you'll be able to handle it better soon  
taking your INSERT MEDS will go a long way in helping you handle 
your diabetes even if it seems tough right now  
you're on the way to being able to better handle your diabetes. You 
may not be there yet, but every day you follow your treatment, you get 
closer  
taking care of your diabetes can be tough, but you can do it. Talk to 
your doctor about educational resources that may help you learn what 
to do  
not everything about diabetes is easy but taking your INSERT MEDS 
as directed is a good first step in managing your care  
it can take time to figure out your own diabetes care, but each day you 
take your medications you are making progress. Keep it up  
controlling diabetes can be challenging but there's a lot in your control, 
like following your medication schedule and eating well  
controlling your diabetes is a challenge but your INSERT MEDS are 
powerful and can help you meet your goals  
meeting the challenges of controlling your diabetes takes time, but 
taking your medications as directed moves you closer every day  
Autonomous 
Motivation 
High you're right. Your diabetes medications are important to improving 
your health. Taking them every day is key to being as health as 
possible  
sounds like you have realized the importance of your medications. 
Keep taking them and even better health will be in your future  
you know the importance of your INSERT MEDS in reaching better 
health. But remember: they only work if you take them as directed 
believing in the power of your medications is a winning attitude when 
you have diabetes. Turn that attitude into action and take them every 
day  
you're right. Taking your diabetes medications is one of the best things 
for your health. So, keep taking them as directed to reach even better 
health  
seems like you know that taking your INSERT MEDS is one of the 
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best things for your health. Show that every day by taking them  
wanting to take responsibility for your own health at AGE is a great 
attitude. Put that to work by following your treatment plan  
taking responsibility for your own health will go a long way in helping 
you improve your condition. Keep that attitude going strong every day  
taking your INSERT MEDS as directed is a great way to show that 
you are taking responsibility for your own health. Show that every day  
you're right, taking your medications is important to a lot of things in 
your life. Be sure to turn that belief into action every day  
knowing that taking your medications can affect your life is important 
and that will go a long way to helping you reach better health  
seems you know that taking INSERT MEDS is important for a lot of 
things in life, things you can better focus on with your diabetes under 
control  
Medium sounds like you are starting to see how important your medications can 
be to your health. Stick with your plan and it will become more clear  
one of the best ways to see the importance of your INSERT MEDS is 
to take them as directed. Then, you can see results in your health  
you're right. Your diabetes medications are important to improving 
your health. Taking them every day is key to being as health as 
possible  
many things are important for your health when you have diabetes. 
Taking your medications as directed is one of them. See for yourself  
every day you take your INSERT MEDS you get closer to better 
health, better control, and to seeing why taking them is so important  
believing in the power of your medications is a winning attitude when 
you have diabetes. Turn that attitude into action and take them every 
day  
taking responsibility for your health takes time but you can do it. Part 
of that is taking your medications as directed, so start there  
the plan your doctor and you outlined, including taking your INSERT 
MEDS, is one way to start taking responsibility for your health  
wanting to take responsibility for your own health at AGE is a great 
attitude. Put that to work by following your treatment plan  
it may be tough to see but feeling better from taking your medications 
can allow you to focus more on the things you love in life  
taking INSERT MEDS can lead to better health and that allow you to 
spend more time on enjoying other aspects of your life  
you're right, taking your medications is important to a lot of things in 
your life. Be sure to turn that belief into action every day  
Low it may not seem like much, but taking your medications goes a long 
way in you being as healthy as possible, even when you're only AGE   
it may be hard to realize their effect but your INSERT MEDS play an 
important role. Take them today for better health tomorrow  
sounds like you are starting to see how important your medications can 
be to your health. Stick with your plan and it will become more clear  
it may be tough to see but taking your diabetes medications is vital to 
your health. Taking them as directed may help you see their value  
your INSERT MEDS is/are a crucial part of reaching good health. 
Taking them will lead to results you can feel and see and then believe 
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in  
many things are important for your health when you have diabetes. 
Taking your medications as directed is one of them. See for yourself  
it may seem hard to have to take responsibility for your health, 
especially at AGE, but tools are out there to help you, like your 
diabetes medications  
it can be hard to be in charge of your health. Take small steps. Start 
with taking your INSERT MEDS. The rest of your care, take one day 
at a time  
taking responsibility for your health takes time but you can do it. Part 
of that is taking your medications as directed, so start there 
your diabetes medications can have many benefits, some you may not 
even think of, but the only way to find our is by taking them as 
directed  
even though they are designed to help control your diabetes, taking 
your INSERT MEDS can improve many aspects of your life  
it may be tough to see but feeling better from taking your medications 
can allow you to focus more on the things you love in life  
External 
Regulation 
High being able to handle your treatment without pressure must be helpful, 
that way you can focus on taking your medications because you 
believe in them  
without pressure from others you are in complete control of your 
treatment. Take that responsibility seriously, every day, and every 
dose  
without pressure from others, taking your INSERT MEDS is solely 
your responsibility. Control your treatment plan every day  
seems the only one that would be upset if you didn't take your 
medications is you. So keep taking them to avoid upsetting your health  
sounds like the only person to satisfy by taking your medications is 
you. Your health will feel satisfied, too. Keep it up  
taking your INSERT MEDS will help avoid stress among others who 
might be upset if you miss your meds  
you're right. You are the only person that needs to know you can stick 
to taking your diabetes medications every day. Keep it up  
sounds like you get it. You only need to prove to yourself that you can 
take your diabetes medications as directed. Great attitude  
stay focused on proving to you and only you that you can take your 
INSERT MEDS. Your opinion is the only one that matters  
you definitely have a great attitude, the only approval you need is the 
feeling of good health by meeting the goals of your treatment. Keep it 
up  
you're right, the only approval you need is your own and that of the 
benefit of the good health you'll see from sticking to your treatment 
plan  
sounds like you are focused on your health for your own approval. 
Good thinking. Taking your INSERT MEDS will help keep you on 
track  
Medium feeling pressure from others about your diabetes can be distracting. 
Just try to focus on taking your medications for your own benefit and 
health  
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just remember that taking your INSERT MEDS is in your hands, focus 
on the benefit to you, not the pressure from others  
being able to handle your treatment without pressure must be helpful, 
that way you can focus on taking your medications because you 
believe in them  
upsetting someone even a little is never fun but not taking your 
medications will upset your body even more. Stick to your plan for 
your health  
missing your INSERT MEDS is not supposed to upset others. Focus 
on yourself, take your meds, and satisfy your health needs  
seems the only one that would be upset if you didn't take your 
medications is you. So keep taking them to avoid upsetting your health  
 
it may be tempting to want to show others that you can take your 
diabetes medications but remember you only need to prove it to 
yourself 
wanting to show others you can take your INSERT MEDS may be 
tempting but stick to proving that to yourself, because that's what 
matters  
you're right. You are the only person that needs to know you can stick 
to taking your diabetes medications every day. Keep it up 
by focusing on your treatment plan you are gaining the only approval 
you need: that of your body. Your medications are designed to help 
with this 
the benefit of taking your INSERT MEDS will lead you to better 
health, better control, and the only approval you need: your body's  
you definitely have a great attitude, the only approval you need is the 
feeling of good health by meeting the goals of your treatment. Keep it 
up  
Low it can be tough to focus on your own care when others are pressuring 
you. Take control of your own care and they'll realize you don't need 
the pressure  
sounds like you may be feeling pressure to take your INSERT MEDS. 
Stick to your plan today and others will see you can handle it  
feeling pressure from others about your diabetes can be distracting. 
Just try to focus on taking your medications for your own benefit and 
health  
it's understandable that you wouldn't want to upset others. More 
importantly, by taking your medications you satisfy your own needs  
others may be upset if you don't take your INSERT MEDS but your 
health will suffer even more. Do it for your own good  
upsetting someone even a little is never fun but not taking your 
medications will upset your body even more. Stick to your plan for 
your health  
showing others you can handle your treatment might be helpful but 
remember you only need to prove to yourself that you can do it  
you may want to show others you can take your INSERT MEDS but 
you only need to prove it to yourself. Prove it today  
it may be tempting to want to show others that you can take your 
diabetes medications but remember you only need to prove it to 
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yourself  
when it comes to health the only approval you need is that of your 
body when it gets the benefit it needs from medications to treat your 
diabetes  
for your diabetes, nothing compares to the approval it will give you 
when you see the benefits from taking your INSERT MEDS as 
directed  
by focusing on your treatment plan you are gaining the only approval 
you need: that of your body. Your medications are designed to help 
with this 
Notes: 
AGE: indicates placement of subject age into the message 
INSERT MEDS: indicates replacement of subject’s medications into the message 
A rotating greeting and the subject’s name were placed before each message stem used 
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